Nasal interface and respiratory therapy system

By designing the first and second nasal delivery elements in the nasal interface in the fluid communication with the gas manifold, and using the bypass restriction to generate pressure difference, the delivery of asymmetric gas flow is solved in the prior art upper airway cleaning. The problems of inadequacy and high noise improve patient comfort.

CN222092283UActive Publication Date: 2024-12-03FISHER & PAYKEL HEALTHCARE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202322548034.1
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Priority Date
2022-09-28
Filing Date
2022-10-21
Publication Date
2024-12-03
Estimated Expiration
2032-10-21

AI Technical Summary

Technical Problem

The existing nasal interfaces are difficult to effectively achieve asymmetric flow when delivering breathing gas, resulting in insufficient cleaning of the dead cavity of the upper airway and high noise.

Method used

A nasal interface is designed, including first and second nasal delivery elements, in fluid communication with the gas inlet through a gas manifold, and a pressure difference is generated in the nasal interface through a bypass restriction member, so that the pressure of the first nasal delivery element is high In the second nasal delivery element, the delivery of asymmetric gas flow is achieved.

Benefits of technology

Through the design of asymmetric flow, the dead cavity cleaning effect of the upper airway is improved, noise is reduced, and patient comfort is improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222092283U_ABST
    Figure CN222092283U_ABST
Patent Text Reader

Abstract

The utility model relates to a nasal interface and a respiratory therapy system. A nasal interface has first and second nasal delivery elements each configured to seal a respective nostril of a patient, and a gas manifold including a gas inlet for delivering breathing gas to the gas manifold. The first and second nasal delivery elements are in fluid communication with the gas inlet via the gas manifold, the first nasal delivery element proximate the gas inlet and the second nasal delivery element remote from the gas inlet. The nasal interface includes a bypass restriction for providing a pressure drop through the nasal interface between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to the first nasal delivery element and the second nasal delivery element such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of utility model patent application 202222808470.3, filed on October 21, 2022, and entitled “PATIENT INTERFACE”. Technical Field

[0002] The present disclosure generally relates to a patient interface for delivering breathing gases to the airway of a patient. Background Art

[0003] A humidifier is used to provide humidified breathing gases to the patient. The gases are delivered to the patient via a patient interface. Examples of patient interfaces include a mouth mask, a nasal mask, a nasal cannula, a combination of a mouth mask and a nasal mask, and the like.

[0004] A patient interface including a nasal interface can be used to deliver a gas flow to a patient. A nasal delivery element is inserted into the patient's nose to deliver the desired therapy. The nasal delivery element may need to be sealed or semi-sealed at the nose, or may not need to be sealed at the nose to deliver therapy. Utility Model Content

[0005] A respiratory interface and respiratory therapy system are disclosed that can use nasal flow, such as through a nasal delivery element in a nasal interface, to deliver respiratory gas to a patient via an asymmetric flow. The asymmetric flow can provide enhanced dead space clearance to the patient's upper airway. Noise can be reduced due to reduced peak expiratory pressure.

[0006] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0007] a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient;

[0008] and a gas manifold comprising a gas inlet for delivering breathing gas to the gas manifold,

[0009] wherein the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet via a gas manifold, wherein the first nasal delivery element is proximate to the gas inlet and the second nasal delivery element is distal to the gas inlet;

[0010] wherein the nasal interface includes a bypass restriction for providing a pressure drop across the nasal interface between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to the first nasal delivery element and the second nasal delivery element, such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element;

[0011] and a bias flow restriction for allowing gas to flow out of the nasal interface.

[0012] In some configurations, the pressure drop across the gas manifold is such that when there is gas flow from the gas inlet to the first nasal delivery element and the second nasal delivery element, the gas flow from the gas inlet to the first nasal delivery element is greater than the gas flow from the gas inlet to the second nasal delivery element.

[0013] In some configurations, the nasal interface includes a gas flow channel in the gas manifold, wherein the bypass restriction provides a reduced cross-sectional area of ​​a portion of the gas flow channel.

[0014] In some configurations, the portion of the gas flow passage is between the first nasal delivery element and the second nasal delivery element, and / or adjacent to the second nasal delivery element.

[0015] In some configurations, the bypass restriction includes at least one protrusion extending into the gas flow passage, optionally wherein the bypass restriction includes a plurality of protrusions extending into the gas flow passage.

[0016] In some configurations, the gas manifold includes a proximal bypass protrusion proximal to the nasal delivery elements, and / or a distal bypass protrusion distal to the nasal delivery elements.

[0017] In some configurations, the gas manifold includes both a proximal bypass protrusion and a distal bypass protrusion that, in combination, define a predetermined bypass size to enable restricted gas flow through the gas manifold between the first nasal delivery element and the second nasal delivery element.

[0018] In some configurations, the bypass restriction includes an angled leading edge and an angled trailing edge that define a converging and diverging bypass restriction in the direction of gas flow from the first nasal delivery element through the gas manifold to the second nasal delivery element.

[0019] In some configurations, the bias flow restriction comprises at least one aperture for allowing gas to flow from the nasal interface to the surrounding environment, optionally wherein the bias flow restriction comprises a plurality of apertures for allowing gas to flow from the nasal interface to the surrounding environment.

[0020] In some configurations, the bias flow restriction includes a filter or diffuser to filter or diffuse the gas flowing through the hole(s).

[0021] In some configurations, the nasal interface includes a filter unit between the gas manifold and the bias flow restriction.

[0022] In some configurations, the bias flow restriction is in fluid communication with the gas manifold, optionally wherein the gas manifold includes the bias flow restriction or is coupled to the bias flow restriction, optionally wherein the bias flow restriction is in fluid communication with the gas manifold but is positioned remotely from the gas manifold.

[0023] In some configurations, the gas inlet is in fluid communication with the breathing conduit.

[0024] In some configurations, the inner diameter of the breathing conduit is between about 12 mm and about 23 mm, optionally greater than about 12 mm and at most about 23 mm, optionally greater than 12 mm and at most about 22 mm, optionally greater than about 12 mm and at most about 21 mm, optionally greater than about 12 mm and at most about 20 mm, optionally greater than about 12 mm and at most about 19 mm, optionally greater than about 12 mm and at most about 18 mm, optionally between about 13 mm and about 17 mm, optionally between about 14 mm and about 16 mm, optionally about 12 mm, optionally about 13 mm, optionally about 14 mm, optionally about 15 mm, optionally about 16 mm, optionally about 17 mm, optionally about 18 mm, optionally about 19 mm, optionally about 20 mm, optionally about 21 mm, optionally about 22 mm, optionally about 23 mm, or optionally any value between any two of these values.

[0025] In some configurations, the gas manifold includes a sealing flange or collar for engaging the first and second nasal delivery elements.

[0026] In some configurations, the bypass restriction includes an insert for attachment to the gas manifold.

[0027] In some configurations, the first and second nasal delivery elements are attached to or integral with a base portion of the interface body.

[0028] In some configurations, the base portion is arranged to be located between the patient's face and the gas manifold in use.

[0029] In some configurations, the interface body includes two side arms extending laterally from respective sides of the base portion.

[0030] In some configurations, the nasal interface includes a headgear having ends of side arms connected to the interface body.

[0031] In some configurations, the bypass restriction provides a cross-sectional area of ​​a portion of the gas flow channel, and the cross-sectional area of ​​this portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0032] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0033] a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient;

[0034] and a gas manifold comprising a gas inlet for delivering breathing gas to the gas manifold,

[0035] wherein the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet via a gas manifold, wherein the first nasal delivery element is proximate to the gas inlet and the second nasal delivery element is distal to the gas inlet;

[0036] wherein the nasal interface is configured to create a pressure difference between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0037] In some configurations, the pressure differential is such that when gas flows from the gas inlet to the first nasal delivery element and the second nasal delivery element, the gas flow from the gas inlet to the first nasal delivery element is greater than the gas flow from the gas inlet to the second nasal delivery element.

[0038] In some configurations, the gas inlet is in fluid communication with the breathing conduit.

[0039] In some configurations, the inner diameter of the breathing conduit is between about 12 mm and about 23 mm, optionally between about 12 mm and about 22 mm, optionally between about 12 mm and about 21 mm, optionally between about 12 mm and about 20 mm, optionally between about 12 mm and about 19 mm, optionally between about 12 mm and about 18 mm, optionally between about 13 mm and about 17 mm, optionally between about 14 mm and about 16 mm, optionally about 12 mm, optionally about 13 mm, optionally about 14 mm, optionally about 15 mm, optionally about 16 mm, optionally about 17 mm, optionally about 18 mm, optionally about 19 mm, optionally about 20 mm, optionally about 21 mm, optionally about 22 mm, optionally about 23 mm, or optionally any value between any two of these values.

[0040] In some configurations, when gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, the gas flow pressure at the second nasal delivery element is at most about 1 cmH2O less than the gas flow pressure at the first nasal delivery element.

[0041] In some configurations, the nasal interface is configured such that the gas flow pressure differential between the first nasal delivery element and the second nasal delivery element is higher during the inhalation phase than during the exhalation phase.

[0042] In some configurations, the nasal interface is configured such that during both the inhalation phase and the exhalation phase, the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0043] In some configurations, the nasal interface is configured to achieve a patient pressure at the first and second nasal delivery elements of between about 2 cmH2O to about 30 cmH2O in use, optionally between about 2 cmH2O to about 25 cmH2O in use, optionally between about 2 cmH2O to about 20 cmH2O in use, optionally between about 2 cmH2O to about 15 cmH2O in use, optionally between about 2 cmH2O to about 14 cmH2O in use, optionally between about 2 cmH2O to about 13 cmH2O in use, optionally between about 2 cmH2O to about 12 cmH2O in use, optionally between about 2 cmH2O to about 11 cmH2O in use, optionally between about 2 cmH2O to about 10 cmH2O in use.

[0044] In some configurations, the pressure differential between the first and second nasal delivery elements is configured to provide an asymmetric flow of at least about 1 liter per minute (lpm), optionally between about 1 lpm and about 5 lpm, through the upper airway of the patient.

[0045] In some configurations, asymmetric flow facilitates removal of CO2 from the patient's anatomical dead space.

[0046] In some configurations, the nasal interface includes a bypass restriction that provides a cross-sectional area of ​​a portion of the gas flow channel that is greater than 0 to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0047] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0048] an interface body portion comprising a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal against a respective nostril of the patient;

[0049] and a gas manifold portion including a gas inlet for delivering breathing gas to the gas manifold portion,

[0050] wherein the interface body portion is engageable with the gas manifold portion so that the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet, such that the first nasal delivery element is proximal to the gas inlet and the second nasal delivery element is distal to the gas inlet, and

[0051] wherein the nasal interface includes at least one gas flow restriction for gas flowing through the nasal interface such that when gas is delivered from the gas inlet to the first nasal delivery element and the second nasal delivery element, the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0052] In some configurations, the at least one gas flow restriction includes a bypass restriction for providing a pressure drop across the gas manifold portion between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to the first nasal delivery element and the second nasal delivery element, such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0053] In some configurations, the bypass restriction provides a cross-sectional area of ​​a portion of the gas flow channel, and the cross-sectional area of ​​this portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0054] In some configurations, the nasal interface includes a gas flow channel in the gas manifold portion, wherein the bypass restriction provides a reduced cross-sectional area of ​​a portion of the gas flow channel.

[0055] In some configurations, the portion of the gas flow passage is between the first nasal delivery element and the second nasal delivery element, and / or adjacent to the second nasal delivery element.

[0056] In some configurations, the bypass restriction includes at least one protrusion extending into the gas flow passage, optionally wherein the bypass restriction includes a plurality of protrusions extending into the gas flow passage.

[0057] In some configurations, the gas manifold portion includes a proximal bypass protrusion proximal to the nasal delivery elements, and / or a distal bypass protrusion distal to the nasal delivery elements.

[0058] In some configurations, the gas manifold portion includes both a proximal bypass protrusion and a distal bypass protrusion that, in combination, define a predetermined bypass size to enable restricted gas flow through the gas manifold between the first nasal delivery element and the second nasal delivery element.

[0059] In some configurations, the bypass restriction includes an angled leading edge and an angled trailing edge that define a converging and diverging bypass restriction in the direction of gas flow from the first nasal delivery element through the gas manifold to the second nasal delivery element.

[0060] In some configurations, the bypass restriction includes an insert for attachment to the gas manifold portion.

[0061] In some configurations, the nasal interface further comprises a bias flow restriction for allowing gas to flow out of the nasal interface.

[0062] In some configurations, the bias flow restriction comprises at least one aperture for allowing gas to flow from the nasal interface to the surrounding environment, optionally wherein the bias flow restriction comprises a plurality of apertures for allowing gas to flow from the nasal interface to the surrounding environment.

[0063] In some configurations, the bias flow restriction includes a filter or diffuser to filter or diffuse the gas flowing through the hole(s).

[0064] In some configurations, the nasal interface includes a filter unit between the gas manifold portion and the bias flow restriction.

[0065] In some configurations, the bias flow restriction is in fluid communication with the gas manifold portion, optionally wherein the gas manifold includes the bias flow restriction or is coupled to the bias flow restriction, optionally wherein the bias flow restriction is in fluid communication with the gas manifold portion but is positioned away from the gas manifold portion.

[0066] In some configurations, the gas inlet is in fluid communication with the breathing conduit.

[0067] In some configurations, the inner diameter of the breathing conduit is between about 12 mm and about 23 mm, optionally between about 12 mm and about 22 mm, optionally between about 12 mm and about 21 mm, optionally between about 12 mm and about 20 mm, optionally between about 12 mm and about 19 mm, optionally between about 12 mm and about 18 mm, optionally between about 13 mm and about 17 mm, optionally between about 14 mm and about 16 mm, optionally about 12 mm, optionally about 13 mm, optionally about 14 mm, optionally about 15 mm, optionally about 16 mm, optionally about 17 mm, optionally about 18 mm, optionally about 19 mm, optionally about 20 mm, optionally about 21 mm, optionally about 22 mm, optionally about 23 mm, or optionally any value between any two of these values.

[0068] In some configurations, the gas manifold portion includes a sealing flange or collar for engaging the first and second nasal delivery elements when the interface body portion is engaged with the gas manifold portion.

[0069] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0070] a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient;

[0071] and a gas manifold comprising a gas inlet for delivering breathing gas to the gas manifold, and a gas flow channel,

[0072] wherein the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet via a gas flow channel, wherein the first nasal delivery element is proximal to the gas inlet and the second nasal delivery element is distal to the gas inlet,

[0073] wherein the nasal interface includes a bypass restriction that provides a cross-sectional area of ​​a portion of the gas flow passage,

[0074] wherein each of the first nasal delivery element and the second nasal delivery element comprises an inner cross-sectional area, wherein the inner cross-sectional areas together provide a combined cross-sectional area of ​​the nasal delivery elements, and wherein the cross-sectional area of ​​the portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0075] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1.3 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 3 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 2 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 5 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 3 of the combined cross-sectional area of ​​these nasal delivery elements.

[0076] In some configurations, the inner cross-sectional area of ​​each of the first and second nasal delivery elements is at the smallest transverse dimension of the respective nasal delivery element.

[0077] In some configurations, the minimum transverse dimension is in a direction transverse to the direction of gas flow through the nasal delivery element.

[0078] In some configurations, the inner cross-sectional area of ​​each of the first and second nasal delivery elements is at the outlet of the corresponding nasal delivery element.

[0079] In some configurations, the portion of the gas flow passage is between the first nasal delivery element and the second nasal delivery element, and / or adjacent to the second nasal delivery element.

[0080] In some configurations, the bypass restriction includes at least one protrusion extending into the gas flow passage, optionally wherein the bypass restriction includes a plurality of protrusions extending into the gas flow passage.

[0081] In some configurations, the gas manifold includes a proximal bypass protrusion proximal to the nasal delivery elements, and / or a distal bypass protrusion distal to the nasal delivery elements.

[0082] In some configurations, the gas manifold includes both a proximal bypass protrusion and a distal bypass protrusion that, in combination, define a predetermined bypass size to enable restricted gas flow through the gas manifold between the first nasal delivery element and the second nasal delivery element.

[0083] In some configurations, the bypass restriction includes an angled leading edge and an angled trailing edge that define a converging and diverging bypass restriction in the direction of gas flow from the first nasal delivery element through the gas manifold to the second nasal delivery element.

[0084] In some configurations, the nasal interface includes an interface body and a gas manifold portion, wherein the interface body and the gas manifold portion together form a gas manifold.

[0085] In some configurations, the gas inlet is at a side of the gas manifold.

[0086] In some configurations, the open area for gas to flow through the bias flow restriction is about 10 mm 2 To about 30mm 2 between, optionally between about 25 mm 2 To about 30mm 2 and optionally about 27.5 mm 2 .

[0087] In some configurations, the open area for gas to flow through the bias flow restriction is greater than 0 mm 2 To about 40mm 2 , optionally at about 2 mm 2 To about 40mm 2 between, optionally between about 2 mm 2 To about 5mm 2 between, optionally between about 12 mm 2 To about 40mm 2 between, optionally between about 20 mm 2 To about 30mm 2 between.

[0088] In some configurations, the bias flow restriction is configured such that when a pressure greater than 0 cmH2O and up to about 30 cmH2O is provided to the gas inlet during use and the nasal delivery element is blocked, gas flow out of the nasal interface through the bias flow restriction is greater than 0 lpm to about 80 lpm.

[0089] In some configurations, the bias flow restriction is configured such that when a pressure between about 3 cmH2O and about 10 cmH2O is provided to the gas inlet during use and the nasal delivery element is blocked, the gas flow rate out of the nasal interface through the bias flow restriction is between about 4 lpm and about 15 lpm.

[0090] In some configurations, the bias flow restriction is configured such that when a pressure between about 4 cmH2O and about 30 cmH2O is provided to the gas inlet during use and the nasal delivery element is blocked, the gas flow rate out of the nasal interface through the bias flow restriction is between about 15 lpm and about 80 lpm.

[0091] In some configurations, the bias flow restriction comprises at least one aperture for allowing gas to flow from the nasal interface to the surrounding environment, optionally wherein the bias flow restriction comprises a plurality of apertures for allowing gas to flow from the nasal interface to the surrounding environment.

[0092] In some configurations, the bias flow restriction includes a filter or diffuser to filter or diffuse the gas flowing through the hole(s).

[0093] In some configurations, the nasal interface includes a filter unit between the gas manifold and the bias flow restriction.

[0094] In some configurations, the bias flow restriction is in fluid communication with the gas manifold, optionally wherein the gas manifold includes the bias flow restriction or is coupled to the bias flow restriction, optionally wherein the bias flow restriction is in fluid communication with the gas manifold but is positioned remotely from the gas manifold.

[0095] In some configurations, the cross-sectional area of ​​the portion of the gas flow channel is between about 10% and at most about 100% of the first cross-sectional area of ​​an adjacent portion of the gas flow channel, optionally about 10% or more and less than 100% of the first cross-sectional area, optionally at most about 90% of the first cross-sectional area, optionally at most about 80% of the first cross-sectional area, optionally at most about 70% of the first cross-sectional area, optionally at most about 60% of the first cross-sectional area, optionally at most about 55% of the first cross-sectional area, optionally at most about 40% of the first cross-sectional area, optionally at most about 30% of the first cross-sectional area, and optionally at most about 25% of the first cross-sectional area.

[0096] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 200 mm 2 , optionally up to about 160 mm 2 , optionally up to about 110 mm 2 , optionally up to about 80 mm 2 , optionally up to about 60 mm 2 , and optionally at most about 50 mm 2 .

[0097] In some configurations, the combined cross-sectional area of ​​the nasal delivery elements is greater than 0 mm 2 And at most about 250mm 2 , optionally at about 1 mm 2 To about 250mm 2 between, optionally between about 1.6 mm 2 To about 250mm 2 between, optionally between about 50 mm 2 To about 250mm 2 Between, optionally about 50mm 2About 200mm 2 between, optionally between about 30 mm 2 About 200mm 2 between, optionally between about 30 mm 2 To about 155mm 2 between, optionally between about 50 mm 2 To about 155mm 2 between, and optionally between about 70 mm 2 To about 155mm 2 between.

[0098] In some configurations, the cross-sectional area of ​​the portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements, and the combined cross-sectional area of ​​the nasal delivery elements is about 1 mm 2 To about 250mm 2 between.

[0099] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1.3 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 3 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 2 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 5 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 3 of the combined cross-sectional area of ​​these nasal delivery elements.

[0100] In some configurations, the combined cross-sectional area of ​​the nasal delivery elements is about 1.6 mm 2 To about 250mm 2 between, optionally between about 50 mm 2 To about 250mm 2 between, optionally between about 50 mm 2 About 200mm 2 between, optionally between about 30 mm 2 About 200mm 2 between, optionally between about 30 mm 2 To about 155mm 2 between, optionally between about 50 mm 2 To about 155mm 2 between, and optionally between about 70 mm 2 To about 155mm 2 between.

[0101] In some configurations, the bypass restriction provides a pressure drop across the nasal interface between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to the first nasal delivery element and the second nasal delivery element, such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0102] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0103] a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient;

[0104] and a gas manifold comprising a gas inlet for delivering breathing gas to the gas manifold, and a gas flow channel,

[0105] wherein the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet via a gas flow channel, wherein the first nasal delivery element is proximal to the gas inlet and the second nasal delivery element is distal to the gas inlet,

[0106] wherein the nasal interface includes a bypass restriction that provides a cross-sectional area of ​​a portion of the gas flow passage,

[0107] wherein each of the first nasal delivery element and the second nasal delivery element comprises an inner cross-sectional area,

[0108] And wherein the internal cross-sectional area of ​​the nasal delivery element and the cross-sectional area of ​​the portion of the gas flow passage are related so as to produce an asymmetric gas flow from the nasal delivery element during use.

[0109] In some configurations, the interior cross-sectional areas together provide a combined cross-sectional area of ​​the nasal delivery elements, and wherein the cross-sectional area of ​​the portion of the gas flow passage is greater than 0 to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0110] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1.3 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 times the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 3 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 2 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 2 / 5 of the combined cross-sectional area of ​​these nasal delivery elements, optionally at most about 1 / 3 of the combined cross-sectional area of ​​these nasal delivery elements.

[0111] In some configurations, the inner cross-sectional area of ​​each of the first and second nasal delivery elements is at the smallest transverse dimension of the respective nasal delivery element.

[0112] In some configurations, the minimum transverse dimension is in a direction transverse to the direction of gas flow through the nasal delivery element.

[0113] In some configurations, the inner cross-sectional area of ​​each of the first and second nasal delivery elements is at the outlet of the corresponding nasal delivery element.

[0114] In some configurations, the cross-sectional area of ​​this portion of the gas flow passage is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area of ​​the nasal delivery elements, and the nasal interface is configured to provide a deviation flow of 20 lpm through the deviation flow restriction when a pressure of 4 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked.

[0115] In some configurations, the cross-sectional area of ​​this portion of the gas flow passage is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area of ​​these nasal delivery elements, and the nasal interface is configured to provide a deviation flow of 32 lpm through the deviation flow restriction when a pressure of 8 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked.

[0116] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and the nasal interface is configured to provide a deviation flow of 20 lpm through the deviation flow restriction when a pressure of 4 cmH2O is provided to the gas inlet and the nasal delivery element is blocked; or is configured to provide a deviation flow of 32 lpm through the deviation flow restriction when a pressure of 8 cmH2O is provided to the gas inlet and the nasal delivery element is blocked; or is configured to provide a deviation flow of 41 lpm through the deviation flow restriction when a pressure of 12 cmH2O is applied to the gas inlet and the nasal delivery element is blocked; or is configured to provide a deviation flow of 48 lpm through the deviation flow restriction when a pressure of 16 cmH2O is applied to the gas inlet and the nasal delivery element is blocked; or is configured to provide a deviation flow of 53 lpm through the deviation flow restriction when a pressure of 20 cmH2O is applied to the gas inlet and the nasal delivery element is blocked.

[0117] In some configurations, the cross-sectional area of ​​this portion of the gas flow passage is at most about 2 / 3 times the combined cross-sectional area of ​​the nasal delivery elements, and the nasal interface is configured to provide a deviation flow of 32 lpm or greater through the deviation flow restriction when a pressure of 8 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked.

[0118] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and the nasal interface is configured to provide a deviation amount of 32 lpm or more through the deviation flow restriction when a pressure of 8 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked, or wherein the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 5 times the combined cross-sectional area of ​​these nasal delivery elements, and the nasal interface is configured to provide a deviation amount of 41 lpm or more through the deviation flow restriction when a pressure of 12 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked, or wherein the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and the nasal interface is configured to provide a deviation amount of 48 lpm or more through the deviation flow restriction when a pressure of 16 cmH2O is provided to the gas inlet and the nasal delivery elements are blocked.

[0119] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0120] an interface body configured to substantially form a seal with the nasal airway of the patient, the interface body configured to deliver gas to a first nostril of the patient and a second nostril of the patient;

[0121] and a gas inlet for delivering breathing gas to the nasal interface, wherein the gas inlet is in fluid communication with the interface body to deliver breathing gas from the gas inlet through the interface body to the first and second nostrils of the patient in use; and

[0122] The nasal interface is configured to receive incoming gas from a gas inlet and to provide from the incoming gas a first flow gas flow configured to be provided substantially to a first nostril of a patient in use and a second flow gas flow configured to be provided substantially to a second nostril of the patient in use, and is configured to direct the incoming gas more to the first flow gas flow than to the second flow gas flow to produce an asymmetric gas flow at the nasal airway of the patient throughout the patient's breathing cycle.

[0123] In some configurations, the interface body includes a first outlet or first outlet portion configured to deliver gas substantially to a first nostril of the patient, and includes a second outlet or second outlet portion configured to deliver gas substantially to a second nostril of the patient.

[0124] In some configurations, the gas inlet is at least partially aligned with the first outlet or first outlet portion and less aligned or non-aligned with the second outlet or second outlet portion.

[0125] In some configurations, the gas inlet is substantially axially aligned with the first outlet or first outlet portion.

[0126] In some configurations, at least half of the transverse cross-sectional area of ​​the gas inlet is axially aligned with at least half of the transverse cross-sectional area of ​​the first outlet or first outlet portion.

[0127] In some configurations, the gas inlet includes an outer portion, and further includes an inner portion in fluid communication with the interface body, the outer portion being adapted to connect to the breathing conduit to provide a flow of gas from the gas source to the interface body.

[0128] In some configurations, an inner portion of the gas inlet is at least partially aligned with the first outlet or the first outlet portion.

[0129] In some configurations, the gas inlet is angled toward the first outlet or first outlet portion.

[0130] In some configurations, at least one dimension of the first flow rate gas flow is greater than a corresponding dimension of the second flow rate gas flow.

[0131] In some configurations, the at least one dimension comprises a lateral dimension of a first flow rate gas flow, and wherein the corresponding dimension comprises a lateral dimension of a second flow rate gas flow.

[0132] In some configurations, the diameter, cross-sectional area, and / or volume of the first flow rate gas stream is greater than the corresponding diameter, cross-sectional area, and / or volume of the second flow rate gas stream.

[0133] In some configurations, the ratio of the cross-sectional area of ​​the first flow gas stream to the corresponding cross-sectional area of ​​the second flow gas stream is between about 2:1 and about 5:1, optionally between about 2:1 and about 4:1, optionally between about 2.5:1 and about 3.5:1, and optionally about 3:1.

[0134] In some configurations, the first outlet or first outlet portion and the second outlet or second outlet portion include substantially the same cross-sectional area.

[0135] In some configurations, the nasal interface is configured to deliver a lower flow rate of gas through the first outlet or first outlet portion than the flow rate of gas delivered through the second outlet or second outlet portion during the inhalation phase of the breathing cycle.

[0136] In some configurations, the nasal interface is configured to deliver a higher pressure flow of gas through the first outlet or first outlet portion than the pressure of the flow of gas delivered through the second outlet or second outlet portion during an inhalation phase of the breathing cycle.

[0137] In some configurations, the nasal interface includes a single outlet for delivering gas to a first nostril and a second nostril of the patient, wherein the single outlet includes a first outlet portion and a second outlet portion, and wherein the nasal interface is configured such that the first flow gas stream is configured to be delivered substantially to the first outlet portion and the second flow gas stream is configured to be delivered substantially to the second outlet portion.

[0138] In some configurations, the interface body includes a first nasal delivery element having a first outlet and a second nasal delivery element having a second outlet, wherein the nasal interface is configured such that a first flow gas stream is configured to be substantially delivered to the first nasal delivery element and a second flow gas stream is configured to be substantially delivered to the second nasal delivery element, and wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient.

[0139] In some configurations, the nasal interface includes a flow director configured to direct incoming gas from the gas inlet more toward the first flow gas flow than toward the second flow gas flow.

[0140] In some configurations, the nasal interface includes a connector or elbow for connecting the breathing conduit to the patient interface.

[0141] In some configurations, the connector or elbow includes or is a flow director.

[0142] In some configurations, the flow director includes a nozzle configured to accelerate flow toward the first outlet or the first outlet portion.

[0143] In some configurations, the nasal interface is configured to direct incoming gas more to the first flow gas flow than to the second flow gas flow during an inhalation phase of a breathing cycle.

[0144] In some configurations, the interface body is a nose pad.

[0145] In some configurations, the nasal interface is configured to deliver breathing gas from the gas inlet through the interface body to both the first and second nostrils of the patient simultaneously in use.

[0146] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0147] an interface body configured to substantially form a seal with the nasal airway of the patient, the interface body configured to deliver gas to a first nostril of the patient and a second nostril of the patient;

[0148] and a gas inlet for delivering breathing gas to the nasal interface, wherein the gas inlet is in fluid communication with the interface body to deliver breathing gas from the gas inlet through the interface body to the first and second nostrils of the patient in use; and

[0149] The nasal interface is configured to provide a greater dynamic pressure at the first nostril of the patient during use and a smaller dynamic pressure at the second nostril of the patient during use, so as to produce an asymmetric gas flow at the nasal airway of the patient throughout the patient's breathing cycle.

[0150] In some configurations, the interface body includes a first outlet or first outlet portion configured to deliver gas to a first nostril of the patient and includes a second outlet or second outlet portion configured to deliver gas to a second nostril of the patient.

[0151] In some configurations, the nasal interface includes a flow director configured to direct incoming gas from the gas inlet more toward the first outlet or first outlet portion than toward the second outlet or second outlet portion.

[0152] In some configurations, the flow director includes a nozzle configured to accelerate flow toward the first outlet or the first outlet portion.

[0153] In some configurations, the nasal interface is configured to receive incoming gas from a gas inlet and to provide a first flow gas stream and a second flow gas stream from the incoming gas, and is configured to direct the incoming gas more to the first flow gas stream than to the second flow gas stream, the first flow gas stream being configured to be provided substantially to a first nostril of a patient in use, and the second flow gas stream being configured to be provided substantially to a second nostril of a patient in use.

[0154] In some configurations, the nasal interface includes a flow splitter configured to unevenly split a flow from the gas inlet into a first flow gas stream and a second flow gas stream.

[0155] In some configurations, the nasal interface is configured to deliver breathing gas from the gas inlet through the interface body to both the first and second nostrils of the patient simultaneously in use.

[0156] The nasal interface of this aspect may have one or more of the features outlined with respect to any of the other aspects.

[0157] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0158] an interface body configured to substantially form a seal with the nasal airway of the patient, the interface body configured to deliver gas to a first nostril of the patient and a second nostril of the patient;

[0159] and a gas inlet for delivering breathing gas to the nasal interface, wherein the gas inlet is in fluid communication with the interface body to deliver breathing gas from the gas inlet through the interface body to the first and second nostrils of the patient in use; and

[0160] A flow splitter configured to unevenly split a flow from a gas inlet into a first flow gas stream configured to be provided substantially to a first nostril of a patient in use and a second flow gas stream configured to be provided substantially to a second nostril of the patient in use, wherein the first flow gas stream is configured to deliver a greater gas flow along the first flow gas stream than the gas flow delivered along the second flow gas stream to produce an asymmetric gas flow at the patient's nasal airway throughout the patient's breathing cycle.

[0161] In some configurations, the interface body includes a first outlet or first outlet portion configured to deliver gas to a first nostril of the patient and includes a second outlet or second outlet portion configured to deliver gas to a second nostril of the patient.

[0162] In some configurations, the gas inlet is at least partially aligned with the first outlet or first outlet portion and less aligned or non-aligned with the second outlet or second outlet portion.

[0163] In some configurations, the gas inlet is substantially axially aligned with the first outlet or first outlet portion.

[0164] In some configurations, at least half of the transverse cross-sectional area of ​​the gas inlet is axially aligned with at least half of the transverse cross-sectional area of ​​the first outlet or first outlet portion.

[0165] In some configurations, the gas inlet includes an outer portion, and further includes an inner portion in fluid communication with the interface body, the outer portion being adapted to connect to the breathing conduit to provide a flow of gas from the gas source to the interface body.

[0166] In some configurations, an inner portion of the gas inlet is at least partially aligned with the first outlet or the first outlet portion.

[0167] In some configurations, the gas inlet is angled toward the first outlet or first outlet portion.

[0168] In some configurations, at least one dimension of the first flow rate gas flow is greater than a corresponding dimension of the second flow rate gas flow.

[0169] In some configurations, the at least one dimension comprises a lateral dimension of a first flow rate gas flow, and wherein the corresponding dimension comprises a lateral dimension of a second flow rate gas flow.

[0170] In some configurations, the diameter, cross-sectional area, and / or volume of the first flow rate gas stream is greater than the corresponding diameter, cross-sectional area, and / or volume of the second flow rate gas stream.

[0171] In some configurations, the ratio of the cross-sectional area of ​​the first flow gas stream to the corresponding cross-sectional area of ​​the second flow gas stream is between about 2:1 and about 5:1, optionally between about 2:1 and about 4:1, optionally between about 2.5:1 and about 3.5:1, and optionally about 3:1.

[0172] In some configurations, the first outlet or first outlet portion and the second outlet or second outlet portion include substantially the same cross-sectional area.

[0173] In some configurations, the nasal interface is configured to deliver a lower flow rate of gas through the first outlet or first outlet portion than the flow rate of gas delivered through the second outlet or second outlet portion during the inhalation phase of the breathing cycle.

[0174] In some configurations, the nasal interface is configured to deliver a higher pressure flow of gas through the first outlet or first outlet portion than the pressure of the flow of gas delivered through the second outlet or second outlet portion during an inhalation phase of the breathing cycle.

[0175] In some configurations, the nasal interface includes a gas manifold, and the interface body, the gas manifold, and / or the gas inlet include a flow diverter.

[0176] In some configurations, the flow splitter includes a wall portion that extends toward or into the gas inlet, wherein the first flow gas stream is located on one side of the wall portion and the second flow gas stream is located on an opposite side of the wall portion.

[0177] In some configurations, the flow splitter extends into the gas inlet and divides the gas inlet into a first flow gas flow portion on the one side of the flow splitter and a second flow gas flow portion on an opposite side of the flow splitter.

[0178] In some configurations, the flow diverter is substantially rigid.

[0179] In some configurations, the interface body is a nose pad.

[0180] In some configurations, the nose pad includes a flow diverter, and wherein the flow diverter is configured to move and / or deform when the nose pad is compressed.

[0181] In some configurations, the flow splitter includes a first wall portion and a second wall portion.

[0182] In some configurations, the first wall portion and the second wall portion are hingedly connected to each other, and wherein the relative angles of the wall portions are configured to change when the nose pad is compressed.

[0183] In some configurations, the first wall portion and the second wall portion overlap each other when the nose pad is in a relaxed state, and wherein the degree of overlap of the wall portions increases as the nose pad is compressed.

[0184] In some configurations, the nasal interface includes a single outlet for delivering gas to a first nostril and a second nostril of the patient, wherein the single outlet includes a first outlet portion and a second outlet portion, and wherein the nasal interface is configured such that the first flow gas stream is configured to be delivered substantially to the first outlet portion and the second flow gas stream is configured to be delivered substantially to the second outlet portion.

[0185] In some configurations, the interface body includes a first nasal delivery element having a first outlet and a second nasal delivery element having a second outlet, wherein the nasal interface is configured such that a first flow gas stream is configured to be substantially delivered to the first nasal delivery element and a second flow gas stream is configured to be substantially delivered to the second nasal delivery element, and wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient.

[0186] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a nasal interface is disclosed, the nasal interface comprising:

[0187] an interface body comprising a first nasal delivery element including a first outlet configured to deliver gas to a first nostril of the patient and a second nasal delivery element including a second outlet configured to deliver gas to a second nostril of the patient, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal against a respective nostril of the patient;

[0188] and a gas inlet for delivering breathing gas into the nasal interface, wherein the gas inlet is in fluid communication with the interface body to deliver breathing gas from the gas inlet through the first nasal delivery element and the second nasal delivery element; and

[0189] A flow splitter for unevenly dividing flow from a gas inlet into a first flow gas stream configured to be provided substantially to a first nasal delivery element and a second flow gas stream configured to be provided substantially to a second nasal delivery element, wherein the first flow gas stream is configured to deliver a greater gas flow along the first flow gas stream than along the second flow gas stream to produce an asymmetric gas flow at the patient's nasal airway throughout the patient's breathing cycle.

[0190] In some configurations, the nasal interface includes a flow director configured to direct incoming gas from the gas inlet more toward the first flow gas flow than toward the second flow gas flow.

[0191] In some configurations, the flow director includes a nozzle configured to accelerate flow toward the first outlet or the first outlet portion.

[0192] In some configurations, the nasal interface is configured to direct incoming gas more to the first flow gas flow than to the second flow gas flow during an inhalation phase of a breathing cycle.

[0193] In some configurations, the interface body is a nose pad.

[0194] In some configurations, the nasal interface is configured to deliver breathing gas from the gas inlet through the interface body to both the first and second nostrils of the patient simultaneously in use.

[0195] In some configurations, the nasal interface includes a bias flow restriction comprising at least one hole for allowing gas to flow from the nasal interface to the surrounding environment.

[0196] In some configurations, the bias flow restriction includes a filter or diffuser to filter or diffuse the gas flowing through the hole(s).

[0197] In some configurations, the nasal interface is configured such that the pressure difference of the gas flow through the first outlet or first outlet portion and the second outlet or second outlet portion is greater during the exhalation phase than during the inspiration phase.

[0198] In some configurations, the nasal interface is configured to achieve a patient pressure at the first outlet or first outlet portion and the second outlet or second outlet portion of between about 2 cmH2O to about 30 cmH2O in use, optionally between about 2 cmH2O to about 25 cmH2O in use, optionally between about 2 cmH2O to about 20 cmH2O in use, optionally between about 2 cmH2O to about 15 cmH2O in use, optionally between about 2 cmH2O to about 14 cmH2O in use, optionally between about 2 cmH2O to about 13 cmH2O in use, optionally between about 2 cmH2O to about 12 cmH2O in use, optionally between about 2 cmH2O to about 11 cmH2O in use, optionally between about 2 cmH2O to about 10 cmH2O in use.

[0199] In some configurations, the pressure differential between the first outlet or first outlet portion and the second outlet or second outlet portion is configured to provide an asymmetric flow of at least about 1 liter per minute (lpm), optionally between about 1 lpm and about 5 lpm, through the patient's upper airway.

[0200] In some configurations, asymmetric flow facilitates removal of CO2 from the patient's anatomical dead space.

[0201] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a respiratory therapy system is disclosed, the respiratory therapy system comprising:

[0202] a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0203] a breathing tube for receiving the pressure-controlled breathing gas; and

[0204] A nasal interface as outlined above or herein is in fluid communication with a breathing tube to deliver breathing gases to a patient.

[0205] In some configurations, the interface body includes a first outlet or first outlet portion configured to deliver gas to a first nostril of the patient, and includes a second outlet or second outlet portion configured to deliver gas to a second nostril of the patient, and wherein the nasal interface is configured to create a pressure differential between the first outlet or first outlet portion and the second outlet or second outlet portion when gas is delivered from the gas inlet to both the first outlet or first outlet portion and the second outlet or second outlet portion, such that the pressure at the first outlet or first outlet portion is higher than the pressure at the second outlet or second outlet portion.

[0206] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, a respiratory therapy system is disclosed, the respiratory therapy system comprising:

[0207] a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0208] a breathing tube for receiving the pressure-controlled breathing gas; and

[0209] A nasal interface having a gas inlet connected to a breathing tube fluid for delivering breathing gas to a patient, the nasal interface comprising a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient, wherein the nasal interface is configured to generate a pressure difference between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, so that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0210] In some configurations, the respiratory therapy system includes a breathing conduit for receiving pressure-controlled breathing gas from a breathing tube, wherein the breathing conduit is in fluid communication with the breathing tube and a gas inlet of the nasal interface.

[0211] In some configurations, the respiratory therapy system further includes a respiratory gas filter.

[0212] In some configurations, the breathing gas filter is located between the breathing tube and the breathing conduit.

[0213] In some configurations, the breathing gas filter is located between the gas manifold and the bias flow restriction.

[0214] In some configurations, the respiratory therapy system further includes a humidifier configured to humidify the pressure-controlled breathing gas before it is delivered to the nasal interface.

[0215] In some configurations, the breathing tube is a heated breathing tube and is configured to receive pressure-controlled breathing gases from a humidifier.

[0216] In some configurations, the temperature of the gas flow exiting the first and second nasal delivery elements is between about 31°C and about 41°C, optionally above 31°C and up to about 41°C, optionally between about 36°C and about 39°C, optionally about 37°C.

[0217] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, there is provided a method for providing respiratory support to a patient, the method comprising:

[0218] A respiratory therapy system is provided, the respiratory therapy system comprising:

[0219] a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0220] a breathing tube for receiving the pressure-controlled breathing gas; and

[0221] a nasal interface having a gas inlet in fluid communication with the breathing tube for delivering breathing gas to the patient, the nasal interface comprising a first nasal delivery element and a second nasal delivery element;

[0222] sealing a corresponding nostril of the patient with each of the first nasal delivery element and the second nasal delivery element;

[0223] operating the respiratory therapy device to provide a flow of gas to the nasal interface; and

[0224] An asymmetric gas flow is delivered from the respiratory therapy device at the patient's nares through the first nasal delivery element and the second nasal delivery element.

[0225] In some configurations, the nasal delivery elements are fluidly connected to the gas inlet via a gas flow channel, wherein the first nasal delivery element is proximal to the gas inlet and the second nasal delivery element is distal to the gas inlet, and wherein the nasal interface includes a bypass restriction that provides a cross-sectional area of ​​a portion of the gas flow channel, wherein each of the first nasal delivery element and the second nasal delivery element includes an inner cross-sectional area, wherein the inner cross-sectional areas together provide a combined cross-sectional area of ​​the nasal delivery elements, and wherein the cross-sectional area of ​​this portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area of ​​the nasal delivery elements.

[0226] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 4cmH2O to the gas inlet so that a deviation flow of 20lpm passes through the deviation flow restriction.

[0227] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 8cmH2O to the gas inlet so that a deviation flow of 32lpm passes through the deviation flow restriction.

[0228] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 4cmH2O to the gas inlet so that a deviation flow of 20lpm passes through the deviation flow restriction; or wherein the method includes: providing a pressure of 8cmH2O to the gas inlet so that a deviation flow of 32lpm passes through the deviation flow restriction; or wherein the method includes: providing a pressure of 12cmH2O to the gas inlet so that a deviation flow of 41lpm passes through the deviation flow restriction; or wherein the method includes: providing a pressure of 16cmH2O to the gas inlet so that a deviation flow of 48lpm passes through the deviation flow restriction; or wherein the method includes: providing a pressure of 20cmH2O to the gas inlet so that a deviation flow of 53lpm passes through the deviation flow restriction.

[0229] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 8 cmH2O to the gas inlet so that 32 lpm or more of the deviation flow passes through the deviation flow restriction.

[0230] In some configurations, the cross-sectional area of ​​this portion of the gas flow channel is at most about 1 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 8 cmH2O to the gas inlet so that 32 lpm or more of the deviation flow passes through the deviation flow restriction, or wherein the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 5 times the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 12 cmH2O to the gas inlet so that 41 lpm or more of the deviation flow passes through the deviation flow restriction, or wherein the cross-sectional area of ​​this portion of the gas flow channel is at most about 2 / 3 times the combined cross-sectional area of ​​these nasal delivery elements, and wherein the method includes: providing a pressure of 16 cmH2O to the gas inlet so that 48 lpm or more of the deviation flow passes through the deviation flow restriction.

[0231] In some configurations, the temperature of the gas flow exiting the first and second nasal delivery elements is between about 31°C and about 41°C, optionally above 31°C and up to about 41°C, optionally between about 36°C and about 39°C, optionally about 37°C.

[0232] In some configurations, the nasal interface is as described above or generally herein.

[0233] In some configurations, the respiratory therapy system is as described above or generally herein.

[0234] According to certain features, aspects, and advantages of at least one embodiment disclosed herein, there is provided a method for providing respiratory support to a patient, the method comprising:

[0235] A respiratory therapy system is provided, the respiratory therapy system comprising:

[0236] a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0237] a breathing tube for receiving the pressure-controlled breathing gas; and

[0238] a nasal interface in fluid communication with breathing tube 16 for delivering breathing gases to the patient;

[0239] sealing the patient's nasal airway with a nasal interface;

[0240] operating the respiratory therapy device to provide a flow of gas to the nasal interface; and

[0241] Incoming gas is received at a gas inlet of the nasal interface and an asymmetric gas flow is generated at the patient's nasal airway.

[0242] In some configurations, the method includes generating an asymmetric gas flow at the nasal airway of the patient throughout a breathing cycle of the patient.

[0243] In some configurations, the nasal interface is as described above or generally herein.

[0244] In some configurations, the respiratory therapy system is as described above or generally herein.

[0245] Features from one or more embodiments or configurations may be combined with features of one or more other embodiments or configurations. In addition, more than one embodiment or configuration may be used together in a respiratory support system during a respiratory support procedure for a patient.

[0246] As used herein, the word "(s)" preceding a noun refers to the plural and / or singular forms of that noun.

[0247] As used herein, the term "and / or" means "and" or "or" or both.

[0248] The term "comprising" as used in this specification means "consisting at least in part of..." When interpreting each statement in this specification containing the term "comprising", there may also be features other than the one or those features following the term. Related terms such as "comprising" and "including" are to be interpreted in the same manner.

[0249] Reference to a numerical range disclosed herein (e.g., 1 to 10) is intended to also include reference to all rational numbers within this range (e.g., 1, 1.1, 2, 3, 3.9, 4, 5, 6, 6.5, 7, 8, 9, and 10), as well as any range of rational numbers within this range (e.g., 2 to 8, 1.5 to 5.5, and 3.1 to 4.7), and thus, all subranges of all ranges explicitly disclosed herein are hereby expressly disclosed. These are merely examples of what is specifically intended to be disclosed, and all possible combinations of numerical values ​​between the lowest and highest values ​​enumerated should be considered to be expressly stated in this application in a similar manner.

[0250] The present disclosure may also be broadly described as the parts, elements and features individually or collectively referred to or specified in the specification of the present application, as well as any or all combinations of any two or more of the parts, elements or features, and, when specific integers having known equivalents in the art to which the present disclosure relates are mentioned herein, such known equivalents are deemed to be incorporated herein as if individually listed.

[0251] The present disclosure includes the foregoing and also contemplates a variety of configurations, only examples of which are given below. BRIEF DESCRIPTION OF THE DRAWINGS

[0252] Certain embodiments and modifications thereof will become apparent to those skilled in the art from the detailed description herein by reference to the following drawings, in which:

[0253] Figure 1 is a front perspective view of a patient interface of an exemplary configuration of the present disclosure, the patient interface including a nasal interface.

[0254] Figure 2 It is a close-up stereoscopic image of the nasal interface.

[0255] Figure 3 is a rear perspective view of the patient interface.

[0256] Figure 4 It is a close-up stereoscopic image of the nasal interface.

[0257] Figure 5 is a front perspective view of a patient interface showing a gas manifold portion separate from an interface body portion including a nasal delivery element, a bias flow restriction portion separate from the gas manifold portion, and a breathing conduit separate from the gas manifold portion.

[0258] Figure 6 A view of a bias flow restriction is shown, wherein Figure 6 (a) is a front perspective view of the bias flow restriction portion, Figure 6 (b) is a front exploded perspective view of the components of the bias flow restriction portion.

[0259] Figure 7 A view of a bias flow restriction is shown, wherein Figure 7 (a) is a three-dimensional cross-sectional view of the bias flow restriction portion, Figure 7 (b) is an orthogonal cross-sectional view of the bias flow restriction portion.

[0260] Figure 8 is an orthogonal view toward the front of the bias flow restriction.

[0261] Fig. 9 is a front partial cross-sectional view of the nasal interface showing the gas flow restrictions in the gas manifold.

[0262] Fig.10 A view of a nasal interface is shown, wherein Fig.10 (a) is a front perspective cross-sectional view of a nasal interface, schematically illustrating the direction of gas flow through the nasal interface; Fig.10 (b) is a front orthogonal cross-sectional view of the nasal interface, schematically illustrating the direction of gas flow through the nasal interface.

[0263] Fig.11 A view of a gas manifold is shown, wherein Fig.11 (a) is the front view stereogram, Fig.11 (b) is a front view taken through a horizontal plane, and Fig.11 (c) is a front view stereogram taken through a vertical plane.

[0264] Fig.12 A view of a gas manifold is shown, wherein Fig.12 (a) is the top view, Fig.12 (b) is along Fig.12 (d) is a cross-sectional view of line bb, Fig.12 (c) is the front view, Fig.12 (d) is an end view, and Fig.12 (e) is along Fig.12 (c) is a cross-sectional view along line ee.

[0265] Fig.13 A view of the facial mounting portion or interface body portion of a nasal interface is shown, wherein Fig.13 (a) is the rear view, Fig.13 (b) is the front view, and Fig.13 (c) is along Fig.13 (b) A cross-sectional view of line cc.

[0266] Fig.14 is a cross-sectional view through the gas manifold and one of the nasal delivery elements.

[0267] Fig.15 It is a schematic diagram of the functions and usage effects of the patient interface.

[0268] Fig.16 shows the side swap function, where Fig.16 In (a), the breathing tube is connected to the right side of the gas manifold, while in Fig.16 (b) The breathing tube is connected to the left side of the gas manifold.

[0269] Fig.17 The remote positioning of the bias flow restriction is shown, wherein Fig.17 (a) shows the remote positioning of the bias flow restriction, Fig.17 (b) shows the remote positioning of the bias flow restriction, and the filter between the gas manifold and the bias flow restriction.

[0270] Fig.18 is an exploded view of the components of the patient interface headgear.

[0271] Fig.19 Schematically shows Figures 1 to 18 The configuration of the nasal interface.

[0272] Fig. 20 Alternative configurations for nasal interfaces are schematically shown.

[0273] Fig.21 Another alternative configuration of a nasal interface is schematically shown.

[0274] Fig. 22A respiratory therapy system incorporating a patient interface and a nasal interface of the present disclosure is shown.

[0275] Fig.23 Shown are test results for different ratios of bypass restriction area to nasal delivery element combined area for a 10i:20e 500Vt (tidal volume) breathing pattern at 15 breaths per minute at pressures of 4 cmH2O and 8 cmH2O.

[0276] Fig.24 Test results for different ratios of bypass restriction area to nasal delivery element combined area for an ARDS (acute respiratory distress syndrome) breathing pattern of 25 breaths per minute at pressures of 4 cmH2O, 8 cmH2O, 12 cmH2O, 16 cmH2O, and 20 cmH2O are shown.

[0277] Fig.25 Test results for different ratios of bypass restriction area to nasal delivery element combined area for a 350Vt (tidal volume) sinusoidal breathing pattern at 45 breaths per minute at pressures of 4cmH2O, 8cmH2O, 12cmH2O, 16cmH2O, and 20cmH2O are shown.

[0278] Fig.26 The effects of different modeled nasal delivery element sizes, different bypass restriction cross-sectional areas, different set pressures, and different bias flow restriction openings on 15 rebreaths per minute with a nasal interface are shown.

[0279] Fig. 27 The effects of different modeled nasal delivery element sizes, different bypass restriction cross-sectional areas, different set pressures, and different bias flow restriction openings on 25 rebreaths per minute with a nasal interface are shown.

[0280] Fig.28 The effects of different modeled nasal delivery element sizes, different bypass restriction cross-sectional areas, different set pressures, and different bias flow restriction openings on 45 rebreaths per minute with a nasal interface are shown.

[0281] Fig.29 An alternative configuration of a nasal interface for use in a patient interface is schematically shown.

[0282] Fig.30 A front perspective view of an exemplary configuration of a nasal interface is shown.

[0283] Fig.31 A front cross-sectional view of the nasal interface is shown, illustrating the gas flow path.

[0284] Fig.32A front cross-sectional view of the nasal interface is shown, illustrating the exhaust gas flow path.

[0285] Fig.33 A partial top cross-sectional view of the nasal interface is shown.

[0286] Fig.34 Another partial top cross-sectional view of the nasal interface is shown.

[0287] Fig.35 A top front stereoscopic view of the interface body / nose pads of the nasal interface is shown.

[0288] Fig.36 A bottom front stereoscopic view of the interface body / nose pad of the nasal interface is shown.

[0289] Fig.37 A cross-sectional front view of a nasal interface is shown in an alternative exemplary configuration.

[0290] Fig.38 A front perspective cross-sectional view of another alternative exemplary configuration of a nasal interface is shown.

[0291] Fig.39 A front perspective view of another alternative exemplary configuration of a nasal interface is shown.

[0292] Fig.40 A partial cross-sectional view of the nasal interface is shown.

[0293] Fig.41 A front perspective cross-sectional view of a nasal interface of an alternative exemplary configuration is shown.

[0294] Fig.42 A front perspective cross-sectional view of a nasal interface of an alternative exemplary configuration is shown.

[0295] Fig.43 A top view of a nasal interface of an alternative exemplary configuration is shown.

[0296] Fig.44 A front cross-sectional view of a nasal interface of an alternative exemplary configuration is shown, wherein Fig.44 (a) shows the nose pad in an idle state, while Fig.44 (b) shows the nose pad in a compressed state.

[0297] Fig.45 A front perspective view of an alternative exemplary configuration of a nose pad for use in a nasal interface is shown.

[0298] Fig.46 A rear perspective view of the nose pad is shown.

[0299] Fig.47 Deformation or movement of a flow guide or diverter of a nose pad is shown.

[0300] Fig.48 Alternative deformations or movements of the flow guide or diverter of the nose pad are shown.

[0301] Fig.49 An alternative exemplary configuration of a nose pad for use in a nasal interface is shown, wherein Fig.49 (a) is the first front view stereogram, and Fig.49 (b) is a second front stereoscopic image.

[0302] Fig.50 (a) to Fig.50 (c) shows three alternative exemplary configurations of nose pads for use in a nasal interface.

[0303] Fig.51 An alternative exemplary configuration of a nose pad for use in a nasal interface is shown, wherein Fig.51 (a) is a top view, and Fig.51 (b) is the front view.

[0304] Fig.52 An alternative exemplary configuration of a nose pad for use in a nasal interface is shown, wherein Fig.52 (a) is the rear view, and Fig.52 (b) is a top view stereogram.

[0305] Fig.53 is a front perspective view of an alternative exemplary configuration of a nasal interface.

[0306] Fig.54 It is a front exploded perspective view of the nasal interface.

[0307] Fig.55 is an exploded perspective view of the nasal interface from the rear.

[0308] Fig.56 is a top cross-sectional view of the nasal interface.

[0309] Fig.57 is a front perspective view of a patient interface including a nasal interface of an alternative exemplary configuration.

[0310] Fig.58 is a top cross-sectional view of the nasal interface.

[0311] Fig.59 is a front stereoscopic image of the nose pads of the nasal interface. DETAILED DESCRIPTION

[0312] The patient interface can be used to deliver breathing gases to the patient's airway. The patient interface can include a nasal interface that can be used to deliver a gas flow to the patient. In some configurations, a nasal delivery element (such as a nasal prong or nasal pillow) is inserted into the patient's nose to deliver the desired therapy. It may be desirable for the nasal delivery element to seal at the nose to deliver therapy. One or more of the nasal delivery elements may include a nasal pillow for sealing at the nose.

[0313] A system for delivering gas to a patient through a nasal interface is disclosed.

[0314] The system provides a pressure differential at the first and second nasal delivery elements of the nasal interface, thereby obtaining different gas flows at the first and second nasal delivery elements. This allows asymmetric flow to be delivered to the two nostrils through the nasal interface. Asymmetric flow as described herein refers to different flows within the nasal interface, or within the nose. In this way, each nasal delivery element can deliver a different flow. Asymmetric flow can also include partial unidirectional flow.

[0315] Delivering an asymmetric gas flow can improve dead space clearance in the upper airway. As described, the nasal interface is configured to produce such an asymmetric flow through the nasal delivery element.

[0316] The flow rate generated by the respiratory therapy depends on the flow through the nasal interface, which depends on the pressure at each nasal delivery element. If the pressure at each nasal delivery element is different, an asymmetric gas flow will be generated.

[0317] If during breathing, the flow, leakage, or the combination of flow and leakage through the nasal interface is asymmetric, the flow through the nose may be asymmetric. Partial unidirectional flow may be the type of asymmetric flow. Partial unidirectional flow can provide improved cleaning of anatomical dead space when air is flushed from the upper airway. Partial unidirectional flow can be more comfortable than total unidirectional flow. The total unidirectional flow herein includes all flows that enter one nostril through the nasal delivery element and leave through the other nostril via the nasal delivery element, flows discharged into the atmosphere due to the absence of nasal delivery elements, and the like. Partial unidirectional flow as described herein includes flows that can enter the nose via two nostrils and leave the nose from one nostril, flows that can enter the nose through one nostril and leave the nose via two nostrils, or different proportions of flows that can enter the nose through two nostrils and / or different proportions of flows that can leave the nose through two nostrils, and can be flows that can enter the nose via two nostrils and leave the nose from one or both nostrils and optionally leave via the mouth. If there is a pressure differential between the first and second nasal delivery elements, during inspiration, the first nasal delivery element will receive more gas flow from the gas inlet than the second nasal delivery element. During exhalation, the second nostril associated with the second nasal delivery element will expel more gas flow than the first nostril associated with the first nasal delivery element. The pressure differential between the first and second nasal delivery elements can change depending on whether the patient's breathing cycle is in the inspiration phase or the exhalation phase.

[0318] The asymmetric flow assessment may be performed over a suitable time period. For example, the asymmetric flow assessment may be performed over one respiratory cycle of the patient, or alternatively over a different number of cycles of the patient.

[0319] Partial unidirectional flow can reduce turbulence in the patient's nasal cavity, which can improve comfort.

[0320] Figures 1 to 5 An exemplary patient interface 1 is shown that includes a nasal interface 100 having nasal delivery elements including a first nasal delivery element 111 and a second nasal delivery element 112 .

[0321] The nasal interface 100 provides a patient interface for the patient, which is suitable for delivering a pressure-controlled, optionally high-humidity gas flow to the patient's nasal cavity / nostril. In some configurations, the nasal interface 100 is adapted to deliver high-flow gas over a wide flow range (e.g., about 8 lpm or greater, depending on other therapeutic applications, approximately 10-50 lpm, 20-40 lpm or greater). The flow rate can be a bias flow averaged over time. In some configurations, the nasal interface 100 is adapted to deliver a lower flow of gas. The flow rate depends on the pressure, so it can fluctuate according to different respiratory pressures and set pressures. Among them, (multiple) set pressures are related to the therapy maintained by the assisted respiratory therapy device and / or (multiple) patient pressures when used in combination with the nasal interface of the present disclosure.

[0322] The nasal interface 100 includes a face mounting portion or interface body 110 portion including a pair of hollow nasal delivery elements 111 and 112 that are integrally molded with, or removably attached to, the interface body 110. The nasal interface 100 includes a gas manifold 120 portion that includes a gas inlet 121. The gas manifold 120 may be removably attached or integrally molded to the breathing conduit 300.

[0323] The interface body 110 portion can be connected or joined to the gas manifold 120 portion, or can be integrally formed or permanently joined to the gas manifold 120 portion. If the interface body 110 portion is engageable with the gas manifold portion 120, the engagement places the first nasal delivery element 111 and the second nasal delivery element 112 in fluid communication with the gas inlet 121, thereby placing the first nasal delivery element 111 closer to the gas inlet 121 and the second nasal delivery element 112 further away from the gas inlet 121.

[0324] The interface body 110 may be formed of a soft, flexible material, such as silicone, a thermoplastic elastomer, or other polymers known in the art. The nasal delivery elements 111 and 112 are preferably pliable and may be formed of sufficiently thin layers of silicone or other materials suitable for achieving this property. The interface body 110 and nasal delivery elements 111, 112 may be formed, for example, of an elastomeric material that can conform to the geometry of the patient's nostrils and / or cheeks and provide an effective pneumatic seal.

[0325] Gas manifold 120 can be formed of a relatively rigid material, such as polycarbonate, high density polyethylene (HDPE), or any other suitable plastic material known in the art. Interface body 110 provides a soft docking component for the patient to comfortably deliver the gas flow through nasal delivery elements 111 and 112, while gas manifold 120 fluidly couples breathing conduit 300 to nasal delivery elements 111 and 112 of interface body 110.

[0326] The nasal delivery elements 111 and 112 are substantially hollow.

[0327] The first nasal delivery element 111 and the second nasal delivery element 112 can have the same shape and configuration as each other, that is, can be symmetrical. In other configurations, the first and second nasal delivery elements can have different shapes and / or configurations from each other, that is, can be asymmetrical.

[0328] The interface body 110 is shaped to generally follow the contours of the patient's face around the upper lip region. The interface body 110 is molded or preformed to conform to the contours of the user's face in the area of ​​the face where the nasal interface is positioned and / or is flexible to fit, adapt and / or correspond to the contours of the user's face.

[0329] See also Fig.13 (a) to Fig.13 (c), the interface body 110 includes a base portion 118 from which the nasal delivery elements 111 and 112 extend.

[0330] The base portion 118 is arranged to be located, in use, between the patient's face and the gas manifold 120. The base portion 118 may act as a cushion to prevent the gas manifold 120 from contacting the patient's face.

[0331] In the illustrated configuration, the interface body 110 includes two side arms extending laterally from respective sides of the base portion 118 .

[0332] In the illustrated configuration, the side arms include wings 113 and 114 extending laterally from respective sides of a base portion 118. The wings 113 and 114 are integrally formed with the base portion 118, but may alternatively be separate parts.

[0333] In some configurations, the nasal delivery elements 111 , 112 extend generally upward and rearward from the base portion 118 of the interface body 110 .

[0334] An adhesive pad (not shown) may be provided on each wing 113, 114 to facilitate coupling of the nasal interface 100 to the patient.

[0335] The gas manifold 120 is generally tubular in shape and has gas ports 121, 122 ( Figure 5 , Fig.11 and Fig.12). At least one of the gas ports 121, 122 may be removably attached to the breathing conduit 300, such as via a threaded engagement, but alternatively via a snap fit or any other type of coupling known in the art. This enables at least one of the gas ports 121, 122 to function as a gas inlet for the gas manifold 120, and thereby the nasal interface 100. Alternatively, the ports 121, 122 may be fixedly coupled to or integrally formed with the breathing conduit 300.

[0336] By extending the breathing conduit 300 from one side of the gas manifold 120, and thereby from one side of the nasal interface 100, the patient's mouth can be easily accessed while wearing the nasal interface for feeding / eating, drinking, or verbal communication, for example.

[0337] Flow enters the nasal interface 100 through the gas inlet and travels through the gas manifold 120 in a direction substantially transverse to the direction in which the flow is intended to travel into the first nasal delivery element 111 and the second nasal delivery element 112 .

[0338] The gas inlet is in fluid communication with the breathing conduit 300 .

[0339] In some configurations, the inner diameter of the breathing conduit 300 is between about 12 mm and about 23 mm, optionally greater than about 12 mm and at most about 23 mm, optionally greater than about 12 mm and at most about 22 mm, optionally greater than about 12 mm and at most about 21 mm, optionally greater than about 12 mm and at most about 20 mm, optionally greater than about 12 mm and at most about 19 mm, optionally greater than about 12 mm and at most about 18 mm, optionally between about 13 mm and about 17 mm. m, optionally between about 14 mm to about 16 mm, optionally about 12 mm, optionally about 13 mm, optionally about 14 mm, optionally about 15 mm, optionally about 16 mm, optionally about 17 mm, optionally about 18 mm, optionally about 19 mm, optionally about 20 mm, optionally about 21 mm, optionally about 22 mm, optionally about 23 mm, or optionally any value between any two of these values.

[0340] See also Fig.11 and Fig.12 , the gas flow path is defined by an internal cavity or flow channel 125 in the gas manifold 120.

[0341] The flow channel 125 extends through the gas manifold from a gas port 121 at one side of the gas manifold 120 to a gas port 122 at the other side of the gas manifold 120 .

[0342] Flow channel 125 is in fluid communication with first gas outlet 123 and second gas outlet 124. First gas outlet 123 is configured for delivering gas to first nasal delivery element 111, and second gas outlet 124 is configured for delivering gas to second nasal delivery element 112.

[0343] The gas outlets 123 , 124 are shaped to correspond to the interface body 110 and fit, for example, by a friction fit or snap fit engagement, such that significant or at least targeted force by a user or caregiver is required to separate the manifold 120 from the interface body 110 .

[0344] When the gas manifold 120 is engaged with the interface body 110 , an effective seal is formed between the gas outlets 123 , 124 and the interface body 110 .

[0345] In the illustrated configuration, each gas outlet is disposed in a respective outlet portion 123a , 124a of the gas manifold 120 .

[0346] Each outlet portion 123a, 124a includes a sealing flange 123b, 124b for engaging with the first nasal delivery element 111 and the second nasal delivery element 112.

[0347] The sealing flanges 123b, 124b extend laterally outwardly from adjacent sections of the respective outlet portions 123a, 123b. The sealing flanges 123b, 124b are received in respective portions 111x, 112x of the nasal delivery elements 111, 112.

[0348] In the illustrated configuration, the sealing flanges 123b, 124b are generally annular in shape, and the corresponding portions 111x, 112x of the nasal delivery elements include annular channels in the inner surface of the nasal delivery elements 111, 112.

[0349] In alternative configurations, the sealing flanges 123b, 124b and corresponding portions 111x, 112x may have different shapes. For example, they may each include one or more discrete components that do not extend around the entire periphery of the outlet portions 123a, 123b and nasal delivery elements 111, 112.

[0350] In the illustrated configuration, the outlet portions 123a, 124a and the sealing flanges 123b, 124b are received within the interior of the nasal delivery elements 111, 112. In an alternative configuration, this can be reversed so that the base of the nasal delivery elements 111, 112 is received within the interior of the body portions 123a, 124a. In this configuration, the outlet portions 123a, 124a can include a sealing collar for engaging with the first and second nasal delivery elements. The sealing collar can engage with the exterior of the nasal delivery elements to provide a seal therebetween.

[0351] The nasal delivery elements 111, 112 may include protrusions received in corresponding recesses of the sealing collar. The protrusions and recesses may be generally annular in shape, or may have a different configuration as described above for the sealing flanges 123b, 124b and complementary portions 111x, 112x.

[0352] In some configurations, the sealing flange or collar, and the complementary portion of the nasal delivery element, additionally serve as retention features to maintain the interface body 110 and the gas manifold 120 in engagement with each other. In alternative configurations, the interface body 110 and the gas manifold 120 may include one or more other retaining features, such as clamps or fasteners, for example, to maintain the interface body 110 and the gas manifold 120 in engagement with each other.

[0353] The gas manifold 120 can be composed of a single part, or can include multiple parts assembled together. For example, the gas manifold 120 can have a first body portion that provides a gas flow channel 125 and optionally provides gas ports 121, 122. The gas manifold 120 can have a second body portion that provides gas outlets 123, 124. Alternatively, the gas manifold 120 can be a single component. In an alternative configuration, the gas manifold 120 can include a single outlet, and the interface body 110 can include a complementary single gas inlet that is coupled to the single outlet of the gas manifold 120 and is in fluid communication with the first nasal delivery element 111 and the second nasal delivery element 112 to deliver gas to the first nasal delivery element 111 and the second nasal delivery element 112.

[0354] See also Figures 1 to 14 and Fig.18 In some configurations, the nasal interface 100 of the present disclosure includes a first nasal delivery element 111 and a second nasal delivery element 112. The first nasal delivery element 111 and the second nasal delivery element 112 are each configured to seal a corresponding nostril of the patient. The first nasal delivery element is configured to seal a first nostril of the patient, and the second nasal delivery element is configured to seal a second nostril of the patient.

[0355] In some configurations, the first nasal delivery element 111 and the second nasal delivery element 112 are configured to seal the entrance to the patient's nostrils. In some configurations, the first nasal delivery element 111 and the second nasal delivery element 112 are configured to seal the interior of the patient's nostrils. In some configurations, the first nasal delivery element 111 and the second nasal delivery element 112 are configured to seal both the entrance to the patient's nostrils and the interior of the nostrils.

[0356] The nasal interface includes a gas manifold 120 including a gas inlet 121 for delivering breathing gas to the gas manifold. The first nasal delivery element 111 and the second nasal delivery element 112 are in fluid communication with the gas inlet 121 via the gas manifold 120.

[0357] The gas inlet 121 is connected to a single gas inlet portion of the gas flow channel 125 of the gas manifold. With this configuration, the respiratory gas enters the gas manifold 125 from a single area of ​​the gas manifold, such as a single side, and is delivered to the first nasal delivery element 111 and the second nasal delivery element 112 from the single area.

[0358] Gas generally flows in one direction from a single side of the gas manifold to an opposite side of the gas manifold, except for passing through the first nasal delivery element 111 and the second nasal delivery element 112.

[0359] The gas manifold 120 may include a single gas inlet 121 .

[0360] See also Fig. 9 , Fig.10 and Fig.11 The nasal interface includes a bypass restriction 130 for providing a pressure drop across the nasal interface 100 between the first nasal delivery element 111 and the second nasal delivery element 112 when gas is delivered from the gas inlet 121 to the first nasal delivery element 111 and the second nasal delivery element 112, so that the pressure at the first nasal delivery element 111 is higher than the pressure at the second nasal delivery element 112.

[0361] As used herein, bypass restriction 130 can be any feature or geometry that provides a pressure drop across nasal interface 100 between first nasal delivery element 111 and second nasal delivery element 112 when gas is delivered from gas inlet 121 to first nasal delivery element 111 and second nasal delivery element 112, such that the pressure at first nasal delivery element 111 is higher than the pressure at second nasal delivery element 112. In some configurations, bypass restriction 130 can be a physical restriction relative to adjacent portions of gas flow passage 125, relative to gas inlet 121, relative to the combined cross-sectional area A3+A4 of first nasal delivery element 111 and second nasal delivery element 112, and / or relative to any other portion of nasal interface 100.

[0362] In some configurations, the bypass restriction 130 may be a flow splitter or a flow guide.

[0363] The pressure drop causes the gas pressure upstream of the bypass restriction to be higher than the gas pressure downstream of the bypass restriction.

[0364] The pressure at the first nasal delivery element 111 can be the pressure at the outlet of the first nasal delivery element, and / or the pressure along the first nasal delivery element and / or adjacent to the first nasal delivery element. The pressure at the second nasal delivery element 112 can be the pressure at the outlet of the second nasal delivery element, and / or the pressure along the second nasal delivery element and / or adjacent to the second nasal delivery element.

[0365] The pressure drop across the gas manifold 120 can be such that when there is gas flowing from the gas inlet 121 to the first nasal delivery element 111 and the second nasal delivery element 112, the gas flow from the gas inlet 121 to the first nasal delivery element 111 is greater than the gas flow from the gas inlet 121 to the second nasal delivery element 112.

[0366] The bypass restriction 130 can restrict the flow of gas through the gas manifold 120 between the first nasal delivery element 111 and the second nasal delivery element 112.

[0367] In some configurations, when gas is delivered from gas inlet 121 to both first nasal delivery element 111 and second nasal delivery element 112, the gas flow pressure at second nasal delivery element 112 is at most about 1 cmH2O less than the gas flow pressure at the first nasal delivery element.

[0368] The pressure drop caused by bypass restriction 130, and thus the gas flow pressure difference between first nasal delivery element 111 and second nasal delivery element 112, is typically higher during the inhalation phase than during the exhalation phase. This is because, when the patient exhales, the exhaled gas passes through second nasal delivery element 112 more than through first nasal delivery element 111. For example, during the inhalation phase, the gas flow pressure at second nasal delivery element 112 may be about 0.6 cmH2O less than the gas flow pressure at first nasal delivery element 111, and during the exhalation phase, the gas flow pressure at second nasal delivery element 112 may be about 0.3 cmH2O less than the gas flow pressure at first nasal delivery element 111. For a given bypass restriction 130, the magnitude of the difference between the gas flow pressure at first nasal delivery element 111 and the gas flow pressure at second nasal delivery element 112 will depend on the set pressure and the phase of the respiratory cycle.

[0369] In some configurations, the nasal interface 100 is configured to achieve a patient pressure at the first nasal delivery element 111 and the second nasal delivery element 112 of between about 2 cmH2O to about 30 cmH2O in use, optionally between about 2 cmH2O to about 25 cmH2O in use, optionally between about 2 cmH2O to about 20 cmH2O in use, optionally between about 2 cmH2O to about 15 cmH2O in use, optionally between about 2 cmH2O to about 14 cmH2O in use, optionally between about 2 cmH2O to about 13 cmH2O in use, optionally between about 2 cmH2O to about 12 cmH2O in use, optionally between about 2 cmH2O to about 11 cmH2O in use, optionally between about 2 cmH2O to about 10 cmH2O in use.

[0370] The nasal interface 100 can be configured such that the pressure at the first nasal delivery element 111 is higher than the pressure at the second nasal delivery element 112 during both the inhalation phase and the exhalation phase.

[0371] A set pressure may be delivered to the second nasal delivery element 112 and a higher pressure may be delivered to the first nasal delivery element 111 .

[0372] As the set pressure increases, the pressure differential between the first nasal delivery element and the second nasal delivery element increases, wherein the increase provides enhanced dead space clearing or flushing.

[0373] In some configurations, the pressure differential between the first nasal delivery element 111 and the second nasal delivery element 112 is configured to provide an asymmetric flow of at least about 1 liter per minute (lpm), optionally between about 1 lpm and about 2 lpm, optionally between about 1 lpm and about 5 lpm, through the upper airway of the patient. In some configurations, the asymmetric flow may be less than 1 lpm.

[0374] Nasal interface 100 is configured to generate an asymmetric gas flow at the patient's nares through first nasal delivery element 111 and second nasal delivery element 112 due to the pressure drop across the gas manifold and the resulting pressure differential between first nasal delivery element 111 and second nasal delivery element 112. The resulting asymmetric gas flow can provide improved dead space clearing.

[0375] In some configurations, the gas manifold 120 includes a gas flow channel 125 in the gas manifold 120 , and the bypass restriction 130 provides a reduced cross-sectional area of ​​a portion of the gas flow channel 125 .

[0376] This is for example in Fig.10, where it can be seen that the spacing through the gas flow passages 125 in the region of the bypass restriction 130 is significantly reduced compared to the spacing through the gas flow passages 125 on either side of the bypass restriction 130.

[0377] The restricted portion of the gas flow channel 125 can be between the first nasal delivery element 111 and the second nasal delivery element 112 and / or can be adjacent to the second nasal delivery element 112. In particular, the restricted portion of the gas flow channel can be between the first gas outlet 123 and the second gas outlet 124 of the gas manifold.

[0378] Fig.19 Schematically shows Figures 1 to 18 1, but additionally illustrates the relative cross-sectional areas of the bypass restriction region (area A2) and the adjacent or main portion (area A1) of the gas flow passage 125. In this configuration, the bypass restriction 130 is shown between the first nasal delivery element 111 and the second nasal delivery element 112.

[0379] In some configurations, the volumes of the air chambers at the bases of the first nasal delivery element 111 and the second nasal delivery element 112 are substantially the same. The bypass restriction 130 can be a partial restriction.

[0380] Fig. 20 An alternative configuration of a nasal interface is schematically illustrated in which a bypass restrictor 130 is adjacent to the second nasal delivery element 112. The bypass restrictor 130 is positioned opposite the base of the second nasal delivery element 112.

[0381] Fig.21 An alternative configuration of a nasal interface is schematically illustrated in which a bypass restrictor 130 is located between and adjacent to the first nasal delivery element 111 and the second nasal delivery element 112. The bypass restrictor 130 is partially opposite the base of the second nasal delivery element.

[0382] The volume of the gas flow channel 125 at the base of the second nasal delivery element 112 is smaller than the volume of the gas flow channel at the base of the first nasal delivery element 111.

[0383] The bypass restriction 130 can extend into the gas flow channel in one or more directions (i.e., from one or more wall portions of the gas flow channel 125). In some configurations, the bypass restriction 130 can extend into the gas flow channel in one direction (e.g., an upward direction, a downward direction, a forward direction, or a rearward direction). In some configurations, the bypass restriction 130 can extend into the gas flow channel in more than one direction (e.g., in more than one of the upward direction, the downward direction, the forward direction, or the rearward direction).

[0384] The bypass restriction 130 can include at least one protrusion 130a, 130b that extends into the gas flow passage 135. In some configurations, the bypass restriction 130 can include multiple protrusions that extend into the gas flow passage 125.

[0385] For example, the bypass restriction 130 may include diametrically opposed protrusions extending into the flow passage.

[0386] In some configurations, the gas manifold 120 includes a proximal bypass protrusion 130a proximal to the first and second nasal delivery elements 111 , 112 , and / or a distal bypass protrusion 130b distal to the first and second nasal delivery elements 111 , 112 .

[0387] In the illustrated configuration, the gas manifold 120 includes both a proximal bypass protrusion 130a and a distal bypass protrusion 130b that combine to define a predetermined bypass dimension BD to enable restricted gas flow through the gas manifold 120 between the first nasal delivery element 111 and the second nasal delivery element 112 .

[0388] The predetermined bypass dimension BD is typically significantly smaller than a dimension of an adjacent or primary portion of the gas flow channel 125 .

[0389] The predetermined bypass dimension BD may be related to the cross-sectional area A2 as outlined below.

[0390] When multiple projections are provided, they may be discrete projections, semi-continuous or continuous. For example, Fig.11 (a) and Fig.11 (b) shows that a portion of the bypass restrictor extends around substantially the entire periphery of the gas flow passage 125 to form the bypass upper protrusion 130a and the bypass lower protrusion 130b.

[0391] See also Fig.11 (c), the bypass restriction 130 includes an angled leading edge 130a', 130b' and an angled trailing edge 130a", 130b", which defines a convergent and divergent bypass restriction in the direction of gas flowing from the first nasal delivery element 111 through the gas manifold to the second nasal delivery element 112.

[0392] The angled leading edges 130a', 130b' and / or the angled trailing edges 130a", 130b" may be substantially straight or planar, or alternatively may be curved. If curved, the curved surface may be convex and arch in a direction toward the center of the gas flow passage 125, or may be concave and arch in a direction away from the center of the gas flow passage 125.

[0393] Any suitable combination of shapes may be provided. For example, at least one of the leading edges 130a', 130b' may be one of straight, concave, or convex, and at least one of the trailing edges 130a", 130b" may be another of straight, concave, or convex.

[0394] The leading edges 130a', 130b' and the trailing edges 130a", 130b" may have the same configuration as each other, or may have different configurations than each other. For example, the gradient and / or curvature of the upstream side may be different from the gradient and / or curvature of the downstream side.

[0395] When a plurality of protrusions are provided for the bypass restrictor 130 , the protrusions may have the same shape and configuration as each other, or may have shapes and configurations different from each other.

[0396] In the configuration shown, the upper protrusion 130a has a shorter width in the direction along the gas flow path than the lower protrusion 130b. In alternative configurations, the upper protrusion 130a may have the same width as the lower protrusion 130b, or may have a shorter width than the lower protrusion.

[0397] In the illustrated configuration, the upper protrusion 130a extends substantially the same distance into the gas flow channel 125 as the lower protrusion 130b. In alternative configurations, the upper protrusion 130a may extend further into the gas flow channel 125 than the lower protrusion 130b, or the lower protrusion 130b may extend further into the gas flow channel 125 than the upper protrusion 130a.

[0398] The bypass restriction 130 may be integrally formed with the gas manifold 120. Alternatively, the bypass restriction 130 may include an insert for attachment to the gas manifold 120. For example, the bypass restriction may be formed as a sleeve or a plug. The sleeve or plug may be attached to the gas manifold in any suitable manner. For example, the sleeve or plug may be press-fit, threaded, fastened, etc. into the gas flow passage 125 of the gas manifold.

[0399] The bypass restriction 130 may be provided by the gas manifold 120 , by the base portion 118 of the interface body, or by both the gas manifold 120 and the base portion 118 of the interface body.

[0400] The bypass restrictor 130 is configured to provide a second cross-sectional area A2 in the gas flow passage 125 that is reduced compared to a first cross-sectional area A1 of an adjacent or main portion of the gas flow passage 125 .

[0401] In some configurations, the second cross-sectional area A2 may be between about 10% and about 40% of the first cross-sectional area A1. In some configurations, the second cross-sectional area A2 may be between about 10% and about 35% of the first cross-sectional area A1, optionally between about 10% and about 30% of the first cross-sectional area A1, optionally between about 10% and about 25% of the first cross-sectional area A1, and optionally about 17.5% of the first cross-sectional area A1. In some configurations, the second cross-sectional area A2 can be about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24%, about 25%, about 26%, about 27%, about 28%, about 29%, about 30%, about 31%, about 32%, about 33%, about 34%, about 35%, about 36%, about 37%, about 38%, about 39% or about 40% of the first cross-sectional area A1, or can be any percentage between any two of these percentages.

[0402] In one exemplary configuration, the first cross-sectional area may be approximately 200 mm 2 (corresponding to a radius of about 8 mm), and the second cross-sectional area may be about 20 mm 2 To about 80mm 2 between, optionally between about 20 mm 2 To about 70mm 2 between, optionally between about 20 mm 2 To about 60mm 2 between, optionally between about 20 mm 2 To about 50mm 2 between, optionally between about 30 mm 2 To about 40mm 2 between, and optionally about 35 mm 2 .

[0403] For example, the predetermined bypass dimension BD can be between about 5 mm and about 10 mm, optionally between about 5 mm and about 9.5 mm, optionally between about 5 mm and about 8.75 mm, optionally between about 5 mm and about 8 mm, optionally between about 6 mm and about 7 mm, optionally between about 6.5 mm and about 7 mm, and optionally about 6.7 mm.

[0404] In some configurations, the nasal interface 100 includes an interface body 110 that includes a first nasal delivery element 111 and a second nasal delivery element 112 .

[0405] In some configurations, the gas manifold 120 is integral with the interface body 110 or is separate from the interface body 110 and coupleable thereto.

[0406] The first nasal delivery element 111 has a first outlet 111a defined by an opening at a tip or terminal end 111b thereof to deliver gas from the first nasal delivery element 111. Gas delivered through the first nasal delivery element 111 exits the first nasal delivery element 111 through the first outlet 111a.

[0407] The second nasal delivery element 112 has a second outlet 112a defined by an opening at a tip or terminal end 112b thereof to deliver gas from the second nasal delivery element 112. Gas delivered through the second nasal delivery element 112 exits the second nasal delivery element through the second outlet 112a.

[0408] The first nasal delivery element 111 and the second nasal delivery element 112 can have any suitable shape to seal the patient's nostrils. For example, in one configuration, the first nasal delivery element 111 and the second nasal delivery element 112 can be generally tubular and sized to be larger than the patient's nostrils, but can be pliable or flexible to deform and seal the nostrils when inserted into the nostrils. In some configurations, the nasal delivery elements 111, 112 are more pliable or flexible than the body portion 118.

[0409] As another example, and as shown, the first nasal delivery element 111 and the second nasal delivery element 112 can include nostril locators or nasal pillows to seal the patient's nostrils.

[0410] In the configuration shown, for example Fig.13 and Fig.14 As shown, each nasal pillow can generally be tapered so that it narrows toward the corresponding outlet 111a, 112a at its tip or terminal end 111b, 112b. Thus, the proximal opening 111a, 112a can have a smaller diameter or transverse dimension than the distal opening 111c, 112c at the base of the nasal pillow. In general, the nasal pillow can be tapered in the proximal direction toward its tip or terminal end 111b, 112b.

[0411] In the illustrated configuration, the tips or terminal ends 111b, 112b of the nasal pillows are configured to be received in the patient's nostrils, and the expanded regions 111d, 112d of the nasal pillows adjacent to the tips or terminal ends 111b, 112b are configured to seal the entrance to the nostrils. In other configurations, the tips or terminal ends 111b, 112b and a portion of the expanded regions 111d, 112d may be configured to be received in the nostrils to seal them.

[0412] The nasal pillow can be pliable or flexible to deform and seal the nostril when inserted into or in contact with the nostril. In some configurations, the nasal pillow is more pliable or flexible than the body portion 118.

[0413] The nasal pillows are also desirably sufficiently stiff to reduce the likelihood of expansion or inadequate self-support, thereby providing an indication to the user of the correct position and orientation of the nasal interface 100 relative to the face. The nasal pillows may have sufficient stiffness to inhibit or prevent significant collapse in response to positioning of the nasal pillows relative to the patient's nares. In some configurations, given the desire to reduce user discomfort while still assisting in positioning the nasal interface, the nasal pillows may have a thickness of approximately 0.7 mm, with some variations being slightly higher and lower.

[0414] The nasal pillows may include one or more stiffening elements or features to inhibit collapse of the nasal pillows.

[0415] The first nasal delivery element 111 and the second nasal delivery element 112 are movable relative to the body portion 118 to enable adjustment of the angle and positioning of the nasal delivery elements 111, 112 in response to contact with the patient's nostrils.

[0416] The nasal pillows and nasal interface may have any one or more of the features described with respect to the nostril locators of U.S. Patent No. 10,918,818, the entire contents of which are incorporated herein by reference.

[0417] If any leakage occurs between the nasal delivery elements 111, 112 and the patient's nares, the leakage will be minimal and can be compensated or controlled by adjusting the therapy gas flow rate.

[0418] The nasal interface 100 is configured to produce an asymmetric gas flow at the patient's nares due to a pressure drop across the gas flow passage 125 of the nasal interface 100 .

[0419] The nasal interface 100 can be configured so that about 10 lpm to about 50 lpm is delivered from the nasal interface 100 through the nasal delivery elements 111, 112. The proportion delivered through each nasal delivery element will vary depending on the patient, pressure differential, and stage of the respiratory cycle.

[0420] Having a flow differential between the nasal delivery elements 111, 112 can provide the asymmetric flow benefits described below.

[0421] In some configurations, there is a relatively constant pressure differential between the nasal delivery elements 111, 112, and thereby a relatively constant asymmetric flow is generated through the nasal delivery elements 111, 112. In some configurations, the pressure differential and the resulting asymmetric flow can vary. Asymmetric flow occurs as long as there is a pressure drop across the gas manifold 120 during at least a portion of the breathing cycle.

[0422] The proportion of the total volume flow delivered through each prong 111, 112 can be determined by delivering a gas having a known volume flow rate to the gas inlet 121 of the nasal interface 100 when the nasal interface is not applied to the patient's nostrils. The volume flow rate exiting each outlet 111a, 112a can be measured by a suitable flow meter or sensor to determine the proportion of the total volume flow rate of gas flowing into the gas inlet 121 that exits from the outlet 111a, 112a of each nasal delivery element 111, 112.

[0423] The nasal interface 100 includes a bias flow restriction 140 for allowing gas to flow out of the nasal interface 100 and, optionally, for allowing gas to flow out of the gas manifold 120 .

[0424] refer to Figures 1 to 5 , Fig.16 and Fig.18 The bias flow restriction 140 is in fluid communication with the gas manifold 120 , and more specifically with the gas port 122 of the gas manifold 120 .

[0425] The bias flow restriction 140 is located downstream of the first nasal delivery element 111 and the second nasal delivery element 112 in the patient interface 100 and opposite to the gas port 121, so that gas can flow out of the nasal interface from the first nasal delivery element 111 and the second nasal delivery element 112 through the bias flow restriction 140. Some of the gas entering the gas inlet port 121 can flow out of the bias flow restriction 140 without flowing through the first nasal delivery element 111 and the second nasal delivery element 112. The gas flowing out of the nasal interface through the bias flow restriction may include exhaled gas, and may further include some inlet gas that does not flow through the first nasal delivery element 111 and the second nasal delivery element 112.

[0426] The bias flow restriction 140 allows pressure therapy to be provided to the patient's nostrils. The bias flow restriction 140 enables a restricted flow of gas through the bias flow restriction and out of the nasal interface 100. Without the bias flow restriction 140 and the gas port 122 closed, all exhaled gas would be re-inhaled. Without the bias flow restriction and the gas port 122 open, the respiratory therapy device would not be able to apply pressure across the nasal interface.

[0427] The open area for gas flow through the bias flow restriction can be selected to provide sufficient area for bias flow while minimizing noise from the bias flow. In one exemplary configuration, when providing a patient pressure of about 10 cmH2O, the gas flow through the nasal interface 100 can be about 25-45 lpm, and the open area for gas flow through the bias flow restriction can be about 10 mm2. 2 To about 15mm 2However, this is just one example, and these values ​​may vary depending on system parameters and patient requirements. In another example, the open area for gas to flow through the bias flow restriction may be about 10 mm 2 To about 30mm 2 between, optionally between about 25 mm 2 To about 30mm 2 and optionally about 27.5 mm 2 .

[0428] The gas manifold 120 may include or may be coupled to a bias flow restriction 140. Fig.18 In the illustrated alternative configuration, the bias flow restriction 140 can be in fluid communication with the gas manifold 120, but located away from the gas manifold 120. In this alternative configuration, the exhaled gas conduit 160 is coupled to the gas port 122 of the gas manifold 120, and the bias flow restriction 140. The exhaled gas conduit 160 can have any suitable length. This configuration enables the exhaled gas and any inlet gas that bypasses the first nasal delivery element 111 and the second nasal delivery element 112 to be discharged through the bias flow restriction 140 at a location spaced apart from the patient.

[0429] See also Figures 6 to 9 The bias flow restriction 140 includes one or more gas outlets for allowing gas to flow from the nasal interface 100, and optionally from the gas manifold 120, to the surrounding environment.

[0430] The one or more gas outlets may include one or more holes. In the illustrated configuration, the one or more gas outlets include a plurality of holes 142 for allowing gas to flow from the nasal interface 100, and optionally from the gas manifold 120, to the surrounding environment.

[0431] The plurality of holes 142 can be provided in any suitable arrangement or array. For example, in the configuration shown, the plurality of holes 142 are provided in an array of four long rows and two outer short rows. However, any other suitable arrangement can be provided, such as more or less number of rows of holes, more or less number of holes in each row, or random hole arrangements.

[0432] The bias flow restriction 140 may include 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50 or more apertures.

[0433] Additionally or alternatively, the one or more gas outlets may include one or more slots, which may be straight, curved, wavy, tortuous or any other suitable shape.

[0434] The outlet size of the one or more gas outlets is typically significantly smaller than the size of the gas inlet into the bias flow restriction 140 to create a pressure drop or resistance to the flow out of the one or more gas outlets. The pressure drop causes the gas pressure upstream of the one or more gas outlets to be higher than the gas pressure downstream of the one or more gas outlets.

[0435] However, when multiple outlets are provided, the sum of the outlet sizes may approach the size of the gas inlet.

[0436] In some configurations, the gas inlet 148 and the one or more gas outlets are arranged in the bias flow restriction 140 so that the gas flow F needs to change direction between entering the bias flow restriction and leaving the bias flow restriction. Figure 7 Indicated by arrow F.

[0437] In some configurations, the one or more gas outlets are provided in the restriction member body 144. The restriction member body 144 defines a body gas flow passage 146 in fluid communication with a body gas inlet 148. The one or more gas outlets are in fluid communication with the body gas flow passage 146 such that gas enters the body gas flow passage 146 from the gas port 122 of the gas manifold and flows out of the one or more gas outlets (e.g., holes 142).

[0438] For example, Figure 7 As shown in (b) of FIG. 1 , the restricting member body 144 may have a tapered configuration in which the body gas flow passage 146 becomes smaller as it moves away from the body gas inlet 148 than it does near the body gas inlet 148. The top plate, end wall 144b, and / or wall 144c of the body containing the one or more gas outlets may be angled so as to be non-parallel and non-perpendicular relative to each other, thereby facilitating flow from the body gas inlet 148 through the one or more gas outlets.

[0439] In some configurations, the bias flow restriction 140 is configured to direct gas out of the bias flow restriction away from the patient's face. In the configuration shown, the bias flow restriction 140 is configured to direct the gas flow at least partially in a forward direction, and in some configurations completely in a forward direction away from the patient's face.

[0440] The bias flow restriction 140 is capable of exhausting carbon dioxide (CO2) by using the one or more gas outlets. In the illustrated embodiment, the nasal interface 100 has (multiple) holes 142 for exhausting gas from the interior of the nasal interface 100 to the environment. (Multiple) holes 142 or other openings can help exhaust carbon dioxide gas from the user to reduce re-breathing of carbon dioxide gas.

[0441] The one or more gas outlets create a controlled or known leak to be able to vent the carbon dioxide gas exhaled by the user. There may be a performance tradeoff between the location of the one or more openings (relative to the patient's nose) and the desired amount of bias. As used herein, bias flow refers to the flow of gas to the environment through the bias flow restriction 140. The flow rate of the bias flow and the design geometry of the one or more openings can have an impact on the noise level and airflow generated by the bias flow and the amount of entrainment that may be caused by the exiting gas flow.

[0442] The one or more gas outlets may include a plurality of through holes 142 for exhausting gas from the nasal interface. In other configurations, the gas outlet may be a slit or a large opening instead of or in addition to the small through holes. In some configurations, the gas outlet may be provided on other portions of the interface. Typically, a relatively small hole size produces less airflow noise than a larger hole size, given the same flow rate through the two hole sizes. Multiple holes help reduce airflow noise when exhausting a given volume of gas compared to one or a few holes with the same ventilation area.

[0443] The one or more gas outlets may have any one or more of the features or functions described for vents in US Pat. No. 10,898,866, the entire contents of which are incorporated herein by reference.

[0444] The bias flow restrictor 140 may include an optional filter or diffuser to filter or diffuse the gas flowing through the one or more gas outlets, such as through the aperture(s).

[0445] The filter may mitigate respiratory contaminants from being released through the bias flow restriction.

[0446] The diffuser may diffuse the gas leaving the bias flow restriction to reduce noise.

[0447] Figure 6 A filter or diffuser member 150 is shown, which is configured to cover the at least one or more gas outlets to filter or diffuse the gas when the gas leaves the one or more gas outlets. The filter or diffuser member 150 may include any suitable material, such as one or more of a non-woven fiber material (including polymer fibers), an open-cell foam, a sintered polymer.

[0448] In some configurations, the restrictor body 144 includes a filter or diffuser recess 145 to receive a filter or diffuser member 150 .

[0449] The bias flow restriction 140 may include a shroud 152 configured to attach to the restriction body 144 and maintain the filter or diffuser member 150 in place over the one or more gas outlets.

[0450] The shield 152 includes an aperture 153 that is at least the size of the at least one opening of the restrictor body 144 .

[0451] The shroud 152 may carry the filter or diffuser member 150 in the aperture 153 , or the filter or diffuser member 150 may be sandwiched between the shroud 152 and the recess 145 .

[0452] The shroud 152 may be removably attached to the restrictor body 144 to enable the filter or diffuser member 150 to be cleaned or replaced.

[0453] The shield 152 may be attached to the restricting member body 144 by any suitable arrangement, such as clamp(s), fastener(s), etc. In the illustrated configuration, the shield 152 includes two inwardly directed engagement members 154 that snap fit into complementary engagement recess(es) 147 on the restricting member body 144.

[0454] The shield may include one or more gripping portions 156 to enable the engagement member 154 to be released from the recess(es) 147, thereby removing the shield 152 from the restraining member body 144. In the illustrated configuration, the gripping portion(s) 156 include outward protrusions to enable a user to apply force in an outward and downward direction to urge the engagement member(s) out of engagement with the restraining member body 152, but any other suitable configuration may be used.

[0455] In some configurations and as Fig.17 As shown in (b), the filter unit 500' may be disposed between the gas manifold 120 and the bias flow restriction member 140. The filter unit 500' may have any one or more features described herein for the filter unit 500.

[0456] In some configurations, the nasal interface 100 of the present disclosure includes: a first nasal delivery element 111 and a second nasal delivery element 112, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are each configured to seal a corresponding nostril of the patient; and a gas manifold 120, the gas manifold including a gas inlet 121 for delivering respiratory gas to the gas manifold, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are fluidly connected to the gas inlet 121 via the gas manifold 120, wherein the first nasal delivery element 111 is close to the gas inlet 121 and the second nasal delivery element 112 is far from the gas inlet 121, wherein the nasal interface 100 is configured to generate a pressure difference between the first nasal delivery element 111 and the second nasal delivery element 112 when gas is delivered from the gas inlet 121 to both the first nasal delivery element 111 and the second nasal delivery element 112, so that the pressure at the first nasal delivery element 111 is higher than the pressure at the second nasal delivery element 112.

[0457] In some configurations, the pressure difference is such that when there is gas flowing from the gas inlet 121 to the first nasal delivery element 111 and the second nasal delivery element 112, the gas flow from the gas inlet 121 to the first nasal delivery element 111 is greater than the gas flow from the gas inlet 121 to the second nasal delivery element 112.

[0458] In some configurations, the gas inlet 121 is in fluid communication with the breathing conduit 300 .

[0459] In some configurations, when gas is delivered from the gas inlet to both the first and second nasal delivery elements, the gas flow pressure at the second nasal delivery element 112 is at most about 1 cmH2O less than the gas flow pressure at the first nasal delivery element 111.

[0460] For example, the gas flow pressure at the second nasal delivery element 112 can be approximately 0.1 cmH2O, approximately 0.2 cmH2O, approximately 0.3 cmH2O, approximately 0.4 cmH2O, approximately 0.5 cmH2O, approximately 0.6 cmH2O, approximately 0.7 cmH2O, approximately 0.8 cmH2O, approximately 0.9 cmH2O, or approximately 1 cmH2O less than the gas flow pressure at the first nasal delivery element 111, or the difference can be any value between any two of these values.

[0461] The gas flow pressure differential between the first nasal delivery element and the second nasal delivery element may be higher during the inhalation phase than during the exhalation phase.

[0462] The nasal interface can be configured to achieve a patient pressure at the first and second nasal delivery elements of between about 2 cmH2O to about 30 cmH2O in use, optionally between about 2 cmH2O to about 25 cmH2O in use, optionally between about 2 cmH2O to about 20 cmH2O in use, optionally between about 2 cmH2O to about 15 cmH2O in use, optionally between about 2 cmH2O to about 14 cmH2O in use, optionally between about 2 cmH2O to about 13 cmH2O in use, optionally between about 2 cmH2O to about 12 cmH2O in use, optionally between about 2 cmH2O to about 11 cmH2O in use, optionally between about 2 cmH2O to about 10 cmH2O in use.

[0463] In some configurations, the pressure differential between the first nasal delivery element 111 and the second nasal delivery element 112 is configured to provide an asymmetric flow rate between about 1 liter per minute (lpm) and about 5 lpm through the upper airway of the patient.

[0464] For example, the asymmetric flow through the patient's upper airway can be about 1 lpm, about 1.25 lpm, about 1.5 lpm, about 1.75 lpm, about 2 lpm, about 2.25 lpm, about 2.5 lpm, about 2.75 lpm, about 3 lpm, about 3.25 lpm, about 3.5 lpm, about 3.75 lpm, about 4 lpm, about 4.25 lpm, about 4.5 lpm, about 4.75 lpm, about 5 lpm, or any value between any two of these values.

[0465] Asymmetric flow promotes removal of CO2 from the patient's anatomical dead space.

[0466] As described above, the interface body 110 can be engaged with the gas manifold 120. Accordingly, in some configurations, the nasal interface 100 of the present disclosure includes an interface body 110 portion, which includes a first nasal delivery element 111 and a second nasal delivery element 112, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal the corresponding nostrils of the patient. The nasal interface 100 of the present disclosure further includes a gas manifold 120 portion, which includes a gas inlet 121 for delivering respiratory gas to the gas manifold portion. The interface body 110 portion can be engaged with the gas manifold 120 portion so that the first nasal delivery element 111 and the second nasal delivery element 112 are in fluid communication with the gas inlet 121, so that the first nasal delivery element 111 is closer to the gas inlet 121, and the second nasal delivery element 112 is farther away from the gas inlet 121. The nasal interface 100 includes at least one gas flow restriction 130 for providing gas flow through the nasal interface so that when gas is delivered from the gas inlet 121 to the first nasal delivery element 111 and the second nasal delivery element 112, the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

[0467] The at least one flow restriction may include a bypass restriction. The bypass restriction may have any one or more of the features and functions described herein for the bypass restriction 130.

[0468] In some configurations, the nasal interface further includes a bias flow restriction. The bias flow restriction can have any one or more of the features and functions described herein for the bias flow restriction 140.

[0469] Thus, the nasal interfaces described herein may include a bypass restriction, a bias flow restriction, or may include both a bypass restriction and a bias flow restriction.

[0470] By providing an asymmetric flow, use of the disclosed nasal interface 100 can reduce dead space (i.e., the volume of air that does not participate in gas exchange in the lungs) compared to conventional continuous positive airway pressure (CPAP) therapy. It should be understood that within the patient's upper airway, a certain proportion of gas moves in a unidirectional manner, flowing into one nostril and out of the other nostril, thereby reducing upper airway dead space. This may be most significant at higher set pressures, which increases asymmetric flow and, therefore, dead space clearance.

[0471] The bypass restriction 130 facilitates obtaining an asymmetric flow. The bias flow restriction 140 in combination with the sealed nasal elements 111, 112 allows for CPAP-style therapy. The nasal interface 100 enables CPAP to enhance dead space clearing. The bypass restriction 130 enables dead space clearing. The sealed nasal delivery elements 111, 112 enable CPAP therapy.

[0472] There will be inspiratory and expiratory airflow in both nostrils. However, the flow is partially unidirectional, with a larger proportion of the inspiratory airflow passing through the nostril near the gas inlet 121 and thereby reaching the flow source.

[0473] The nasal interface 100 can be used for controlled pressure therapy, but with higher humidity than conventional CPAP therapy. The higher humidity is believed to work beneficially with enhanced dead space clearance.

[0474] In some configurations, the nasal interface 100 may be adapted or may be used for pressure controlled therapy at a therapy pressure between about 2 cmH2O and about 10 cmH2O (depending on patient requirements and therapy requirements).

[0475] For example, the nasal interface can be suitable for or can be used for pressure-controlled therapy with a therapy pressure of about 2 cmH2O, 2.5 cmH2O, 3 cmH2O, 3.5 cmH2O, 4 cmH2O, about 4.5 cmH2O, about 5 cmH2O, about 5.5 cmH2O, about 6 cmH2O, about 6.5 cmH2O, about 7 cmH2O, about 7.5 cmH2O, about 8 cmH2O, about 8.5 cmH2O, about 9 cmH2O, about 9.5 cmH2O, or about 10 cmH2O.

[0476] The pressure may be set or controlled by a respiratory therapy system, examples of which are described below.

[0477] To maintain the desired pressure, a gas flow is provided, and the flow rate depends on the phase of the respiratory cycle and the geometry of the bias flow restriction 130, among other factors.

[0478] Fig.10 (a) and Fig.10(b) shows the gas flow through the nasal interface 100. As the gas flow F enters the flow channel 125 of the gas manifold 120, a portion F1 of the flow continues through the upstream first nasal delivery element 111 and through the patient's upper airway. A portion F2 of the flow continues through the bypass restriction 130. The flow portion F2 that continues through the bypass restriction 130 enables the flow F3 to pass through the downstream second nasal delivery element 111, so that inspiration can be performed through these two nasal delivery elements 111, 112 (assuming that the nostrils are not blocked).

[0479] During inspiration, flow F preferentially enters the upstream nostril, and slightly more flow enters the upstream nostril than the downstream nostril. During exhalation, since flow F3 is less than F1, flow preferentially leaves the downstream nostril (flow F5), and more flow leaves the downstream nostril than the upstream nostril (flow F4).

[0480] When holding the breath, since the flow F1 flowing into the upstream nostril is greater than the flow F3 flowing into the downstream nostril, part of the flow enters the upstream nostril and flows out of the downstream nostril.

[0481] The geometry of the bias flow restriction 140 defines the volume of forward flow through the nasal interface 100. A larger bias flow area produces a higher flow rate required for the gas source to reach the desired therapy pressure.

[0482] The bypass restriction 130 creates a pressure drop between the gas F1 delivered to the upstream nostril and the gas F3 delivered to the downstream nostril, thereby creating a pressure differential at the first nasal delivery element 111 and the second nasal delivery element 112 .

[0483] The pressure drop creates an asymmetric flow, which causes the dead space to be "flushed" or "cleared," which is the volume of gas that does not participate in gas exchange within the alveoli and consists primarily of CO2.

[0484] In some configurations, the asymmetric flow configuration can be between about 1 lpm and about 5 lpm.

[0485] In some configurations, the pressure at the downstream nostril can be about 1 cmH2O less than the pressure delivered to the upstream nostril, such as about 6 cmH2O at the upstream nostril and about 5 cmH2O at the downstream nostril.

[0486] Bias flow restriction 140 may be configured to prevent negative flow during provision of respiratory therapy.

[0487] As is well known, negative flow can lead to dead space or rebreathing. Therefore, the bias flow restriction 140 should be large enough to achieve a sufficiently high bias flow, thereby reducing or eliminating the occurrence of negative flow and rebreathing volume.

[0488] Asymmetric flow will reduce the amount of gas rebreathed throughout the respiratory cycle due to ventilation of the upper airway volume.

[0489] This may alternatively be described as reducing dead space, or reducing the amount of gas that does not participate in gas exchange during the respiratory cycle.

[0490] For example, the effect of reducing dead space can also be seen in high-flow therapy.

[0491] This reduces rebreathing of CO2 and increases the amount of oxygen available for gas exchange.

[0492] The delivered gas may require additional humidity than is typically used for non-invasive ventilation (NIV) or continuous positive airway pressure (CPAP) therapy. This additional humidity is to prevent upper airway drying as the gas in the dead space is replaced by the gas provided by the therapy.

[0493] The anatomical dead space volume for a given patient may typically be between 100 ml and 150 ml.

[0494] The bypass flow generated by the bypass restriction 130 is such that there is a pressure differential between the two nostrils in response to the device delivering flow during breathing or during apnea. Some possible configurations of the bypass restriction may be as described, however, in alternative configurations of the bypass restriction, this may be achieved by one, or a combination of two or more of the following:

[0495] • Restricting the bypass flow, for example by having a reduced cross-section or having some element that creates such a restriction, such as one or more protrusions or nozzles or some other cross-section reduction.

[0496] • The geometry of the bypass restriction can be designed so that it preferentially follows one path rather than another, for example by utilizing a geometry that has a higher pressure drop in one direction than the other, such as a bell-mouth nozzle or restriction, a low pressure ejector, or a check valve.

[0497] • Flexible elements or valves that create a preferential (but not exclusive) flow from the upstream to downstream direction.

[0498] User adjustable valves, where a screw or some other mechanism is used to change the cross-sectional area through which the bypass flow passes.

[0499] • Flow enters the first nasal delivery element axially, radially, tangentially at an angle, or some combination of these flows to preferentially direct the gas flow to the first nasal delivery element rather than the second nasal delivery element.

[0500] • Bypass restrictions include a web of sparse material used to create a pressure drop, such as filters, non-woven polypropylene, foamed plastics, sintered materials, or any other material that creates a pressure drop across it when flow is present.

[0501] The bypass restriction may include any one or more of the features described in US2016 / 0228665, the entire contents of which are incorporated herein by reference.

[0502] The overall amount of bias is primarily controlled by selecting the geometry on the bias flow restriction 140. Some possible configurations of the bias flow restriction may be as described, however, in alternative configurations, the pressure drop of the bias flow restriction may be achieved by one, or a combination of two or more of the following:

[0503] • Restricting the amount of deflection, for example by having a reduced cross section or having some element that creates such a restriction, such as one or more members or nozzles or some other cross section reduction.

[0504] • A flexible element or valve that allows preferential (and possibly exclusive) flow out of the nasal interface to reduce or prevent entrainment of ambient air.

[0505] Check valves can be used to reduce / prevent ambient air entrainment.

[0506] • Flexible elements that can be used to create a pressure drop but are less likely to clog in the presence of water or phlegm than rigid holes / nozzles.

[0507] • There may be a web of sparse material that creates a pressure drop, such as a filter, non-woven polypropylene, foam, sintered material or any other material that creates a pressure drop across it when there is flow.

[0508] User adjustable valves, where the flow cross-sectional area is varied by means of a screw or some other mechanism.

[0509] Change the direction of the flow multiple times.

[0510] The pressure drop across the nasal interface 100 may be relatively constant over the patient's breathing cycle, or alternatively may vary over the patient's breathing cycle.

[0511] See also Fig.15 , Table 1 summarizes the different gas flows that may be encountered during use of the nasal interface 100.

[0512]

[0513]

[0514] Table 1 - Overview of Flows

[0515] exist Fig.15In the example, positive flow is in the direction of the arrow, while negative flow is in the opposite direction of the arrow. "Either" means that the flow can move in either direction based on a variety of factors. Zero means there is no net flow in this case.

[0516] If the upstream nostril is completely blocked, the patient receives flow to the downstream nostril.

[0517] If the downstream nostril is completely blocked, the patient receives flow through the upstream nostril.

[0518] In both cases, the patient does not receive any asymmetric flow, but continues to be provided with therapy without this component.

[0519] If either nostril is significantly but not completely blocked, reduced asymmetric flow occurs.

[0520] The device can be used in similar patient populations suitable for non-invasive ventilation (NIV).

[0521] The nasal cycle may cause fluctuations in the asymmetric flow provided by the nasal interface 100 .

[0522] like Fig.15 As schematically indicated, nasal interface 100 forms a circuit with the patient's upper airway and lungs. A first portion of the circuit includes a first nasal delivery element 111, a patient's upstream nostril associated with the first nasal delivery element 111, the patient's upper airway and lungs, a second nasal delivery element 112, and a patient's downstream nostril associated with the second nasal delivery element 112. A second portion of the circuit includes the first nasal delivery element 111, a bypass restriction 130, and the second nasal delivery element 112. The bypass restriction provides a pressure drop across the gas manifold between the first nasal delivery element 111 and the second nasal delivery element 112, which achieves an asymmetric flow across the first nasal delivery element 111 and the second nasal delivery element 112.

[0523] The nasal interface 100 creates a pressure differential between the two nostrils such that, for at least some portions of the breathing cycle, the upstream nostril is at a higher pressure than the downstream nostril.

[0524] This pressure difference creates flow in the upper airway, where after a full respiratory cycle, more flow enters the upstream nostril than the downstream nostril, and more flow leaves the downstream nostril than the upstream nostril. This extra flow into the upstream nostril and out of the downstream nostril is asymmetric flow.

[0525] Asymmetric flow dilutes the gas in the patient's airway, which is known in the art as washout or dead space clearance.

[0526] There are a number of ways to achieve this pressure difference between the entrances of the two nostrils, including providing a bypass flow between the nostrils that is adjusted to provide some pressure drop.

[0527] In some configurations of nasal interface 100, gas manifold 120 may be configured to allow breathing conduit 300 to be connected to the right side of the gas manifold ( Fig.16 (a)) or on the left side of the gas manifold ( Fig.16 That is, the breathing conduit 300, and optionally the bias flow restriction 140, can be interchanged laterally relative to the gas manifold 120. This enables the breathing conduit 300 to be positioned on the right or left side of the patient during use.

[0528] In some configurations, the gas ports 121, 122 may have the same configuration as each other, so that the breathing conduit 300 may be selectively coupled to either of the gas ports 121, 122. The gas port connected to the patient's breathing conduit forms the gas inlet of the gas manifold 120, while the opposite gas port forms the gas outlet of the gas manifold. Fig.16 In the configuration of (a), the gas port 121 forms a gas inlet, and the first nasal delivery element 111 forms an upstream nasal delivery element closer to the gas inlet. Fig.16 In the configuration of (b), the gas port 122 forms a gas inlet, and the second nasal delivery element 112 forms an upstream nasal delivery element closer to the gas inlet.

[0529] The internal features of the gas manifold 120 can be symmetrical so that the performance of the nasal interface 100 does not change depending on which side of the gas manifold the breathing conduit 300 is connected to.

[0530] When a bias flow restriction 140 is provided, the bias flow restriction may be selectively coupleable with either of the gas ports 121, 122, as opposed to the breathing conduit 300. The breathing conduit 300 and the bias flow restriction 140 may have the same coupling features as each other.

[0531] Although the breathing conduit 300 can be selectively connected to either side of the gas manifold 120, at any stage during use of the nasal interface, one of the ports 121, 122 serves as a single gas inlet into the gas manifold 120. The other of the ports 121, 122 typically serves as a gas outlet from the gas manifold to deliver gas to the bias flow restriction 140.

[0532] The nasal interface 100 may be provided with one or more pressure ports to allow pressure measurement for controlling a respiratory therapy device or for reporting purposes. The pressure port(s) may be provided upstream and / or downstream and / or internal to the nasal interface 100 .

[0533] Gases entering and / or leaving the nasal interface 100 may be filtered. Upstream and / or downstream filters may be provided for this purpose.

[0534] In the illustrated configuration, the patient interface 1 includes a filter 500 in fluid communication with the breathing conduit 300 to filter gas entering the breathing conduit 300 .

[0535] The filter(s) may have any one or more of the features and functions of the filter of US Pat. No. 6,619, 287, the entire contents of which are incorporated herein by reference.

[0536] It may be desirable to configure the cross-sectional area through the bypass restriction 130 to be as wide as possible to increase patient comfort. However, increasing the cross-sectional area through the bypass restriction 130 risks reducing the amount of asymmetric flow. That is, increasing the cross-sectional area through the bypass restriction 130 reduces the degree of restriction, which in turn reduces the pressure difference between the upstream nasal delivery element 111 and the downstream nasal delivery element 112 that drives asymmetric flow and flushing.

[0537] As outlined above, bypass restriction 130 can be any feature or geometry that provides a pressure drop across nasal interface 100 between first nasal delivery element 111 and second nasal delivery element 112 as gas is delivered from gas inlet 121 to first nasal delivery element 111 and second nasal delivery element 112, such that the pressure at first nasal delivery element 111 is higher than the pressure at second nasal delivery element 112. In some configurations, bypass restriction 130 can be a physical restriction relative to adjacent portions of gas flow passage 125, relative to gas inlet 121, relative to the combined cross-sectional area A3+A4 of first nasal delivery element 111 and second nasal delivery element 112, and / or relative to any other portion of nasal interface 100.

[0538] The inventors have found that effective asymmetric flow can be maintained at a wide variety of ratios of the bypass restriction cross-sectional area to the combined cross-sectional area of ​​the nasal delivery element. This can allow optimization of patient comfort while maintaining a therapeutically effective asymmetric flow.

[0539] By adequately flushing the dead space of the patient's upper airway, a therapeutically effective asymmetric flow can be provided. The flushing level can be at least about 10% of the patient's upper airway volume, optionally at least about 20% of the volume, optionally at least about 30% of the volume, optionally at least about 40% of the volume, optionally at least about 50% of the volume, optionally at least about 60% of the volume, optionally at least about 70% of the volume, optionally at least about 80% of the volume, optionally at least about 90% of the volume, optionally about 100% of the volume. In some configurations, the flushing level can be determined over a single respiratory cycle.

[0540] The ratio of the cross-sectional area A2 of the bypass restriction 130 to the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 helps achieve asymmetric flow and thus helps achieve effective flushing. The cross-sectional area A2 of the bypass restriction 130 and the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 are the cross-sectional areas or inner cross-sectional areas for gas flow. The combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 can be at the smallest transverse dimension of the respective nasal delivery elements 111, 112.

[0541] The bypass restriction 130 drives asymmetric flow by restricting gas flow to the downstream nasal delivery element 112 relative to the upstream nasal delivery element 111. Therefore, the cross-sectional area A2 of the bypass restriction 130 should be sufficiently narrow (or in other words, sufficiently restrictive) relative to the cross-sectional area A3+A4 of the nasal delivery elements 111, 112 so that the restriction and therefore the pressure differential is achieved.

[0542] However, it is also desirable that the cross-sectional area A2 of the bypass restriction 130 is as wide as possible to increase the comfort of the patient and the versatility of the therapy. In particular, it is desirable that the cross-sectional area A2 of the bypass restriction 130 is wide enough so that if the upstream nasal delivery element 111 or the nostril is blocked during therapy, the patient can still receive CPAP therapy through the downstream nasal delivery element 112. The increased effort to inhale may potentially cause the patient to feel insufficient air. Making the cross-sectional area A2 of the bypass restriction 130 larger means that a larger portion of the flow passes through the downstream nasal delivery element 112 to the downstream nostril during inhalation. This reduces the pressure drop experienced by the patient and reduces such discomfort. However, making the cross-sectional area A2 of the bypass restriction 130 larger will cause the therapy to tend toward traditional CPAP therapy without therapeutically effective asymmetric flow. Patients receiving traditional CPAP therapy may feel more comfortable and less restricted because the device can more easily control the flow, thereby reducing the flow rate and reducing noise and the feeling of spraying in the nostrils.

[0543] In some configurations, the nasal interface 100 of the present disclosure includes: a first nasal delivery element 111 and a second nasal delivery element 112, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are each configured to seal a corresponding nostril of a patient; and a gas manifold 120, the gas manifold including a gas inlet 121 for delivering respiratory gas to the gas manifold 120, and a gas flow channel 125, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are in fluid communication with the gas inlet 121 via the gas flow channel 125, wherein the first nasal delivery element 111 is adjacent to the gas inlet 121. And the second nasal delivery element 112 is away from the gas inlet 121, wherein the nasal interface includes a bypass restriction 130, which provides a cross-sectional area A2 of a portion of the gas flow channel 125, wherein each of the first nasal delivery element 111 and the second nasal delivery element 112 includes an inner cross-sectional area A3, A4, wherein the inner cross-sectional areas A3, A4 together provide a combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and wherein the cross-sectional area A2 of this portion of the gas flow channel 125 is greater than 0 times to about 1.5 times the combined cross-sectional area A3+A4 of these nasal delivery elements.

[0544] This configuration having the described relative cross-sectional areas may be used in any of the nasal interfaces 100 disclosed herein.

[0545] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is 0.25 times to about 1.5 times the combined cross-sectional area A3 + A4 of the nasal delivery element.

[0546] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is at most about 1.3 times the combined cross-sectional area A3+A4 of these nasal delivery elements, optionally at most about 1 times the combined cross-sectional area A3+A4 of these nasal delivery elements, optionally at most about 2 / 3 of the combined cross-sectional area A3+A4 of these nasal delivery elements, optionally at most about 1 / 2 of the combined cross-sectional area A3+A4 of these nasal delivery elements, optionally at most about 2 / 5 of the combined cross-sectional area A3+A4 of these nasal delivery elements, optionally at most about 1 / 3 of the combined cross-sectional area A3+A4 of these nasal delivery elements.

[0547] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is greater than 0 mm 2 and at most about 375mm 2 , optionally at about 1 mm 2 To about 375mm 2 between, optionally between about 1 mm 2 To about 250mm 2 between, optionally between about 1 mm 2 About 200mm 2 between, optionally between about 1 mm2 To about 167mm 2 between, optionally between about 50 mm 2 To about 167mm 2 between, optionally between about 50 mm 2 To about 103mm 2 between, optionally between about 35 mm 2 To about 100mm 2 The cross-sectional area A2 of the bypass restrictor 130 can be any other value or range of values ​​related to the combined cross-sectional areas A3+A4 of the nasal delivery elements 111, 112 described herein.

[0548] In some configurations, the inner cross-sectional area A3, A4 of each of the first nasal delivery element 111 and the second nasal delivery element 112 is at the minimum transverse dimension of the respective nasal delivery element.

[0549] In some configurations, the inner cross-sectional area of ​​each of the first and second nasal delivery elements 111, 112 is at the outlet 111a, 112a of the respective nasal delivery element 111, 112. Alternatively, the inner cross-sectional area may be elsewhere; for example, midway along the nasal delivery element 111, 112 or at the entrance or base of the nasal delivery element.

[0550] The inner cross-sectional area A3, A4 of each nasal delivery element 111, 112 can be in a direction transverse to the direction of gas flow through the nasal delivery element 111, 112.

[0551] In some configurations, the bypass restriction 130 includes at least one protrusion 130a, 130b that extends into the gas flow channel 125. In some configurations, the bypass restriction 130 includes a plurality of protrusions that extend into the gas flow channel 125.

[0552] In some configurations, the gas manifold 120 includes a proximal bypass protrusion 130a proximal to the nasal delivery elements 111 , 112 , and / or a distal bypass protrusion 130b distal to the nasal delivery elements 111 , 112 .

[0553] In some configurations, the gas manifold 120 includes both a proximal bypass protrusion 130a and a distal bypass protrusion 130b that, in combination, define a predetermined bypass dimension BD to achieve a restricted gas flow through the gas manifold 120 between the first nasal delivery element 111 and the second nasal delivery element 112. In some configurations, the predetermined bypass dimension BD can be restricted relative to an adjacent portion of the gas flow channel 125, relative to the gas inlet 121, relative to the combined cross-sectional area A3+A4 of the first nasal delivery element 111 and the second nasal delivery element 112, and / or relative to any other portion of the nasal interface 100.

[0554] The predetermined bypass dimension BD is typically significantly smaller than a dimension of an adjacent or primary portion of the gas flow channel 125 .

[0555] In some configurations, the bypass restriction 130 includes angled leading edges 130a', 130b' and angled trailing edges 130a", 130b", which define converging and diverging bypass restrictions in the direction of gas flow from the first nasal delivery element 111 through the gas manifold to the second nasal delivery element 112.

[0556] In some configurations, the gas manifold 120 includes a single inlet and a single outlet.

[0557] In some configurations, the nasal interface 100 includes an interface body 110 and a gas manifold portion, and the interface body 110 and the gas manifold portion together form a gas manifold 120 .

[0558] In some configurations, the portion of the gas flow channel providing the cross-sectional area A2 is provided by the interface body 110 and the gas manifold.

[0559] As described above, the interface body 110 may be formed from a soft, flexible material.

[0560] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel can be variable. For example, when a patient wears the nasal interface 100, a portion of the patient's face may hit the base of the nasal delivery elements 111, 112 or the interface body 110 to cause the bypass restrictor 130 and thereby narrow the cross-sectional area A2 of this portion of the gas flow channel. This may be affected by the distance between the base of the nasal delivery elements 111, 112 and the patient's nasal septum. In some configurations, the interface body 110 or a portion thereof can be configured to limit the variability of the cross-sectional area A2 of this portion of the gas flow channel when the patient wears the nasal interface 100. For example, a portion of the interface body 110 can be reinforced with another more rigid material, using a more rigid material, and / or designed to have a specific geometry.

[0561] In some configurations, the gas manifold 120 or gas manifold portion can be separate from the interface body 110 .

[0562] In some configurations, the gas inlet 121 is at a side of the gas manifold 120 .

[0563] In some configurations, the nasal interface 100 includes a bias flow restriction 140 for allowing gas to flow out of the nasal interface 100 through the bias flow restriction 140 .

[0564] In some configurations, the bias flow restriction 140 includes at least one hole 142 for allowing gas to flow from the nasal interface 100 to the surrounding environment. In some configurations, the bias flow restriction 140 includes a plurality of holes 142 for allowing gas to flow from the nasal interface 100 to the surrounding environment.

[0565] In some configurations, the bias flow restrictor 140 includes a filter or a diffuser to filter or diffuse the gas flowing through the aperture(s) 142 .

[0566] In some configurations, the nasal interface includes a filter unit 500 ′ between the gas manifold 120 and the bias flow restriction 140 .

[0567] In some configurations, the bias flow restriction 140 is in fluid communication with the gas manifold 120. In some configurations, the gas manifold 120 includes the bias flow restriction 140, or is coupled to the bias flow restriction 140. In some configurations, the bias flow restriction 140 is in fluid communication with the gas manifold 120, but is located remotely from the gas manifold.

[0568] In some configurations, the bias flow restriction 140 includes an open area for gas to flow through the bias flow restriction 140 and out of the nasal interface 100. In some configurations, the open area is greater than 0 mm. 2 To about 40mm 2 , optionally at about 2 mm 2 To about 40mm 2 between, optionally between about 2 mm 2 To about 5mm 2 between, optionally between about 12 mm 2 To about 40mm 2 between, optionally between about 20 mm 2 To about 30mm 2 between.

[0569] In some configurations, the open area for gas to flow through the bias flow restriction and out of the nasal interface 100 is about 1 mm 2 , about 2mm 2 , about 3mm 2 , about 4mm 2 , about 5mm 2 , about 6mm 2 , about 7mm 2 , about 8mm 2 、About 9mm 2 , about 10mm 2 , about 11mm 2 , about 12mm 2 , about 13mm 2 , about 14mm 2 , about 15mm 2 , about 16mm 2, about 17mm 2 , about 18mm 2 、Approx. 19mm 2 , about 20mm 2 , about 21mm 2 、Approx. 22mm 2 、Approx. 23mm 2 , about 24mm 2 , about 25mm 2 、Approx. 26mm 2 、Approx. 27mm 2 、Approx. 28mm 2 、Approx. 29mm 2 , about 30mm 2 、Approx. 31mm 2 、Approx. 32mm 2 、Approx. 33mm 2 、Approx. 34mm 2 、Approx. 35mm 2 、Approx. 36mm 2 、Approx. 37mm 2 、Approx. 38mm 2 、Approx. 39mm 2 , or about 40mm 2 , or any value between any two of these values.

[0570] For a given pressure differential between the bulk gas flow passage 146 and the exterior of the bias flow restriction 140, the flow through the bias flow restriction 140 is primarily determined by the cross-sectional area of ​​the holes 142 and their geometry. The geometric factor may be referred to as the discharge coefficient. For example, a cylindrical outlet hole 142 with sharp edges allows less flow through than a smooth hole shaped like a venturi nozzle, or a hole with a relatively large radius, chamfer, or other expansion and contraction features on the inlet or outlet side. Viscous effects, such as in a long, thin channel, may also reduce the total flow through the hole, depending on the shape of the hole.

[0571] The size of the apertures 140 may be increased, but the design of the filter or diffuser may additionally or alternatively be adjusted to increase resistance.

[0572] Thus, if appropriate, the upper end of the range of open area sizes for air to flow out of the nasal interface 100 through the bias flow restriction 140 may be increased by up to 25% (e.g., 50 mm 2 Instead of 40mm 2 ), if a suitably configured filter or diffuser is used.

[0573] Similarly, if an orifice 142 with a high discharge coefficient is used, the lower end of the size range of the open area for gas can be reduced by up to 50% (e.g., 6 mm 2Instead of 12mm 2 ).

[0574] In some configurations, the bias flow restriction 140 is configured such that when a pressure greater than 0 cmH2O and up to about 30 cmH2O is provided to the gas inlet 121 in use, a gas flow rate out of the nasal interface 100 through the bias flow restriction 140 is greater than 0 lpm to about 80 lpm.

[0575] In some configurations, the bias flow restriction 140 is configured such that when a pressure of about 5 cmH2O, about 10 cmH2O, about 15 cmH2O, about 20 cmH2O, about 25 cmH2O, about 30 cmH2O, or any value between any two of these values ​​is provided to the gas inlet 121 during use, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is about 5 lpm, about 10 lpm, about 15 lpm, about 20 lpm, about 25 lpm, about 30 lpm, about 35 lpm, about 40 lpm, about 45 lpm, about 50 lpm, about 55 lpm, about 60 lpm, about 65 lpm, about 70 lpm, about 75 lpm, about 80 lpm, or any value between any two of these values.

[0576] In some configurations, the bias flow restriction 140 is configured such that when a pressure between about 5 cmH2O and about 10 cmH2O is applied to the gas inlet 121 during use and the nasal delivery elements 111, 112 are blocked, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is between about 35 lpm and about 55 lpm.

[0577] In some configurations, the bias flow restriction 140 is configured such that when a pressure between about 3 cmH2O and about 10 cmH2O is provided to the gas inlet 121 during use and the nasal delivery elements 111, 112 are blocked, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is between about 4 lpm and about 15 lpm.

[0578] In some configurations, the bias flow restriction 140 is configured such that when a pressure of about 3 cmH2O, about 4 cmH2O, about 5 cmH2O, about 6 cmH2O, about 7 cmH2O, about 8 cmH2O, about 9 cmH2O, about 10 cmH2O, or any value between any two of these values ​​is provided to the gas inlet 121 during use and the nasal delivery elements 111, 112 are blocked, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is about 5 lpm, about 6 lpm, about 7 lpm, about 8 lpm, about 10 lpm, about 11 lpm, about 12 lpm, about 13 lpm, about 14 lpm, about 15 lpm, or any value between any two of these values.

[0579] In some configurations, the bias flow restriction 140 is configured such that when a pressure between about 4 cmH2O and about 30 cmH2O is provided to the gas inlet 121 during use and the nasal delivery elements 111, 112 are blocked, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is between about 15 lpm and about 80 lpm.

[0580] In some configurations, the bias flow restriction 140 is configured such that when a pressure of about 5 cmH2O, about 10 cmH2O, about 15 cmH2O, about 20 cmH2O, about 25 cmH2O, about 30 cmH2O, or any value between any two of these values ​​is provided to the gas inlet 121 during use and the nasal delivery elements 111, 112 are blocked, the gas flow rate flowing out of the nasal interface 100 through the bias flow restriction 140 is about 15 lpm, about 20 lpm, about 25 lpm, about 30 lpm, about 35 lpm, about 40 lpm, about 45 lpm, about 50 lpm, about 55 lpm, about 60 lpm, about 65 lpm, about 70 lpm, about 75 lpm, about 80 lpm, or any value between any two of these values.

[0581] In some configurations, in addition to or in lieu of having a bias flow restriction, the nasal interface 100 can be connected to the expiratory limb of a ventilator, or have a positive end-expiratory pressure (PEEP) valve to control the amount of bias flow out of the nasal interface 100, which can affect the pressure and flushing at the nasal interface 100.

[0582] In some configurations, the cross-sectional area A2 of the portion of the gas flow channel 125 is transverse to the direction of gas flow through the portion of the gas flow channel 125 .

[0583] The inner cross-sectional area A3+A4 of each nasal delivery element 111, 112 can be the cross-sectional area defined by the inner wall of the nasal delivery element 111, 112. For non-circular cross-sections, the diameters mentioned herein can be interpreted as transverse dimensions. In some configurations, the diameters mentioned herein include but are not limited to hydraulic diameters.

[0584] In some configurations, the cross-sectional area A2 of the portion of the gas flow channel 125 is reduced compared to the cross-sectional area A1 of an adjacent portion of the gas flow channel 125 .

[0585] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is between about 10% and at most about 100% of the first cross-sectional area A1 of an adjacent portion of the gas flow channel, optionally about 10% or more and less than 100% of the first cross-sectional area, optionally at most about 90% of the first cross-sectional area A1, optionally at most about 80% of the first cross-sectional area A1, optionally at most about 70% of the first cross-sectional area A1, optionally at most about 60% of the first cross-sectional area A1, optionally at most about 55% of the first cross-sectional area A1, optionally at most about 40% of the first cross-sectional area A1, optionally at most about 30% of the first cross-sectional area A1, and optionally at most about 25% of the first cross-sectional area A1.

[0586] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is at most about 200 mm 2 , optionally up to about 160 mm 2 , optionally up to about 110 mm 2 , optionally up to about 80 mm 2 , optionally up to about 60 mm 2 , and optionally at most about 50 mm 2 .

[0587] In some configurations, the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 is greater than 0 mm. 2 And at most about 250mm 2 , optionally at about 1 mm 2 To about 250mm 2 between, optionally between about 1.6 mm 2 To about 250mm 2 between, optionally between about 50 mm 2 To about 250mm 2 Between, optionally about 50mm 2 About 200mm 2 between, optionally between about 30 mm 2 About 200mm 2 between, optionally between about 30 mm 2 Up to about 155mm 2 between, optionally between about 50 mm 2 Up to about 155mm 2 between.

[0588] In some configurations, the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 is about 1 mm 2 , about 1.6mm 2 , about 5mm 2 , about 10mm 2 , about 15mm2 , about 20mm 2 , about 25mm 2 , about 30mm 2 、Approx. 35mm 2 、Approx. 40mm 2 、Approx. 45mm 2 , about 50mm 2 、Approx. 55mm 2 、Approx. 60mm 2 、Approx. 65mm 2 、Approx. 70mm 2 、Approx. 75mm 2 、Approx. 80mm 2 、Approx. 85mm 2 、Approx. 90mm 2 、Approx. 95mm 2 , about 100mm 2 、Approx. 105mm 2 、Approx. 110mm 2 、Approx. 115mm 2 , about 120mm 2 , about 125mm 2 、Approx. 130mm 2 、Approx. 135mm 2 、Approx. 140mm 2 、Approx. 145mm 2 , about 150mm 2 、Approx. 155mm 2 、Approx. 160mm 2 、Approx. 165mm 2 、Approx. 170mm 2 、Approx. 175mm 2 、Approx. 180mm 2 、Approx. 185mm 2 、Approx. 190mm 2 、Approx. 195mm 2 , about 200mm 2 、About 205mm 2 、About 210mm 2 、Approx. 215mm 2 、Approx. 220mm 2 、Approx. 225mm 2 、Approx. 230mm 2 、Approx. 235mm 2 、Approx. 240mm 2 、Approx. 245mm 2 , or about 250mm 2 , or any value between any two of these values.

[0589] In some configurations, the bypass restrictor 130 can provide a pressure drop across the nasal interface 100 between the first nasal delivery element 111 and the second nasal delivery element 112 when gas is delivered from the gas inlet 121 to the first nasal delivery element 111 and the second nasal delivery element 112, such that the pressure at the first nasal delivery element 111 is higher than the pressure at the second nasal delivery element 112.

[0590] In some configurations, the nasal interface 100 of the present disclosure includes: a first nasal delivery element 111 and a second nasal delivery element 112, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are each configured to seal a corresponding nostril of the patient; and a gas manifold 120, the gas manifold including a gas inlet 121 for delivering respiratory gas to the gas manifold 120, and a gas flow channel, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are in fluid communication with the gas inlet 121 via the gas flow channel 125, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are in fluid communication with the gas inlet 121 via the gas flow channel 125. The nasal interface comprises a bypass restriction member 130 which provides a cross-sectional area A2 of a portion of the gas flow channel, wherein each of the first nasal delivery element 111 and the second nasal delivery element 112 comprises an inner cross-sectional area A3, A4, and wherein the inner cross-sectional areas A3, A4 of the nasal delivery elements and the cross-sectional area A2 of this portion of the gas flow channel are related so as to produce an asymmetric gas flow from the nasal delivery elements 111, 112 during use.

[0591] In some configurations, the inner cross-sectional areas A3 and A4 together provide a combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the cross-sectional area A2 of this portion of the gas flow channel 125 is greater than 0 times to about 1.5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112.

[0592] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is at most about 1.3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, optionally at most about 1 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, optionally at most about 2 / 3 of the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, optionally at most about 1 / 2 of the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, optionally at most about 2 / 5 of the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, optionally at most about 1 / 3 of the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112.

[0593] In some configurations, the inner cross-sectional area A3 , A4 of each of the first nasal delivery element 111 and the second nasal delivery element 112 is at the minimum transverse dimension of the respective nasal delivery element 111 , 112 .

[0594] In some configurations, the inner cross-sectional area A3, A4 of each of the first and second nasal delivery elements 111, 112 is at the outlet 111a, 112a of the respective nasal delivery element 111, 112. Alternatively, the inner cross-sectional area may be elsewhere; for example, midway along the nasal delivery element or at the entrance or base of the nasal delivery element 111, 112.

[0595] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a 20 lpm of bias flow through the bias flow restriction 140 when a pressure of 4 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked. For example, this may occur in a patient with a 10i:20e 500Vt adult breathing pattern of 15 breaths per minute (BPM).

[0596] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a 32 lpm of bias flow through the bias flow restriction 140 when a pressure of 8 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked. For example, this may occur in a patient with an adult breathing pattern of 10i:20e 500Vt at 15 BPM.

[0597] In some configurations, the cross-sectional area A2 of this portion of the gas flow passage 125 is at most about 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a 20 lpm of diversion flow through the diversion flow restriction 140 when a pressure of 4 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked (this may occur at a 10i:20e with 15 BPM). 500Vt adult breathing pattern in patients or patients with ARDS and 25BPM adult breathing pattern); or configured to provide 32lpm of deviation through the deviation restriction 140 when a pressure of 8cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked; or configured to provide 41lpm of deviation through the deviation restriction 140 when a pressure of 12cmH2O is applied to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked; or configured to provide 48lpm of deviation through the deviation restriction 140 when a pressure of 16cmH2O is applied to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked; or configured to provide 53lpm of deviation through the deviation restriction 140 when a pressure of 20cmH2O is applied to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked. For example, this can occur in a patient with ARDS who has an adult breathing pattern of 25 BPM.

[0598] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a deviation amount of 32 lpm or more through the deviation flow restriction 140 when a pressure of 8 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked. This can occur in patients with a 10i:20e 500Vt adult breathing pattern of 15 BPM, or in patients with ARDS and an adult breathing pattern of 25 BPM, or in patients with an adult breathing pattern of 350 sinusoidal breathing pattern of 25 BPM.

[0599] In some configurations, the cross-sectional area A2 of this portion of the gas flow passage 125 is at most about 1 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a deflection flow of 32 lpm or more through the deflection flow restriction 140 when a pressure of 8 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked, or wherein the cross-sectional area A2 of this portion of the gas flow passage is at most about 2 / 5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a deflection flow of 32 lpm or more through the deflection flow restriction 140 when a pressure of 8 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked. When a pressure of 12 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked, a deviation amount of 41 lpm or more is provided through the deviation restriction 140, or wherein the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the nasal interface is configured to provide a deviation amount of 48 lpm or more through the deviation restriction 140 when a pressure of 16 cmH2O is provided to the gas inlet 121 and the nasal delivery elements 111, 112 are blocked.

[0600] The effectiveness of the asymmetric flow (and thus washout) of the nasal interface 100 was evaluated for six different ratios in three different tests.

[0601] Each test consisted of a set breathing pattern, based on which the CPAP settings varied. Tables 2 and 3 show the constant settings and the varying settings for these tests, respectively. Figure 23 to Figure 25 The results of these tests are shown in .

[0602]

[0603] Table 2

[0604]

[0605] Table 3

[0606] In the table above, xi:ye is the ratio of inspiration time x to expiration time y, Vt is the tidal volume and is a measure of the amount of air (in ml) that moves in and out of the lungs during each respiratory cycle.

[0607] In each test, asymmetric flow and washout were measured with rebreathing (the lower the rebreathing, the greater the washout). In the absence of asymmetric flow, a typical rebreathing level in CPAP is approximately 60 ml. Therefore, for the purposes of these tests, washout can be understood to be equal to "60 ml - x", where x = rebreathing volume in ml. 60 ml is an exemplary figure for an upper airway model, excluding the interface itself and assuming no dead space in the interface.

[0608] like Figure 23 to Figure 25 As shown, effective flushing is typically achieved at a ratio of 102:154 (approximately 2 / 3) and below (cross-sectional area of ​​bypass restrictor (BRA): combined cross-sectional area of ​​nasal delivery elements (CNDEA)).

[0609] Ratios of 1:1 (BRA:CNDEA) and above were tested with inconsistent and / or minimal washout. However, ratios up to 1.5:1 (BRA:CNEDA) showed / expected such washout. In practice, the ratios chosen may be lower than 1:1 (BRA:CNDEA).

[0610] Test 1 (15 bpm; 4,8 cmH2O) showed significant washout at ratios of 102:154 (approximately 2 / 3) (BRA:CNEDA) and below, inconsistent washout at a ratio of 1:1 (BRA:CNDEA), and minimal washout at a ratio of 200:154 (approximately 1.5) (BRA:CNDEA).

[0611] Test 2 (25 bpm; 4, 8, 12, 16, 20 cmH2O) showed that washout was significant at ratios of 102:154 (approximately 2 / 3) (BRA:CNDEA) and below, but washout was minimal at ratios of 1:1 (BRA:CNDEA) and above.

[0612] Test 3 (45 bpm; 4, 8, 12, 16, 20 cmH2O) showed that at higher cmH2O levels, washout was present at ratios of 102:154 (approximately 2 / 3) (BRA:CNDEA) and below, with no significant washout observed otherwise.

[0613] More specifically and see Fig.23 , in Test 1, significant washout was achieved at ratios of 102:154 (approximately 2 / 3) (BRA:CNDEA) and below. A ratio of 1:1 (BRA:CNEDA) showed effective washout at 8 cmH2O, but minimal washout at 4 cmH2O. Minimal washout was obtained at 200:154 (approximately 1.5) (BRA:CNDEA).

[0614] See 24, in Test 2, significant flushing was achieved at ratios of 102:154 (about 2 / 3) (BRA:CNDEA) and below (except at 4 cmH2O when BRA:CNDEA was 102:154). For ratios of 1:1 (BRA:CNDEA) and above, flushing was minimal at 4, 8, and 12 cmH2O levels. These ratios were not tested at 16 cmH2O and 20 cmH2O levels.

[0615] At low pressures and high respiratory rates, rebreathing may occur due to insufficient bias flow. This may affect the results especially at low pressures, since at higher pressures the bias flow increases.

[0616] See 25. In Test 3, significant flushing was achieved for higher cmH2O levels at ratios of 102:154 (about 2 / 3) (BRA:CNDEA) and below, but not at lower cmH2O levels. Flushing better than baseline was achieved in the following cases: 8 cmH2O and above for 50:154 (about 1 / 3) (BRA:CNDEA), 12 cmH2O and above for 60:154 (about 2 / 5) (BRA:CNDEA), and 16 cmH2O and above for 75:154 (about 1 / 2) and 102:154 (about 2 / 3) (BRA:CNDEA). In this test, flushing was not achieved at ratios of 1:1 (BRA:CNDEA) or higher.

[0617] Figure 26 to Figure 28 The effects of different modeled nasal delivery element 111, 112 sizes, different bypass restriction cross-sectional areas, different set pressures, and different bias flow restriction openings on 15 rebreathings per minute, 25 rebreathings per minute, and 45 rebreathings per minute using a nasal interface, respectively, are shown.

[0618] The Y-axis (relative axis) on the graph shows rebreathing, where lower amounts are better and show more washout.

[0619] The “Nasal Delivery Element Size” in each graph shows the combined cross-sectional area A3 + A4 of the nasal delivery elements 111 , 112 .

[0620] A is smaller than B. AB provides a possible range for the combined cross-sectional area A3+A4.

[0621] As outlined herein, in some configurations, the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 is greater than 0 mm. 2 (A) and up to about 250mm 2 (B), optionally at about 1 mm 2 To about 250mm 2 between, optionally between about 1.6 mm 2 To about 250mm 2 between, optionally between about 50 mm 2 To about 250mm 2 Between, optionally about 50mm 2 About 200mm 2 between, optionally between about 30 mm 2 About 200mm 2 between, optionally between about 30 mm2 To about 155mm 2 between, optionally between about 50 mm 2 To about 155mm 2 between, and optionally between about 70 mm 2 To about 155mm 2 between.

[0622] The “Bypass Restriction Size” portion of each graph shows the cross-sectional area A2 of the bypass restriction 130 , ie, the cross-sectional area A2 of the portion of the gas flow passage.

[0623] C is smaller than D. CD provides a possible range of cross-sectional areas A2 of the bypass restriction.

[0624] As outlined herein, in some configurations, the cross-sectional area A2 of the bypass restrictor 130 is greater than 0 times to about 1.5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, optionally about 0.25 times to about 1.5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, optionally about 1 times or less the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, optionally about 2 / 3 times or less the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112.

[0625] As outlined herein, in some configurations, the cross-sectional area A2 of the bypass restriction 130 is greater than 0 mm. 2 (C) and up to approximately 375 mm 2 (D), optionally at about 1 mm 2 To about 375mm 2 between, optionally between about 1 mm 2 To about 250mm 2 between, optionally between about 1 mm 2 About 200mm 2 between, optionally between about 1 mm 2 To about 167mm 2 between, optionally between about 50 mm 2 To about 167mm 2 between, optionally between about 50 mm 2 To about 103mm 2 between, optionally between about 35 mm 2 To about 100mm 2 The cross-sectional area A2 of the bypass restrictor 130 can be any other value or range of values ​​related to the combined cross-sectional areas A3+A4 of the nasal delivery elements 111, 112 described herein.

[0626] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel is greater than 0 times to about 1.5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 is about 1 mm 2 To about 250mm 2 between.

[0627] The “Set Pressure” portion of each graph shows the pressure applied to the gas inlet 121 of the nasal interface 100 .

[0628] E is less than F. EF provides a possible range of pressures applied to the gas inlet 121 .

[0629] As outlined herein, in some configurations, a pressure greater than 0 cmH2O (E) and up to about 30 cmH2O (F) is provided to the gas inlet 121 in use.

[0630] In some configurations, a pressure between about 3 cmH2O and about 10 cmH2O is provided to the gas inlet 121 during use.

[0631] In some configurations, a pressure between about 4 cmH2O and about 30 cmH2O is applied to the gas inlet 121 during use.

[0632] The "Bias Flow" portion of each graph shows the effect of the open area for gas to flow out of the nasal interface 100 through the bias flow restriction 140 on rebreathing and washout. "Unfiltered" indicates a more open bypass restriction, where there is no filter or diffuser. "Filtered" shows a more closed bypass restriction, where a filter or diffuser is located on the bypass restriction.

[0633] As outlined above, in some configurations, the bias flow restriction 140 includes an open area for gas to flow through the bias flow restriction 140 and out of the nasal interface 100. In some configurations, the open area is greater than 0 mm 2 To about 40mm 2 , optionally at about 2 mm 2 To about 40mm 2 between, optionally between about 2 mm 2 To about 5mm 2 between, optionally between about 12 mm 2 To about 40mm 2 between, optionally between about 20 mm 2 To about 30mm 2 between.

[0634] In some configurations, the bias flow restriction 140 is configured such that when a pressure greater than 0 cmH2O and up to about 30 cmH2O is provided to the gas inlet 121 in use, a gas flow rate out of the nasal interface through the bias flow restriction is greater than 0 lpm to about 80 lpm.

[0635] In some configurations, the bias flow restriction 140 is configured such that when a pressure between about 3 cmH2O to about 10 cmH2O is provided to the gas inlet 121 in use, the gas flow rate out of the nasal interface through the bias flow restriction is between about 4 lpm to about 15 lpm.

[0636] In some configurations, the bias flow restriction 140 is configured such that when a pressure between about 4 cmH2O and about 30 cmH2O is provided to the gas inlet 121 in use, the gas flow rate out of the nasal interface through the bias flow restriction is between about 15 lpm and about 80 lpm.

[0637] These graphs show that at lower breathing rates (15 BPM and 25 BPM), increasing the combined cross-sectional area of ​​the nasal delivery elements, decreasing the cross-sectional area of ​​the bypass restriction, increasing the pressure applied to the gas inlet, and / or increasing the open area for gas to flow through the deflection restriction 140 reduces the amount of rebreathing and increases the amount of washout.

[0638] The combined cross-sectional area A3 + A4 of the nasal delivery elements 111, 112 may be maximized to increase flushing until it is sized to fit comfortably within the patient's nostrils.

[0639] The cross-sectional area A2 of the bypass restriction 130 may be minimized to increase washout, but increasing the cross-sectional area may improve patient comfort.

[0640] These graphs show that at higher breathing rates (e.g., 45 BPM), changing the cross-sectional area of ​​the nasal delivery element or bypass restriction may have a negative effect due to rebreathing in the gas conduit (hence the left two boxes in the 45 BPM graph are shaded grey as they had no statistically significant effect on the results). Increasing the pressure applied to the gas inlet 121 and / or increasing the open area for gas to flow through the bias flow restriction 140 reduces the amount of rebreathing and increases the amount of washout.

[0641] A headgear may be used to hold the nasal interface 100 on the patient's face. The headgear includes a head strap 200. The head strap 200 may be a single continuous length and adapted to extend along the patient's cheeks, over the ears and around the back of the head in use, may be adjustable, and / or may extend around other portions of the patient's head.

[0642] The headgear has ends of side arms connected to the interface body 110.

[0643] In the shown Fig.18 ), the main end portions 201 and 202 of the strap 200 are adapted to be releasably connected to corresponding structures 101 and 102 on one side of the nasal interface 100 to hold the nasal interface 100 in place during use.

[0644] In one configuration, a clamp component is provided at each end portion 201, 202, which can be received and retained in the corresponding structure 101, 102. The clamp component can be connected to the corresponding main end portion of the strap. In addition, the length of the head strap 200 is adjustable to help customize the strap to the wearer's head. The strap 200 can be formed of a soft and retractable / elastic material (such as an elastic, textile material / fabric that is comfortable for the wearer). Alternatively, the strap 200 can be formed of a substantially more rigid, or less flexible material (such as a hard plastic material).

[0645] The headgear may further include additional straps or connecting straps 200 to extend over other headgear components over the top of the patient's head in use. The top strap or top component may have the following benefits: the straps 200 are pulled upwards and over the patient's ears in use to improve fit and comfort.

[0646] The rear portion of the strap 200 may extend through the receiver 204. The receiver 204 may allow the rear portion of the strap 200 to be adjusted to adjust the size of the headgear to fit the patient's head.

[0647] A tether section having a fixed length may be releasably connected to the main tether to extend its length.

[0648] A plurality of lace segments with varying predetermined lengths may be provided to provide a plurality of alternative adjustment lengths. For example, one or more lace segments may be provided with a length in the range of about 1 cm to about 10 cm, or in the range of about 2 cm to about 6 cm. These lace segments 220 have a length of, for example, about 2 cm, about 4 cm, or about 6 cm. It should be understood that these examples are not intended to be limiting and the length of each lace segment may be of any size, as this depends on the user and / or application.

[0649] In addition, each end of each lace segment can be connectable to a corresponding end of another lace segment and / or a corresponding secondary end portion of the main lace 210, thereby enabling a user to combine one or more lace segments of the same or varying lengths to customize the overall length of the extension as desired.

[0650] These additional strap segments can be formed of soft and stretchable / elastic materials (such as elastic, textile materials / fabrics that are comfortable for the wearer). For example, a tubular knit type head strap or multiple segments of head strap 210 can be used above the user's ears, especially for comfort.

[0651] It should be appreciated that particular comfort can be achieved with a head strap that can provide suitable positioning of the nasal interface 100 in a relatively stable position on the user's face while also providing a relatively loose fit or low tension fit around the user's head.

[0652] Alternatively, the further tether segments may be formed from a substantially rigid material, such as a hard plastics material.

[0653] The interface connectors 240 are disposed at the main end portions 201 and 202 of the main tether 210. These connectors 240 have a tether connection mechanism connecting the main end portions 201, 202, but include a clamp member, such as a push-fit clamp 241, at the end of the connector 240 opposite the tether end. The clamp 241 is configured to releasably couple a corresponding structure 101, 102 on one side of the nasal interface 100. The clamp member 241 can be a bendable portion, such as a plastic portion, which forms a hinged portion relative to the tether. The clamp 241 can be preformed to have a curved shape along its length, such as a curved shape having an angle between flat and 20 degrees. This curvature allows the clamp 241 to adapt to the facial contours of the patient in the area of ​​the clamp 241.

[0654] The nasal interface may include sleeves 270. Each sleeve 270 may be preformed to have a curved shape along its length, such as a curved shape having an angle between flat and 20 degrees. The curvature allows the sleeve to conform to the contour of the patient's face or cheek in the sleeve area in use. Alternatively, the sleeve 270 may take the shape of a curved sleeve when engaged with the main end portion 201, 202 or connector 240 of the head strap 200.

[0655] The sleeve 270 provides a surface area with a relatively high friction surface material for frictionally engaging with the user's face or facial skin. This surface area will be positioned for frictional engagement with the user's facial cheek skin. The surface area is at least localized to the strap or the segment of the strap that will be positioned on the user's cheek. The surface area provided with a relatively high friction surface material can have a material that is smooth and comfortable on the patient's skin. Therefore, the sleeve 270 or at least the surface area 271 is formed of a relatively softer material than the connector 240.

[0656] In one configuration, the surface region 271 or sleeve 270 is formed from a soft thermoplastic elastomer (TPE), but may alternatively be formed from another plastic material, such as silicone, or any other biocompatible material.

[0657] Surface area 271 can be a surface having a wider surface area closer to the patient interface than a surface area further away from the patient interface. In one configuration, sleeve 270 tapers from a relatively wider surface area 273 to a relatively smaller surface area 274 in a direction extending away from the connection point between connector 240 and nasal interface 100. The width of one end 273 of the sleeve can be the same or similar to the width of the tapered distal end of the corresponding wing portions 113, 114 of the facial mount 110. This provides a smooth transition between the nasal interface 100 and the headgear to improve aesthetics and achieve a visually appealing effect.

[0658] The sleeve 270 can be colored to provide identification of the nasal interface 100. As described herein, the nasal interface can be provided in different sizes, such as small, medium, and large. The sleeves 270 having each of these sizes can include different colors to represent the different sizes. Alternatively or in addition, the sleeves can be colored in a particular manner to represent that the nasal interface has an asymmetric rather than a symmetric nasal delivery element.

[0659] The headgear may include a plurality of cheek supports 270 as described or similar at or near either side end of the headgear strap of the interface, connected to the nasal interface for frictional engagement with the user's face to stabilize the mask at the cheeks on the face. Such headgear may also include a single head strap adapted to extend along the patient's cheeks over the ears and around the back of the head in use, with the ends including clamps in any suitable form that couple to the nasal interface on either side (or are permanently attached to the nasal interface).

[0660] The patient interface 1 may include a tube retaining clamp (not shown). The tube retaining clamp may support the breathing conduit 300 or other gas supply tube 16 from a portion of the patient interface 1. By supporting the breathing conduit 300 or other gas supply tube from or near the nasal interface 100, the tube retaining clamp will resist bending moments applied to the breathing conduit 300 or other gas supply tube 16 due to asymmetric flow through the first nasal delivery element 111 and the second nasal delivery element 112, and / or movement of the patient's head, thereby enhancing patient comfort.

[0661] The patient interface 1 may have any one or more of the features and functions described in PCT Publication No. WO 2014 / 182179 or US Pat. No. 10,406,311. The contents of these specifications are incorporated herein by reference in their entirety.

[0662] As an alternative to headgear, the patient interface may include a securing system of the type described in PCT Publication No. WO 2012 / 053910 or U.S. Pat. No. 10,238,828. The contents of those specifications are incorporated herein by reference in their entirety.

[0663] Fig.29 A nasal interface 1100 of an alternative configuration for use in patient interface 1 is schematically shown. Unless described differently below, the features, functions, alternatives, and uses of nasal interface 1100 are the same as described for nasal interface 100. Like reference numerals refer to like parts, but are incremented by 1000. See below Figures 30 to 59 To describe exemplary configurations of nasal interfaces in more detail.

[0664] The nasal interface 1100 includes an interface body 1110 that is configured to substantially form a seal with the nasal airway of the patient. The interface body 1110 is configured to deliver gas to a first nostril of the patient and a second nostril of the patient.

[0665] Nasal interface 1100 includes a gas inlet 1121 for delivering breathing gas into nasal interface 1100. Gas inlet 1121 is in fluid communication with interface body 1110 to deliver breathing gas from gas inlet 1121 through interface body 1110 to a first nostril and a second nostril of a patient in use.

[0666] The nasal interface 1100 is configured to receive an incoming gas F0 from a gas inlet 1121 and provide from the incoming gas F0 a first flow gas flow F1 configured to be provided substantially to a first nostril of a patient in use and a second flow gas flow F2 configured to be provided substantially to a second nostril of a patient in use.

[0667] The nasal interface 1100 is configured to direct incoming gas more to the first flow gas flow F1 than to the second flow gas flow F2 to produce an asymmetric gas flow at the patient's nasal airway throughout the patient's breathing cycle.

[0668] The flow rate generated by the respiratory therapy depends on the flow rate through the nasal interface 1100. The flow rate through the nasal interface 1100 is related to the pressure at each outlet 1111a, 1112a of the nasal interface. If the pressure at each outlet 1111a, 1112a is different, an asymmetric gas flow will be generated.

[0669] The nasal interface may include distinct outlets 1111a, 1112a for delivering breathing gases to respective nostrils of the patient. Alternatively, the nasal interface may include a single outlet defining a first outlet portion and a second outlet portion for delivering breathing gases to respective nostrils of the patient. Therefore, the "first outlet" and "second outlet" referred to herein may alternatively be viewed as a "first outlet portion" and a "second outlet portion", respectively. Some of these possible exemplary configurations are described in more detail below.

[0670] The nasal interface 1100 provides asymmetric flow by directing more flow to the first nostril / first outlet 1111a than to the second nostril / second outlet 1112a. This can be considered flow directionality.

[0671] The nasal interface 1100 can be constructed and configured to provide flow directionality in different ways. For example, the nasal interface 1100 can include a flow guide and / or a flow splitter and / or align the gas inlet with the first outlet 1111a at least partially to provide flow directionality. Some of these possible exemplary configurations are described in more detail below.

[0672] In some configurations, the nasal interface 1100 can include an interface body 1110 and a gas manifold 1120 .

[0673] The interface body 1110 and the gas manifold 1120 can cooperate to define a gas chamber 1115 therein. In some alternative configurations, the gas chamber 1115 can alternatively be substantially or solely defined by the interface body 1110. Instead of having a gas manifold 1120, the nasal interface 1100 can include a frame component to support the interface body, and / or one or more other components (such as a gas inlet 1121, a headgear 200, and / or an interface body 1110). Therefore, the "gas manifold" mentioned herein can be alternatively considered as a "frame".

[0674] The interface body 1110 can be configured to contact and seal the interior of a patient's nostrils, can be configured to contact and seal at the entrance of a patient's nostrils, and / or can be configured to seal around the outer surface of the nose (e.g., the wings and front of the nose).

[0675] In some configurations, the interface body 1110 includes a first outlet 1111a configured to deliver gas substantially to a first nostril of the patient, and includes a second outlet 1111b configured to deliver gas substantially to a second nostril of the patient.

[0676] In some configurations, the interface body 1110 includes a first nasal delivery element 1111 and a second nasal delivery element 1112 that are configured to seal against respective nostrils of the patient.

[0677] In some configurations, the interface body 1110 is a nasal cushion. The nasal cushion can include a single outlet providing a first outlet portion and a second outlet portion. Alternatively, the nasal cushion can include a first nasal delivery element 1111 and a second nasal delivery element 1112, each of which is configured to seal a corresponding nostril of the patient.

[0678] The nasal interface 1110 is constructed and configured to produce an asymmetric gas flow at the nasal airway of the patient throughout the patient's breathing cycle.

[0679] exist Fig.29 In the configuration shown, the gas inlet 1121 is at least partially aligned with the first outlet 1111a and is less aligned or non-aligned with the second outlet 1112a.

[0680] This configuration allows the gas flow to flow substantially directly from the gas inlet 1121 to the first outlet 1111a. The alignment of the gas inlet 1121 with the first outlet 1111a may act as a flow director.

[0681] The flow path for gas to flow from the gas inlet 1121 to the second outlet 1112a is more tortuous than the flow path for gas to flow from the gas inlet 1121 to the first outlet 1111a. Additionally or alternatively, the flow path for gas to flow from the gas inlet 1121 to the second outlet 1112a may be longer than the flow path for gas to flow from the gas inlet 1121 to the first outlet 1111a.

[0682] The gas inlet 1121 is offset from the central axis CA of the nasal interface 1100.

[0683] In some configurations, the gas inlet 1121 is substantially axially aligned with the first outlet 1111a.

[0684] In some configurations, at least half of the transverse cross-sectional area A0 of the gas inlet 1121 is axially aligned with at least half of the transverse cross-sectional area A1 of the first outlet 1111a.

[0685] The gas inlet includes an outer portion 1121a and further includes an inner portion 1121b in fluid communication with the interface body 1110 , the outer portion being used to connect to the breathing conduit 300 or other gas supply tube 16 to provide a gas flow of a gas source to the interface body 1110 .

[0686] The inner portion 1121b of the gas inlet 1121 is at least partially aligned with the first outlet 1111a or the first outlet portion.

[0687] The inner portion 1121b and the outer portion 1121a may be aligned with each other or may be angled relative to each other.

[0688] In some configurations, the first outlet 1111a and the second outlet 1112a comprise substantially the same cross-sectional area. That is, the flow asymmetry is caused by other features in the nasal interface 1100 other than the different outlet sizes.

[0689] In some configurations, the first outlet 1111a and the second outlet 1112a can be symmetrical and identical in structure.

[0690] In some configurations, the nasal interface 1100 is configured to deliver a lower flow rate of gas through the first outlet 1111a than the flow rate of gas delivered through the second outlet 1112a during the inhalation phase of the breathing cycle.

[0691] Due to the less restricted flow path to the first outlet 1111a, the first flow rate gas flow F1 has a lower flow velocity and a higher pressure than the second flow rate gas flow F2 along the more restricted flow path to the second outlet 1112a.

[0692] The nasal interface 1100 may include a restriction that restricts flow to the second outlet 1112a. The restriction may be provided by one or more of a flow guide, a flow splitter, or any other suitable feature. The flow restriction may include a bypass restriction.

[0693] In some configurations, the nasal interface 1100 is configured to deliver a higher pressure flow of gas through the first outlet 1111a than the pressure of the flow of gas delivered through the second outlet 1112a during the inhalation phase of the breathing cycle.

[0694] exist Fig.29 In the configuration shown, the interface body 1110 includes a first nasal delivery element 1111 having a first outlet 1111a and a second nasal delivery element 1112 having a second outlet 1112a, wherein the nasal interface 1100 is configured such that a first flow gas flow F1 is configured to be substantially delivered to the first nasal delivery element 1111, and a second flow gas flow F2 is configured to be substantially delivered to the second nasal delivery element 1112, and wherein the first nasal delivery element and the second nasal delivery element are each configured to seal the corresponding nostrils of the patient.

[0695] In some configurations, the nasal interface includes a flow director configured to direct incoming gas F0 from the gas inlet 1121 more toward the first flow gas flow F1 than toward the second flow gas flow F2.

[0696] Fig.29A first exemplary configuration of a flow director is shown. In this configuration, the flow director includes an inner portion 1121a of a gas inlet 1121. Because the gas inlet is more aligned with the first outlet 1111a than with the second outlet 1112a, the flow director directs the incoming gas F0 more toward the first flow gas flow F1 than toward the second flow gas flow F2.

[0697] In some configurations and as described below, the nasal interface includes a connector or elbow for connecting the breathing conduit 300 to the patient interface.

[0698] The connector or elbow may include or may be a flow director. That is, the connector or elbow may be a component that directs the flow more toward the first outlet 1111a than toward the second outlet 1112a.

[0699] In some configurations, the nasal interface 1100 is configured to direct the incoming gas to the first flow gas flow F1 more than to the second flow gas flow F2 during the inhalation phase of the breathing cycle. Additionally, this can also occur during the exhalation phase of the breathing cycle. The inhalation phase and the exhalation phase can define a breathing cycle.

[0700] In some configurations, the flow path F1 to the first nostril comprises a converging flow path. Additionally or alternatively, the flow path F2 to the second nostril comprises a diverging flow path.

[0701] In some configurations, the flow director includes a nozzle configured to accelerate the flow toward the first outlet 1111a.

[0702] In this configuration, a first portion of the nozzle, near the gas inlet 1121 or near the inlet 1121a into the gas inlet, can have a relatively large cross-sectional dimension, and a second portion of the nozzle, far from the gas inlet 1121 or far from the inlet 1121a into the gas inlet (and near the gas plenum in the interface body 1110 and / or the gas manifold 1120), can have a relatively small cross-sectional dimension. Due to the reduction in cross-sectional area, the nozzle accelerates the gas through the nozzle toward the first outlet 1111a.

[0703] In some configurations, the reduction in the cross-sectional area of ​​the nozzle may be a gradual reduction, such as a taper, in the cross-sectional area between the first and second portions of the nozzle. In another configuration, the reduction in the cross-sectional area of ​​the nozzle may be one or more sudden significant reductions, such as one or more step changes, in the cross-sectional area between the first and second portions of the nozzle.

[0704] The nozzle may include a portion of the gas inlet 1121 , or may be coupled to or in fluid communication with the gas inlet 1121 .

[0705] In some configurations, the nozzle may be provided in combination with an additional flow deflector. Alternatively, the nozzle may act as a flow deflector.

[0706] Nasal interface 1100 is configured to deliver breathing gases from gas inlet 1121 through interface body 1110 to both a first nostril and a second nostril of a patient simultaneously in use.

[0707] The nasal interface 1100 includes a bias flow restrictor 1140 that includes at least one aperture 1140a and optionally a plurality of apertures 1140a for allowing gas to flow from the nasal interface 1100 to the surrounding environment.

[0708] The bias flow restriction 1140 may provide the functionality described above for the bias flow restriction 140 .

[0709] During respiratory therapy, there is typically a positive flow of gas out of the patient interface 1100 through the bias flow restriction 1140 .

[0710] The bias flow restrictor 1140 may include a filter and / or a diffuser to filter or diffuse the gas flowing through the hole(s) 1140a. In some configurations, when a filter is used, the filter may also act as a diffuser.

[0711] In the illustrated configuration, a bias flow restriction 1140 is provided in the gas manifold 1120 .

[0712] In some configurations, the bias flow restriction is positioned closer to the second nasal delivery element 1112 and the second outlet 1112a than to the first nasal delivery element 1111 and the first outlet 1111a. This encourages exhaled gas to pass through the second nasal delivery element 1112 and through the bias flow restriction 1140 to exit the nasal interface.

[0713] The bias flow restriction 1140 may be positioned elsewhere rather than in the gas manifold 1120 .

[0714] When inlet gas is delivered to the nasal interface 1100 and the nasal interface is not mounted on a patient and the outlets are unrestricted, there is an asymmetric gas flow through the first outlet 1111a and the second outlet 1112a. The pressure at the outlets 1111a, 1111b can be checked to determine if there is an asymmetric flow.

[0715] The nasal interface 1100 is configured to provide a greater dynamic pressure at a first nostril of a patient in use, and to provide a lesser dynamic pressure at a second nostril of a patient in use.

[0716] Thus, the nasal interface 1100 can be viewed as including an interface body 1110 configured to substantially form a seal with the nasal airway of a patient, the interface body 1110 being configured for delivering gas to a first nostril of the patient and a second nostril of the patient.

[0717] The nasal interface 1100 includes a gas inlet 1121 for delivering breathing gas therein, wherein the gas inlet 1121 is fluidly connected to the interface body 1110 so as to deliver breathing gas from the gas inlet 1121 through the interface body 1110 to the first and second nostrils of the patient during use.

[0718] The nasal interface 1100 is configured to provide a greater dynamic pressure at a first nostril of a patient during use, and to provide a lesser dynamic pressure at a second nostril of a patient during use. In use, the greater dynamic pressure at the first nostril compared to the lesser dynamic pressure at the second nostril will produce an asymmetric gas flow at the patient's nasal airway. During the inhalation phase of the respiratory cycle, an asymmetric gas flow may be produced at the patient's nasal airway. Additionally, this may also occur during the exhalation phase of the respiratory cycle. The inhalation phase and the exhalation phase may define a respiratory cycle. Thus, throughout the patient's entire respiratory cycle, the nasal interface 1100 may provide an asymmetric flow at the patient's nasal airway.

[0719] The nasal interface 1100 provides asymmetric flow. In use of the nasal interface, when providing flow or pressure therapy (such as CPAP or BiPAP) to a patient, there is a net flow from the patient's first nostril to the patient's second nostril throughout the breath or respiratory cycle.

[0720] In some configurations, the patient may be breathing spontaneously.

[0721] The breathing cycle can be described as having an inhalation phase, an inflection phase where the patient neither inhales nor exhales (which phase can also be called a breath-hold phase), and an exhalation phase. The time period over which the inflection phase occurs can be significantly shorter than the inhalation and / or exhalation phases.

[0722] Flow enters the nasal interface 1100 from the gas inlet 1121 at a certain total pressure delivered by the respiratory assistance device. Flow has a static component of pressure and a dynamic component of pressure, where the dynamic component of pressure refers to the flow component.

[0723] The gas flow from the gas inlet is divided in the nasal interface, thereby generating a first flow gas flow F1 and a second flow gas flow F2, wherein the first flow gas flow (which may have a larger cross-sectional area (referred to herein as A-1)) is directed toward the first nostril, and the second flow gas flow (which may have a smaller cross-sectional area (referred to herein as A-2)) is directed toward the second nostril and the deflection restriction 1140.

[0724] This division of the convection flow can have the effect of biasing it towards the first nostril.

[0725] In some configurations, area A-1 is larger than area A-2, and the pressure drop or flow restriction of gas flowing through area A-2 is greater than the pressure drop or flow restriction of gas flowing through area A-1.

[0726] In some configurations, area A-1 is larger than area A-2, and a majority of the airflow is directed in the direction of the first nostril.

[0727] In some configurations, area A-1 may not be greater than area A-2, but the incoming gas flow may be directed more toward the first nostril than toward the second nostril, and / or the flow path for the second flow gas flow F2 to the second nostril may be more tortuous than the flow path for the first flow gas flow F1 to the first nostril.

[0728] In such a configuration, at least a portion of area A-2 may include a filter or diffuser to filter or diffuse the gas flowing through the second flow gas stream F2 to the second nostril. The filter or diffuser provided in at least a portion of area A-2 may function to produce a biasing effect toward the first nostril.

[0729] The flow is biased toward the first nostril so that the dynamic pressure at the first nostril is greater than the dynamic pressure at the second nostril. The dynamic pressure is the flow component of the total pressure because the flow enters in the direction in which its energy is directed toward the first nostril.

[0730] During the inspiratory phase of breathing, flow from the gas inlet 1121 enters the two nostrils in different proportions, where due to the deflection generated as described above, more flow enters the first nostril than the second nostril. Flow that does not enter the first and / or second nostril can exit the patient interface to the atmosphere through the deflection restriction 1140. In some configurations, flow can exit the second nostril during some or all of the inspiration period instead of entering the second nostril. This flow can be a portion of the flow from the gas inlet 1121, or flow that exits the patient's airway via the second nostril, or a combination thereof.

[0731] During the breath holding phase, the flow from the gas inlet 1121 is divided in the nasal interface, and some of the divided flow enters the first nostril and exits the second nostril via the patient's airway. The flow of the divided flow (or a portion thereof) and / or the flow exiting the patient's airway via the first and / or second nostril passes through the bias flow restriction 1140 and exits to the atmosphere.

[0732] During the exhalation phase of breathing, flow exits both nostrils, or flow may enter the first nostril and exit the second nostril, depending on the configuration of exit through the bias flow restriction 1140. Some flow may flow back through the nasal interface to the gas inlet 1121. If flow exits the first nostril, the incoming gas stagnates and flows with the flow from the first nostril through the gas plenum 1115 to the second nostril and out to the atmosphere through the bias flow restriction 1140. Since the total pressure at the second nostril is less than the total pressure at the first nostril, if there is net flow out of the lungs, the flow exits the second nostril.

[0733] The nasal interface provides a pressure differential between the flow paths of the first flow gas stream F1 and the second flow gas stream F2.

[0734] In at least some configurations, the respiratory gases from the gas inlet 1121 are more likely to enter the first nostril because they are directed toward this nostril and there is resistance to movement toward the second nostril (e.g., in the form of a tortuous and / or reduced flow path). The second flow gas stream F2 may need to backtrack or pass through a restriction to enter the second nostril, but the first flow gas stream F1 does not need to do so, thereby allowing more gas to flow to the first nostril. Similarly, at the second nostril, exhaled gases from the patient are more likely to exit through the second nostril because the exhaled gases are directed toward the bias flow restriction 1140 and there is resistance to return movement toward the first nostril (again through a tortuous and / or restricted flow path). Therefore, there is a dynamic pressure difference in the two directions (entering the first nostril and exiting the second nostril).

[0735] The nasal interface 1100 may have a single gas inlet 1121. Thus, the first outlet 1111a or first outlet portion and the second outlet 1112a or second outlet portion receive their gas flows from the breathing gas from the inlet.

[0736] The nasal interface 1100 can be used with a single gas source, such as a single flow generator.

[0737] See below Figures 30 to 59 Describes the provision of Fig.29 The features, functions, alternatives, and uses of these nasal interfaces are the same as those described for nasal interface 1100 or any other nasal interface described, unless described differently below. For each exemplary configuration, the same reference numerals indicate the same parts, but are increased by 100.

[0738] Figure 30 to Figure 36 An alternative configuration of a nasal interface 1200 is shown.

[0739] The nasal interface 1200 includes an interface body 1210 and a gas manifold 1220 .

[0740] The gas manifold 1220 and the interface body 1210 are coupled together to define a gas plenum 1215 therein. The gas plenum 1215 provides fluid communication between the gas inlet 1221 and the first and second outlets 1211a, 1212a.

[0741] The nasal interface 1200 includes a bias flow restriction 1240 that includes at least one hole for allowing gas to flow from the nasal interface 1100 to the surrounding environment.

[0742] The bias flow restriction 1240 is at least partially aligned with the second outlet 1212a and is less aligned or non-aligned with the first outlet 1211a.

[0743] In the illustrated configuration, the bias flow restriction is substantially axially aligned with the second outlet 1212a.

[0744] The gas inlet 1221 is provided as part of or coupled to a connector or elbow 1222 to connect the breathing conduit 300 to the patient interface 1200 .

[0745] The connector or elbow 1222 enters the gas manifold 1220 from the front of the gas manifold. Alternatively, the connector or elbow 1222 may enter the gas manifold 1220 from a different location, such as the side of the gas manifold 1220 or below the gas manifold.

[0746] The nasal interface 1200 includes connection portions 1213, 1214 for connecting the headgear 200 to the gas manifold 1220 and / or the interface body 1210.

[0747] like Fig.31 As shown, the incoming flow F0 is divided into two flow gas flows F1, F2 along corresponding flow paths, each flow gas flow is directed to a corresponding outlet 1211a, 1212a and a corresponding nostril.

[0748] like Fig.31 As shown, at least one dimension D1 of the first flow gas flow F1 is greater than the corresponding dimension D2 of the second flow gas flow F2. The same can be applied to other nasal interface configurations described herein.

[0749] The at least one dimension D1 comprises a lateral dimension of the first flow rate gas flow F1 , and the corresponding dimension D2 comprises a lateral dimension of the second flow rate gas flow F2 .

[0750] For example, the diameter, cross-sectional area and / or volume of the first flow rate gas flow F1 may be greater than the corresponding diameter, cross-sectional area and / or volume of the second flow rate gas flow F2.

[0751] In some configurations, the ratio of the cross-sectional area (in the direction of dimension D1) of the first flow gas flow F1 to the corresponding cross-sectional area (in the direction of dimension D2) of the second flow gas flow F2 is between about 2:1 and about 5:1, optionally between about 2:1 and about 4:1, optionally between about 2.5:1 and about 3.5:1, and optionally about 3:1.

[0752] In some configurations, the ratio of the cross-sectional area of ​​the first flow gas flow F1 to the corresponding cross-sectional area of ​​the second flow gas flow F2 is approximately 2:1, 2.25:1, 2.5:1, 2.75:1, 3:1, 3.25:1, 3.5:1, 3.75:1, 4:1, 4.25:1, 4.5:1, 4.75:1, 5:1, or any value between any two of these values.

[0753] For example only, the combined cross-sectional area of ​​the first flow rate gas flow F1 and the second flow rate gas flow F2 at or near the gas inlet 1221 may be about 200 mm 2 The cross-sectional area of ​​the first flow rate gas flow F1 can be about 150mm 2 And the cross-sectional area of ​​the second flow gas flow F2 can be about 50mm 2 .

[0754] Although the relationship between at least one dimension D1 of the first gas flow F1 and the corresponding dimension D2 of the second gas flow F2 is about Figure 30 to Figure 36 , but the same relationship can be used for Figure 29 to Figure 59 in any configuration.

[0755] These flow relationships may differ slightly between inspiration and expiration, and / or may differ slightly as the flow generator delivers different pressures / flows.

[0756] In some configurations, the nasal interface 1200 is configured to provide less asymmetry during the inhalation phase of the breathing cycle and more asymmetry during the exhalation phase of the breathing cycle, but is configured to provide asymmetric flow throughout the breathing cycle. That is, the pressure difference of the gas flow flowing through the first outlet 1121a and the second outlet 1221b is greater during the exhalation phase than during the inhalation phase.

[0757] Due to the flow guidance, a larger flow is provided to the first outlet 1211 a , and a smaller flow is provided to the second outlet 1212 a .

[0758] In this way, the first nasal delivery element 1211 and the first outlet 1211a are provided with a higher pressure than the second nasal delivery element 1212 and the second outlet 1212a.

[0759] This creates a pressure differential between the nostrils, providing an asymmetric gas flow in the patient's airway.

[0760] Since the flow rate into one nostril (the first nostril associated with the first outlet 1211a) is greater than the flow rate into the other nostril (the second nostril associated with the second outlet 1212a), this means that the other nostril can be used for exhalation. Fig.32 , which shows the main exhalation flow EF. The nostril associated with the first outlet 1212a can also exhale, but the exhalation flow from this nostril will follow a longer and more tortuous flow path toward the bias flow restriction 1240.

[0761] This flushes the dead space as the flow enters primarily the first nostril and exits the other nostril.

[0762] As described elsewhere herein, these nasal interfaces can be used with pressure controlled therapies (ie, CPAP, BiPAP).Asymmetric flow in a nasal interface is a result of pressure differentials.

[0763] When using a nasal interface, if one nostril is completely blocked, pressure controlled therapy (i.e., CPAP, BiPAP) is provided at the unobstructed nostril without asymmetry. The work of rebreathing may increase. By default, the nasal interface provides this functionality by not directing 100% of the incoming gas flow to one nostril.

[0764] In the configuration shown, the nasal interface 1200 has two flow deflector features. Different configurations of the nasal interface 1200 may have a single flow deflector feature, or both flow deflector features.

[0765] The first deflector feature is to position the gas inlet 1221 closer to the first outlet 1211a than the second outlet 1212b, as described above with respect to Fig.29 Described.

[0766] The second flow director feature includes a flow splitter 1230 configured to unevenly split the gas flow F0 from the gas inlet 1221 into a first flow gas flow F1 configured to be provided substantially to the first nostril of the patient in use and a second flow gas flow F2 configured to be provided substantially to the second nostril of the patient in use. The first flow gas flow F1 is configured to deliver a greater gas flow along the first flow gas flow F1 than the gas flow delivered along the second flow gas flow F2 to produce an asymmetric gas flow at the patient's airway in use.

[0767] In some configurations, the nasal interface 1200 includes: an interface body 1210 configured to substantially form a seal with the nasal airway of the patient, the interface body 1210 being configured to deliver gas to a first nostril of the patient and a second nostril of the patient; and a gas inlet 1221 for delivering respiratory gas to the nasal interface, wherein the gas inlet 1221 is in fluid communication with the interface body 1210 to deliver respiratory gas from the gas inlet 1221 through the interface body 1210 to the first nostril and the second nostril of the patient in use; and a diverter 1230, the flow splitter is configured to unevenly divide the flow from the gas inlet 1221 into a first flow gas flow F1 configured to be substantially provided to the first nostril of the patient in use and a second flow gas flow F2 configured to be substantially provided to the second nostril of the patient in use, wherein the first flow gas flow F1 is configured to deliver a larger gas flow along the first flow gas flow F1 than the gas flow delivered along the second flow gas flow F2, so as to produce an asymmetric gas flow at the nasal airway of the patient throughout the patient's breathing cycle.

[0768] In some configurations, the nasal interface 1200 includes: an interface body 1210, the interface body including a first nasal delivery element 1211 and a second nasal delivery element 1212, the first nasal delivery element including a first outlet 1211a, configured to deliver gas to a first nostril of a patient, the second nasal delivery element including a second outlet 1212a, configured to deliver gas to a second nostril of a patient, wherein the first nasal delivery element 1211 and the second nasal delivery element 1212 are each configured to seal a corresponding nostril of the patient; and a gas inlet 1221 for delivering respiratory gas to the nasal interface 1200, wherein the gas inlet 1221 is in fluid communication with the interface body 1210. , to deliver the respiratory gas from the gas inlet 1221 through the first nasal delivery element 1211 and the second nasal delivery element 1212; and a splitter 1230, for unevenly dividing the flow from the gas inlet 1221 into a first flow gas flow F1 configured to be substantially provided to the first nasal delivery element 1211 and a second flow gas flow F2 configured to be substantially provided to the second nasal delivery element 1212, wherein the first flow gas flow F1 is configured to deliver a larger gas flow along the first flow gas flow F1 than the gas flow delivered along the second flow gas flow F2, so as to produce an asymmetric gas flow at the patient's nasal airway throughout the patient's entire breathing cycle.

[0769] The flow divider 1230 may be provided in the interface body 1210, the gas manifold 1220, and / or the gas inlet 1221. The gas inlet 1221 may be part of the elbow / connector 1222, or may be a separate component.

[0770] The flow divider 1230 may be integrally formed with one or more of these components, or may be formed separately and connected to one or more of these components.

[0771] The shunt 1230 can be a removable insert arranged to connect to one or more of these components. The removable insert can be used to convert an existing nasal interface to an asymmetric nasal interface.

[0772] In the configuration shown, the flow splitter 1230 includes a wall portion extending toward or into the gas inlet 1221, with a first flow gas stream F1 located on one side of the wall portion and a second flow gas stream F2 located on an opposite side of the wall portion.

[0773] In some configurations, the flow splitter 1230 extends into the gas inlet and divides the gas inlet 1221 into a first flow gas flow portion on the first side of the flow splitter 1230 and a second flow gas flow portion on an opposite side of the flow splitter 1230 .

[0774] like Figure 31 to Figure 34 as well as Fig.35 and Fig.36 As shown, for example, the diverter 1230 may include a cylindrical wall that is aligned with the first outlet 1211a and extends in a direction away from the first outlet 1211a (and toward or into the gas inlet 1221). Alternatively, the diverter 1230 may have a different configuration. For example, the diverter 1230 may include a wall (planar or another shape) located between the first nasal delivery element 1211 and the second nasal delivery element 1212.

[0775] The flow splitter 1230 may be a substantially rigid portion to provide a substantially constant relationship between the first flow rate gas flow F1 and the second flow rate gas flow F2.

[0776] In some configurations, the nasal interface can include a flow director configured to direct incoming gas from the gas inlet 1221 more toward the first flow stream F1 than toward the second flow stream F2. In addition to the flow splitter 1230, a flow director can also be provided.

[0777] In some configurations, the flow director can include a nozzle configured to accelerate the flow toward the first outlet 1221 .

[0778] like Fig.32 As shown, the body portion 1210 is provided with a coupling feature 1210 a for engaging with a complementary coupling feature 1220 a on the gas manifold 1220 .

[0779] In the illustrated configuration, coupling feature 1210a comprises an inwardly open recess, while complementary coupling feature 1220a comprises a radially outwardly extending flange received in the recess.Alternatively, coupling feature 1210a may comprise a radially inwardly oriented flange, while complementary coupling feature may comprise an outwardly open recess.

[0780] In the configuration shown, the interface body 1210 is a nose pad.

[0781] The nose pads are made of one or more compliant materials, such as thermoplastic elastomers, latex, vinyl, silicone, or polyurethane.

[0782] Still see Fig.32 In some configurations, the inner portion 1210b of the nose pad configured to contact the user's face is more flexible than the outer portion 1210c of the nose pad configured not to contact the user's face. The outer portion 1210c is more rigid or stiff than the more flexible or pliable inner portion 1210b. The inner portion 1210b includes a first nasal delivery element 1211 and a second nasal delivery element 1212 and / or a first outlet 1211 and a second outlet 1212.

[0783] The more rigid outer portion 1210c supports the general shape of the nose pad. The more flexible inner portion 1210b enhances the seal to the patient's face and also enhances patient comfort.

[0784] In the configuration shown, at least a portion of the more rigid outer portion 1210c has thicker walls than the more flexible inner portion 1210b. Additionally or alternatively, the more rigid outer portion 1210c may include one or more features to enhance its rigidity, such as one or more ribs.

[0785] The nose pad and nose interface may have any one or more features outlined in U.S. Patent No. 10,792,451 or U.S. Patent Application Publication No. 2020 / 0046928. The contents of those specifications are incorporated herein by reference in their entirety.

[0786] Fig.37 Another exemplary configuration of a nasal interface 1300 is shown.

[0787] In this configuration, a flow divider 1330 is provided in the interface body 1310 and the gas manifold 1320 .

[0788] The flow diverter includes a first flow diverter portion 1330 a in the interface body 1310 and a second flow diverter portion 1330 b in the gas manifold 1320 .

[0789] The first diverter portion 1330a comprises a wall portion extending towards or into the gas inlet 1321. The second diverter portion 1330b comprises a wall portion in the gas inlet 1321.

[0790] The second splitter portion 1330b splits the gas inlet 1321 into a first flow gas flow portion on one side of the second splitter portion 1330b and a second flow gas flow portion on the opposite side of the second splitter portion 1330b.

[0791] The first diverter portion 1330a and the second diverter portion 1330b are configured to be in close proximity to each other and may contact or at least partially overlap each other.

[0792] The first flow gas flow F1 is located on one side of the first and second diverter portions 1330a and 1330b, while the second flow gas flow F2 is located on the opposite side of the first and second diverter portions 1330a and 1330b.

[0793] The second splitter portion 1330b splits the gas inlet 1321 into a first flow gas flow portion on one side of the second splitter portion 1330b and a second flow gas flow portion on the opposite side of the second splitter portion 1330b.

[0794] Fig.38 Another exemplary configuration of a nasal interface 1400 is shown.

[0795] This configuration uses gas inlet alignment and a tortuous flow path to produce asymmetric gas flow at the patient's nasal airways throughout the patient's breathing cycle.

[0796] In this configuration, the gas inlet 1421 is substantially aligned with the first outlet 1411a or first outlet portion. This provides a substantially direct flow path for the first flow rate gas flow F1 to the first outlet 1411a.

[0797] The flow divider 1430 provides a restricted tortuous flow path (by Fig.38 1415 in the figure).

[0798] The tortuous flow path increases the flow velocity and thus reduces the pressure at the second outlet 1412a.

[0799] Fig.39 and Fig.40 Another exemplary configuration of a nasal interface 1500 is shown.

[0800] This configuration uses gas inlet alignment and a tortuous flow path to produce an asymmetric gas flow at the patient's nasal airway. During the inhalation phase of the respiratory cycle, an asymmetric gas flow can be produced at the patient's nasal airway. Additionally, this can also occur during the expiratory phase of the respiratory cycle. The inhalation phase and the expiratory phase can define a respiratory cycle. Thus, the nasal interface 1100 can provide an asymmetric flow at the patient's nasal airway throughout the patient's respiratory cycle.

[0801] In this configuration, the gas inlet 1521 is substantially aligned with the first outlet 1511a or first outlet portion. This provides a substantially direct flow path for the first flow rate gas stream F1 to the first outlet 1511a.

[0802] A restriction 1530 is provided in a gas plenum 1515 formed between the gas manifold 1520 and the interface body 1510 .

[0803] The restriction provides a restricted tortuous flow path for the second flow rate gas flow F2 to the second outlet 1512a.

[0804] The tortuous flow path increases the flow velocity and thus reduces the pressure at the second outlet 1512a.

[0805] Fig.41 Another exemplary configuration of a nasal interface 1600 is shown.

[0806] In this configuration, the gas inlet 1621 enters the gas manifold 1620 from the side rather than the front.

[0807] The gas inlet 1621 includes an outer portion 1621a for connecting to the breathing conduit 300 to provide a gas flow from a gas source to the interface body, and further includes an inner portion 1621b in fluid communication with the interface body 1610 .

[0808] The inner portion 1621b of the gas inlet 1621 is at least partially aligned with the first outlet 1611 or the first outlet portion.

[0809] The gas inlet 1621 includes a change in direction between an outer portion 1621a and an inner portion 1621b.

[0810] The change in direction can be any suitable angle. In some configurations, the change in direction can be between about 30 degrees to about 100 degrees, optionally between about 45 degrees to about 100 degrees, optionally between about 60 degrees to about 100 degrees, and optionally about 90 degrees.

[0811] Likewise, the nasal interface 1600 provides a restricted tortuous flow path for the second flow rate gas flow F2.

[0812] Fig.42 Another exemplary configuration of a nasal interface 1700 is shown.

[0813] The configuration of the flow divider 1730 is similar to Fig.37 The shunt in .

[0814] The difference in this configuration is that the gas inlet 1721 is not aligned with the first outlet 1711a, but enters the nasal interface more centrally, that is, the axis along the center of the gas inlet is relatively centrally located between the axes extending through the outlets 1711a, 1712a.

[0815] In some configurations, the gas inlet 1721 is located in the center of the nasal interface.

[0816] exist Fig.42 In the configuration, the diverter 1730 can provide flow directionality alone.

[0817] Fig.43 Another exemplary configuration of a nasal interface 1800 is shown.

[0818] In this configuration, the gas inlet 1821 is offset from, but angled toward, the first outlet 1811a or first outlet portion. This directs the gas flow more toward the first outlet 1811a or first outlet portion than toward the second outlet 1812a or second outlet portion.

[0819] Due to the angling of the gas inlet 1821 , an axis AA extending through the gas inlet 1821 is at a non-parallel angle relative to a central axis CA passing through the nasal interface 1800 .

[0820] The angle will depend on the amount of offset between the gas inlet 1821 into the gas manifold 1820 and the first outlet 1811a.

[0821] In some configurations, the angle is greater than 0 degrees and at most about 30 degrees, optionally at most about 20 degrees, optionally at most about 15 degrees, and optionally at most about 10 degrees.

[0822] The angled gas inlet 1821 configuration can be used in nasal interfaces with a centrally located gas inlet, or in nasal interfaces with a gas inlet offset from the first outlet 1811a or a portion of the first outlet.

[0823] This angled gas inlet 1821 configuration can be the only feature of the nasal interface 1800 that directs flow toward the first outlet 1811a or first outlet portion. Alternatively, the nasal interface 1800 can have one or more other flow directing features described herein, such as a flow splitter.

[0824] Fig.44 Another exemplary configuration of a nasal interface 1800 is shown.

[0825] In this configuration, the interface body 1910 is a nose pad.

[0826] In order to properly seal with the patient's face and provide a comfortable experience for the patient, the nose pad is flexible and designed to be compressed / deformed against the patient's face. The nose pad can be compressed / deformed in multiple directions when positioned on and in contact with the face.

[0827] The nose pad includes a diverter 1930. In this configuration, the diverter 1930 is configured to move and / or deform when the nose pad is compressed.

[0828] Compression / deformation of the nasal pad may cause the ratio or proportion of flow directed or split between the patient to vary, depending on the degree of compression / deflection in the nasal pad.

[0829] The shape of the split flow can be changed by moving and / or deforming the splitter 1930, thereby changing the ratio between the first flow rate gas flow F1 and the second flow rate gas flow F2.

[0830] The flow diverter 1930 may be flexible and may be configured to deform when the nose pad is compressed / deformed. Alternatively, the flow diverter 1930 may be more rigid.

[0831] In the configuration shown, the flow diverter 1930 is configured to be operative when the nose pad is compressed / deformed (eg, Fig.44 (b)) moves more toward or into the gas inlet 1921. Compared with the idle position of the nose pad (as shown in FIG. Fig.44 This may allow the flow to be directed more along the first flow rate gas flow F1 than along the second flow rate gas flow F2 ), compared to FIG.

[0832] Fig.45 and Fig.46 An alternative exemplary configuration of a nose pad 2010 is shown that may be used as an interface body in any of the nasal interfaces disclosed herein.

[0833] In this configuration, the nasal cushion 2010 includes a single outlet for delivering gas to the first and second nostrils of the patient. The single outlet includes a first outlet portion 2011a' and a second outlet portion 2012a'. The nasal cushion 2010 and thus the nasal interface are configured such that the first flow gas stream F1 is configured to be substantially delivered to the first outlet portion 2011a', and the second flow gas stream F2 is configured to be substantially delivered to the second outlet portion 2012a'.

[0834] In the illustrated configuration, the nose pad 2010 includes a diverter 2030 having a first wall portion 2030a and a second wall portion 2030b. The first wall portion 2030a and the second wall portion 2030b are hingedly connected to each other. The relative angle of the first wall portion 2030a and the second wall portion 2030b is configured to change when the nose pad 2010 is deformed / compressed.

[0835] The deformation of the flow splitter 2030 can be configured to maintain a substantially constant ratio between the first flow gas flow F1 and the second flow gas flow F2 when the nose pad 2010 is deformed or compressed. Alternatively, the deformation of the flow splitter 2030 can be configured to change the ratio between the first flow gas flow F1 and the second flow gas flow F2 when the nose pad 2010 is deformed or compressed.

[0836] Fig.47 and Fig.48 An exemplary deformation of the diverter 2030 is shown when the nose pad 2010 is compressed.

[0837] As shown in these figures, in some configurations, the peripheral wall 2030c opposite the first wall portion 2030a and the second wall portion 2030b can also deform when the nose pad 2010 is deformed / compressed.

[0838] Fig.49 An alternative exemplary configuration of a nose pad 2110 is shown that may be used as an interface body in any of the nasal interfaces disclosed herein.

[0839] Also, in this configuration, the flow splitter 2130 includes a first wall portion 2130a and a second wall portion 2130b.

[0840] The first wall portion 2130a and the second wall portion 2130b overlap each other in the relaxed state of the nose pad 2110. The degree of overlap of the wall portions 2130a, 2130b increases when the nose pad 2110 is compressed.

[0841] Figure 47 to Figure 49 The configuration may be used in a nasal cushion or interface body where the first and second nasal delivery elements have corresponding outlets rather than a single outlet having first and second outlet portions.

[0842] As outlined above, any nasal interface disclosed herein can use a nasal cushion having a single outlet to deliver gas to a first nostril and a second nostril of a patient. The single outlet includes a first outlet portion and a second outlet portion. The single outlet can have no significant septum splitting between the nostrils, which can be more comfortable for the patient by having no septum contacting portion.

[0843] In this configuration, flow diversion / diversion will occur before the outlet section. Fig.50Three exemplary configurations of such nose pads 2210 , 2310 , 2410 are shown, wherein flow directing features or flow splitters 2330 , 2430 are provided by the gas manifold portions 2220 , 2320 , 2420 .

[0844] Alternatively, the flow-guiding feature may be provided by a nose pad, for example Figures 45 to 48 The configuration described.

[0845] In an alternative configuration, the nose pad may have a septum contacting portion. Fig.51 An exemplary configuration of such a nose pad 2510 is shown.

[0846] The septum contacting portion 2513 forms a first outlet 2511a and a second outlet 2512a for delivering gas to the respective nostrils of the patient.

[0847] The septum contacting portion 2513 may provide greater flow separation between the first flow gas flow F1 and the second flow gas flow F2 and reduce mixing of these flow flows before they are delivered through the first outlet 2511a and the second outlet 2512a.

[0848] Fig.52 An alternative exemplary nose pad 2610 is shown.

[0849] The configuration includes a short first nasal delivery element 2611 and a second nasal delivery element 2612. For example, these nasal delivery elements are shorter than Fig.31 Those shown in the embodiments are shorter.

[0850] By having a shorter nasal delivery element, the first opening 2611a and the second opening 2612a can be larger than with a longer nasal delivery element.

[0851] The nasal delivery elements 2611a, 2612a form positioning features to help position the nasal delivery elements 2611a, 2612a in the nostrils and may assist in holding the nostrils open.

[0852] Figure 53 to Figure 56 Another exemplary configuration of a nasal interface 2700 is shown.

[0853] In this configuration, the flow director includes a gas inlet 2721 that is angled toward the first outlet 2711a. This directs the gas flow more toward the first outlet 2711a than toward the second outlet 2712a.

[0854] The gas inlet 2721 includes a nozzle configured to accelerate the flow towards the first outlet 2711a or first outlet portion.

[0855] In the configuration shown, a first portion of the nozzle, near the inlet 2721a of the gas inlet, has a relatively large cross-sectional dimension D3, and a second portion of the nozzle, away from the inlet 2721a of the gas inlet (and near the gas plenum 2715 in the interface body 2710 and / or gas manifold 2720), has a relatively small transverse cross-sectional dimension. The nozzle will accelerate the gas through the nozzle toward the first outlet 2711a or outlet portion.

[0856] In some configurations, the outlet at the second portion of the nozzle has a diameter of about 15 mm. 2 To about 150mm 2 The cross-sectional area between.

[0857] The nozzle may comprise a portion of the gas inlet 2721, or may be coupled to or in fluid communication with the gas inlet.

[0858] In the illustrated configuration, the gas inlet 2721 is part of a connector or elbow 2722. Thus, the connector or elbow 2722 is configured to direct the gas flow more toward the first outlet 2711a than toward the second outlet 2712a.

[0859] The gas inlet 2721 and the connector or elbow 2722 may be integrally formed or may be coupled to each other.

[0860] In the configuration shown, the nozzle acts as a flow director. In an alternative configuration, the nozzle can be provided in combination with an additional flow director. For example, the nozzle can be shorter than shown, and additional flow directors in the interface body 2710 and / or gas manifold 2720 can direct more of the flow from the nozzle to the first outlet 2711a or first outlet portion than to the second outlet 2712a or second outlet portion.

[0861] The second flow gas flow F2 has a more restricted tortuous flow path than the first flow gas flow F1.

[0862] The bias flow restriction may be provided at any suitable location on the nasal interface 2700.

[0863] In one configuration, the bias flow restrictor 2740 ′ is provided in the interface body 2710 / nose cushion. In another alternative, the bias flow restrictor 2740 ″ may be provided in the gas manifold 2720 .

[0864] Figure 57 to Figure 59 Another exemplary configuration of a patient interface 2800 is shown.

[0865] In this configuration, a flow divider 2830 is provided in the interface body 2810 and the gas manifold 2820 .

[0866] The flow diverter includes a first flow diverter portion 2830a in the interface body 2810 and a second flow diverter portion 2830b in the gas manifold 2820 .

[0867] The first diverter portion 2830a includes a wall portion extending toward or into the gas inlet 2821. The second diverter portion 2830b includes a wall portion of the gas inlet 2821.

[0868] The first diverter portion 2830a is received in the second diverter portion 2830b of the gas inlet 2821 .

[0869] The first splitter portion 2830a splits the gas flow F0 from the gas inlet into a first flow rate gas flow portion on one side of the first splitter portion 2830a and a second flow rate gas flow portion on the opposite side of the first splitter portion 2830a.

[0870] The first diverter portion 2830a and the second diverter portion 2830b are configured to be in close proximity to each other and partially overlap.

[0871] A gap is provided between the outside of the first splitter portion 2830a and the inside of the second splitter portion. The gap provides a flow path for the second flow gas stream F2 to travel on a restricted tortuous path to be delivered to the second outlet 2812a or second outlet portion.

[0872] In the illustrated configuration, the bias flow restrictor 2840 includes an array of holes 2840a on the front of the gas manifold 2820.

[0873] In some configurations, the strap 210' of the headgear 200' can be integrally formed with the gas manifold 2820. For example, the strap 210' can be overmolded with the gas manifold 2820.

[0874] As outlined above for the nasal interface 100, in some configurations of the nasal interfaces 1100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800, the nasal interface is configured to achieve a patient pressure at the first outlet or first outlet portion and at the second outlet or second outlet portion of between about 2 cmH2O to about 30 cmH2O in use, optionally between about 2 cmH2O to about 25 cmH2O in use, optionally between about 2 cmH2O to about 30 ... Optionally between about 2 cmH2O to about 20 cmH2O during use, optionally between about 2 cmH2O to about 15 cmH2O during use, optionally between about 2 cmH2O to about 14 cmH2O during use, optionally between about 2 cmH2O to about 13 cmH2O during use, optionally between about 2 cmH2O to about 12 cmH2O during use, optionally between about 2 cmH2O to about 11 cmH2O during use, optionally between about 2 cmH2O to about 10 cmH2O during use.

[0875] As outlined above for the nasal interface 100, in some configurations of the nasal interfaces 1100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800, the pressure differential between the first outlet 1111a or first outlet portion and the second outlet 1112a or second outlet portion is configured to provide an asymmetric flow of at least about 1 liter per minute (lpm), optionally between about 1 lpm to about 5 lpm, through the upper airway of the patient.

[0876] The asymmetric flow provided by the nasal interface 100, 1100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 facilitates the removal of CO2 from the patient's anatomical dead space.

[0877] The nasal interfaces 100, 1100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 disclosed herein are configured for delivering breathing gas from a gas inlet through the interface body to both a first nostril and a second nostril of a patient during use.

[0878] In some configurations, during the exhalation phase, as the patient exhales, flow can exit one or both of the first and / or second nostrils. Then, as the patient then inhales, some of the gas exhaled from the first and / or second nostril can enter the first and / or second nostril.

[0879] A patient interface 1 having a nasal interface 100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 configured according to the present invention can be used in the following methods: delivering gas to the airway of a patient in need, improving ventilation of a patient in need, reducing the volume of anatomical dead space within the airway volume of a patient in need, and / or treating a respiratory condition in a patient in need, as described above.

[0880] A patient interface 1 comprising a nasal interface 100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 of the type disclosed herein may be used in a respiratory therapy system to deliver gases to a patient.

[0881] Because the patient interface 1 may include any nasal interface (or nasal interface component, such as interface bodies 2110, 2210, 2310, 2410, 2610) of the type disclosed herein, references to the nasal interface 100 herein and below may alternatively be considered references to any other nasal interface 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800.

[0882] In some configurations, the respiratory therapy system 1000 includes a respiratory therapy device 1100 and a patient interface 1 having a nasal interface 100 .

[0883] Fig. 22 An exemplary respiratory therapy device 1100 is shown.

[0884] The respiratory therapy device 1100 includes a main housing 1101 that houses a flow generator 1011 (e.g., a blower) in the form of a motor / impeller arrangement, an optional humidifier 1012, a controller 1013, and a user interface 1014 (including, for example, a display and (multiple) input devices, such as (multiple) buttons, a touch screen, etc.).

[0885] The controller 1013 may be configured or programmed to control the operation of the device. For example, the controller may control components of the device, including, but not limited to: operating the flow generator 1011 to generate a gas flow (flows of each gas) for delivery to the patient; operating the humidifier 1012 (if present) to humidify and / or heat the generated gas flow; controlling the flow of oxygen into the flow generator blower; receiving user input from the user interface 1014 to reconfigure and / or user-defined operations of the device 1000; and outputting information to the user (e.g., on a display).

[0886] The user may be a patient, a healthcare professional, or any other person interested in using the device. As used herein, "gas flow" may refer to any gas flow that may be used in a respiratory assistance or breathing apparatus, such as an ambient air flow, a flow containing substantially 100% oxygen, a flow containing some combination of ambient air and oxygen, and the like.

[0887] The controller 1013 may be implemented as a pure hardware controller, a software solution running on controller hardware, or software operable on other non-dedicated controller hardware of the device. Alternatively, the controller may be implemented as any number of combinations of the aforementioned implementation examples.

[0888] In various forms, controller 1013 may include a processor and memory.

[0889] It will be appreciated that various detection, operation, sensing, comparison, enabling or disabling, triggering, pulsing, monitoring, receiving, determining, and such similar steps may be autonomously, automatically, or dynamically implemented by the controller 1013 or as part of a method of operation of the device. For example, these steps or individual ones of these steps may be performed by a controller, whether the controller is hardware, hardware and software, or an internal or external system implementation, independent of any other input or control signal. As a further example, these steps may be automatically performed in response to one or more precursor steps or prerequisites.

[0890] In the case where a method or control step or structural element is described as being associated with another method or control step or structural element, this will be generally understood to indicate the relationship between the two features. In particular, with respect to a method or control step, this may indicate a relationship of precedence, dependency, subsequent or overall connection with a method or control step. With respect to structural elements, this may indicate a functional association between structural elements, such as a working relationship for providing a specific result or a connection or synergy. Alternatively, with respect to structural elements, this may indicate a direct physical relationship between two structural elements. Where appropriate, the further meaning of the term "associated" associated with such elements or steps should be understood from the surrounding context.

[0891] One end of the breathing tube 16 is connected to a gas flow outlet 1021 in the housing 1100 of the respiratory therapy device 1100. The other end of the breathing tube 16 is connected to a nasal interface 100 having a gas manifold 120 and nasal prongs 111, 112. The connection to the nasal interface 100 can be a direct connection to the nasal interface, or can be connected via a breathing conduit 300 and optionally a filter 500.

[0892] The gas flow generated by the respiratory therapy device 1100 can be humidified and delivered to the patient via the breathing tube 16 through the nasal interface 100. The breathing tube 16 can have a heater to heat the gas flow flowing to the patient. For example, the breathing tube 16 can have a heating wire 16a to heat the gas flow flowing to the patient. The heating wire 16a can be controlled by the controller 1013. The breathing tube 16a, the breathing conduit 300 (when provided) and / or the nasal interface 100 can be considered as a part of the respiratory therapy device 1100, or alternatively at its periphery. The respiratory therapy device 1100, the breathing tube 16, the breathing conduit 300 (when provided), and the patient interface 1 including the nasal interface 100 can form a respiratory therapy system 1000.

[0893] Controller 1013 can control flow generator 1011 to generate gas flow with desired flow rate. Controller 1013 can also control supplementary oxygen inlet to allow delivery of supplementary oxygen, humidifier 1012 (if present) can humidify gas flow and / or heat gas flow to appropriate level, etc. Gas flow is guided to the patient through breathing tube 16, breathing conduit 300 and nasal interface 100. Controller 1013 can also control the heating element in humidifier 1012 and / or the heating element 16a in patient conduit 16 to heat gas to desired temperature to achieve patient's desired therapy level and / or comfort level. Controller 1013 can be programmed with suitable target temperature of gas flow or can determine suitable target temperature of gas flow. In some configurations, administration of gas mixture composition and / or therapeutic drug including supplementary oxygen can be provided through supplementary oxygen inlet. The gas mixture composition may include oxygen, heliox, nitrogen, nitric oxide, carbon dioxide, argon, helium, methane, sulfur hexafluoride, and combinations thereof, and / or the supplemental gas may include aerosolized medication.

[0894] Operation sensors 1003a, 1003b, 1003c (such as flow sensors, temperature sensors, humidity sensors and / or pressure sensors) can be placed in various locations in the respiratory therapy device 1100. Additional sensors (e.g., sensors 1020, 1025) can be placed in various locations on the breathing tube 16, the breathing conduit 300 and / or the nasal interface 100 (e.g., a temperature sensor 1029 can be present at or near one end of the inspiratory tube). The output from the sensor can be received by the controller 1013 to assist the controller in operating the respiratory therapy device 1100 in a manner that provides appropriate therapy. In some configurations, providing appropriate therapy includes meeting the patient's peak inspiratory demand. The device 1100 can have a transmitter and / or a receiver 1015 so that the controller 1013 can receive signals 1008 from the sensor and / or control various components of the respiratory therapy device 1100, including but not limited to a flow generator 1011, a humidifier 1012 and a heating wire 16 or accessories or peripherals associated with the respiratory therapy device 1100. Additionally or alternatively, the transmitter and / or receiver 1015 may deliver data to a remote server or enable remote control of the device 1100 .

[0895] In some configurations, the respiratory therapy system 1000 includes: a gas source 1011 of breathing gas configured to provide pressure-controlled breathing gas; a breathing tube 16 for receiving the pressure-controlled breathing gas; and a nasal interface.

[0896] In some configurations of respiratory therapy system 1000, nasal interface 100 includes any one or more of the features outlined herein in fluid communication with breathing tube 16 to deliver pressure-controlled breathing gases to the patient.

[0897] In some configurations of the respiratory therapy system 1000, the nasal interface 100 has a gas inlet 121 that is fluidly connected to the breathing tube 16 to deliver respiratory gas to the patient, the nasal interface includes a first nasal delivery element 111 and a second nasal delivery element 112, wherein the first nasal delivery element 111 and the second nasal delivery element 112 are each configured to seal a corresponding nostril of the patient, wherein the nasal interface 100 is configured to generate a pressure difference between the first nasal delivery element 111 and the second nasal delivery element 112 when gas is delivered from the gas inlet 121 to both the first nasal delivery element 111 and the second nasal delivery element 112, so that the pressure at the first nasal delivery element 111 is higher than the pressure at the second nasal delivery element 112.

[0898] In some configurations of a respiratory therapy system, a nasal interface 1100 used in a respiratory therapy system includes an interface body 1110 configured to substantially form a seal with the nasal airway of a patient. The interface body 1110 is configured to deliver gas to a first nostril of the patient and a second nostril of the patient. The nasal interface 1100 includes a gas inlet 1121 for delivering respiratory gas to the nasal interface 1100. The gas inlet 1121 is fluidly connected to the interface body 1110 to deliver respiratory gas from the gas inlet 1121 to the first nostril and the second nostril of the patient through the interface body 1110 in use. The nasal interface 1100 is configured to receive an incoming gas F0 from the gas inlet 1121 and provide a first flow gas flow F1 configured to be substantially provided to the first nostril of the patient in use and a second flow gas flow F2 configured to be substantially provided to the second nostril of the patient in use from the incoming gas F0. The nasal interface 1100 is configured to direct incoming gas more to the first flow gas flow F1 than to the second flow gas flow F2 to produce an asymmetric gas flow at the patient's nasal airway throughout the patient's breathing cycle.

[0899] In some configurations of the respiratory therapy system, a nasal interface 1100 used in the respiratory therapy system includes an interface body 1110 configured to substantially form a seal with the nasal airway of a patient, the interface body 1110 being configured to deliver gas to a first nostril of the patient and a second nostril of the patient. The nasal interface 1100 includes a gas inlet 1121 for delivering respiratory gas into the nasal interface, wherein the gas inlet 1121 is in fluid communication with the interface body 1110 to deliver respiratory gas from the gas inlet 1121 through the interface body 1110 to the first nostril and the second nostril of the patient in use. The nasal interface 1100 is configured to provide a greater dynamic pressure at the first nostril of the patient in use, and to provide a lesser dynamic pressure at the second nostril of the patient in use, to produce an asymmetric gas flow at the nasal airway of the patient.

[0900] During the inhalation phase of the breathing cycle, an asymmetric gas flow can be generated at the patient's nasal airway. Additionally, this can also occur during the exhalation phase of the breathing cycle. The inhalation phase and the exhalation phase can define a breathing cycle. Thus, the nasal interface 1100 can provide an asymmetric flow at the patient's nasal airway throughout the patient's breathing cycle.

[0901] In some configurations, the interface body 1100 includes a first outlet 1111a or a first outlet portion configured to deliver gas to a first nostril of the patient, and includes a second outlet 1112a or a second outlet portion configured to deliver gas to a second nostril of the patient, and wherein the nasal interface 1100 is configured to create a pressure differential between the first outlet 1111a or a first outlet portion and the second outlet 1112a or a second outlet portion when gas is delivered from the gas inlet 1221 to both the first outlet 1111a or a first outlet portion and the second outlet 1112a or a second outlet portion, such that the pressure at the first outlet 1111a or a first outlet portion is higher than the pressure at the second outlet 1112a or a second outlet portion.

[0902] In some configurations, the respiratory therapy system 1000 includes a breathing conduit 300 for receiving pressure-controlled breathing gas from the breathing tube 16 , wherein the breathing conduit 300 is in fluid communication with the breathing tube 16 and the gas inlet 121 of the nasal interface 100 , 1100 .

[0903] In some configurations, the respiratory therapy system 1000 includes a respiratory gas filter 500 .

[0904] In some configurations, the breathing gas filter 500 is located between the heated breathing tube 16 and the breathing conduit 300. In additional or alternative configurations, for example, Fig.17 As shown in (b), the breathing gas filter 500' can be located between the gas manifold 120 and the bias flow restriction 140. For example, Fig.18 In the configuration of , the breathing gas filter 500 ′ may be located between the breathing gas conduit 160 and the bias flow restriction 140 .

[0905] In some configurations, the respiratory therapy system further includes a humidifier 1012 configured to humidify the pressure-controlled breathing gas before it is delivered to the nasal interface 100 , 1100 .

[0906] In some configurations, the breathing tube 16 is a heated breathing tube and is configured to receive pressure-controlled breathing gases from the humidifier 1012 .

[0907] In some configurations, the temperature of the gas flow exiting the first and second nasal delivery elements 111, 112, or exiting the nasal interface 1100 for delivery to the patient's nasal airways can be between about 31° C. and about 41° C., optionally greater than about 31° C. and up to about 41° C., optionally between about 36° C. and about 39° C., optionally about 37° C. For example, the temperature can be about 31° C., about 32° C., about 33° C., about 34° C., about 35° C., about 36° C., about 37° C., about 38° C., about 39° C., about 40° C., or about 41° C., or can be any value between any two of these values.

[0908] The respiratory therapy system may have any one or more of the features and functions described in PCT Publication No. WO 2021 / 048744, and U.S. Provisional Application Nos. 62 / 897,899 and 63 / 025,151, and / or PCT Publication No. WO 2021 / 049954, and U.S. Provisional Application No. 62 / 898,464. The contents of these specifications are incorporated herein by reference in their entirety.

[0909] The patient interface 1 and nasal interface 100 used in the respiratory therapy system 1000 can have any one or more of the features and / or functionality described herein for the nasal interface 100, or any other nasal interface disclosed herein.

[0910] In some configurations, the nasal interface 100, patient interface 1, and / or respiratory therapy system 1000 can be used in methods of providing respiratory support to a patient.

[0911] In some configurations, the method for providing respiratory support to a patient includes:

[0912] A respiratory therapy system 1000 is provided, the respiratory therapy system comprising:

[0913] a gas source 1011 of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0914] a breathing tube 16 for receiving the pressure-controlled breathing gas; and

[0915] A nasal interface 100 having a gas inlet 121 in fluid communication with a breathing tube 16 for delivering breathing gas to a patient, the nasal interface 100 comprising a first nasal delivery element 111 and a second nasal delivery element 112;

[0916] sealing a corresponding nostril of the patient with each of the first nasal delivery element 111 and the second nasal delivery element 112;

[0917] Respiratory therapy device 1000 is operated to provide a flow of gas to nasal interface 100 ; and to deliver an asymmetric flow of gas from respiratory therapy device 1000 through first nasal delivery element 111 and second nasal delivery element 112 at the nares of the patient.

[0918] In some configurations, the nasal delivery elements 111, 112 are fluidly connected to the gas inlet 121 via the gas flow channel 125, wherein the first nasal delivery element 111 is close to the gas inlet 121 and the second nasal delivery element 112 is away from the gas inlet 121, and wherein the nasal interface includes a bypass restriction 130, which provides a cross-sectional area A2 of a portion of the gas flow channel 125, wherein each of the first nasal delivery element 111 and the second nasal delivery element 112 includes an inner cross-sectional area A3, A4, wherein these inner cross-sectional areas together provide a combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and wherein the cross-sectional area A2 of this portion of the gas flow channel 125 is greater than 0 times to about 1.5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112.

[0919] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the method includes: providing a pressure of 4 cmH2O to the gas inlet 121 so that a deviation flow of 20 lpm passes through the deviation flow restriction 140.

[0920] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 1 times, optionally at most about 2 / 3 times, the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the method includes: providing a pressure of 8 cmH2O to the gas inlet 121 so that a deviation flow of 32 lpm passes through the deviation flow restriction 140.

[0921] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the method includes: providing a pressure of 4cmH2O to the gas inlet 121 so that a deviation flow of 20lpm passes through the deviation flow restriction 140; or wherein the method includes: providing a pressure of 8cmH2O to the gas inlet 121 so that a deviation flow of 32lpm passes through the deviation flow restriction 140; or wherein the method includes: providing a pressure of 12cmH2O to the gas inlet 121 so that a deviation flow of 41lpm passes through the deviation flow restriction 140; or wherein the method includes: providing a pressure of 16cmH2O to the gas inlet 121 so that a deviation flow of 48lpm passes through the deviation flow restriction 140; or wherein the method includes: providing a pressure of 20cmH2O to the gas inlet 121 so that a deviation flow of 53lpm passes through the deviation flow restriction 140.

[0922] In some configurations, the cross-sectional area A2 of this portion of the gas flow channel 125 is at most approximately 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the method includes: providing a pressure of 8 cmH2O to the gas inlet 121 so that a deviation flow of 32 lpm or more passes through the deviation flow restriction 140.

[0923] In some configurations, the cross-sectional area A2 of the portion of the gas flow channel 125 is at most about 1 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112, and wherein the method includes: providing a pressure of 8 cmH2O to the gas inlet 121 so that a deviation amount of 32 lpm or more passes through the deviation flow restriction 140, or wherein the cross-sectional area A2 of the portion of the gas flow channel 125 is at most about 2 / 5 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111, 112 , and wherein the method includes: providing a pressure of 12 cmH2O to the gas inlet 121 so that a deviation flow of 41 lpm or more passes through the deviation flow restriction 140, or wherein the cross-sectional area A2 of this portion of the gas flow channel 125 is at most about 2 / 3 times the combined cross-sectional area A3+A4 of the nasal delivery elements 111 and 112, and wherein the method includes: providing a pressure of 16 cmH2O to the gas inlet 121 so that a deviation flow of 48 lpm or more passes through the deviation flow restriction 140.

[0924] In some configurations, the temperature of the gas flow exiting the first nasal delivery element 111 and the second nasal delivery element 112 is between about 31°C and about 41°C, optionally above 31°C and at most about 41°C, optionally between about 36°C and about 39°C, and optionally about 37°C.

[0925] In some configurations, the method for providing respiratory support to a patient includes:

[0926] A respiratory therapy system 1000 is provided, the respiratory therapy system comprising:

[0927] a gas source 1011 of breathing gas, the gas source being configured to provide pressure-controlled breathing gas;

[0928] a breathing tube 16 for receiving the pressure-controlled breathing gas; and

[0929] a nasal interface 1100 in fluid communication with the breathing tube 16 for delivering breathing gases to the patient;

[0930] Sealing the patient's nasal airway with the 1100 nasal interface;

[0931] Respiratory therapy device 1000 is operated to provide a flow of gas to nasal interface 1100; and to receive incoming gas at a gas inlet 1221 of the nasal interface and generate an asymmetric gas flow at the nasal airway of the patient.

[0932] During the inhalation phase of the breathing cycle, an asymmetric gas flow can be generated at the patient's nasal airway. Additionally, this can also occur during the exhalation phase of the breathing cycle. The inhalation phase and the exhalation phase can define a breathing cycle. Thus, the nasal interface 1100 can provide an asymmetric flow at the patient's nasal airway throughout the patient's breathing cycle.

[0933] The nasal interface can be any one of the nasal interfaces 1100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 disclosed herein.

[0934] In some configurations, the system is configured to deliver gas through the nasal interface 100, 1100 at a relative humidity of up to 100%.

[0935] In some configurations, the system is configured to deliver gas through the nasal interface 100, 1100 at an absolute humidity of between about 14 mg / l to about 34 mg / l.

[0936] In some configurations, the temperature of the flow of gas exiting the first and second nasal delivery elements 111, 112 and / or exiting the nasal interface 1100 for delivery to the patient's nares is between about 16°C and about 32°C.

[0937] In some configurations, the system is configured to deliver gas through the nasal interface 100, 1100 at an absolute humidity greater than about 33 mg / l. In some configurations, the system is configured to deliver gas through the nasal interface 100 at an absolute humidity of at most about 44 mg / l.

[0938] In some configurations, the system is configured to deliver gas through the nasal interface 100, 1100 at an absolute humidity of at most about 54 mg / l.

[0939] In some configurations, the temperature of the gas flow exiting the first and second nasal delivery elements 111, 112 and / or exiting the nasal interface 1100 for delivery to the patient's nares is at most about 41°C.

[0940] The patient interface 1 and nasal interfaces 100 , 1100 used in the method may have any one or more of the features and / or functions described herein for nasal interfaces 100 , 1100 , 1200 , 1300 , 1400 , 1500 , 1600 , 1700 , 1800 , 1900 , 2000 , 2500 , 2700 , 2800 .

[0941] The respiratory therapy system 1000 used in the method may have any one or more of the features and / or functionalities described herein for the respiratory therapy system 1000 .

[0942] When performing CPAP therapy using the patient interface 1 and nasal interfaces 100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 of the present disclosure, CPAP therapy can provide one or more of the following compared to high-flow therapy: quieter therapy, increased therapy pressure, easy detection of respiratory rate, nasal interface removal and / or leakage (due to pressure control).

[0943] The nasal interfaces 100, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 2700, 2800 disclosed herein can be used in a healthcare facility, a home environment, an emergency vehicle, or any other suitable environment. Therefore, references herein to "patients" should be interpreted as any suitable subject using a nasal interface.

[0944] Although the present disclosure has been described with respect to specific embodiments, other embodiments that are apparent to those of ordinary skill in the art are also within the scope of the present disclosure. Therefore, various changes and modifications may be made without departing from the spirit and scope of the present disclosure. For example, various components may be repositioned as needed. Features from any one of the described embodiments may be combined with one another, and / or the device may include one, more than one, or all of the features of the above-described embodiments. In addition, not all of these features, aspects, and advantages are essential to practicing the present disclosure. Therefore, the scope of the present disclosure is intended to be limited only by the appended claims.

Claims

1. A nasal interface, It is characterized in that The nasal interface includes: a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a respective nostril of a patient; and a gas manifold comprising a gas inlet for delivering breathing gas to the gas manifold, wherein the first nasal delivery element and the second nasal delivery element are in fluid communication with the gas inlet via the gas manifold, wherein the first nasal delivery element is proximal to the gas inlet and the second nasal delivery element is distal to the gas inlet, wherein the nasal interface is configured to create a pressure difference between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, such that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

2. The nasal interface according to claim 1, It is characterized in that The pressure differential is such that when there is gas flow from the gas inlet to the first nasal delivery element and the second nasal delivery element, the gas flow from the gas inlet to the first nasal delivery element is greater than the gas flow from the gas inlet to the second nasal delivery element.

3. The nasal interface according to claim 1, It is characterized in that The gas inlet is in fluid communication with the breathing conduit.

4. The nasal interface according to claim 3, It is characterized in that The inner diameter of the breathing tube is between 12 mm and 23 mm.

5. The nasal interface according to claim 4, It is characterized in that The inner diameter of the breathing tube is between 12 mm and 16 mm.

6. The nasal interface of claim 1, It is characterized in that When gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, the gas flow pressure at the second nasal delivery element is at most 1 cmH2O less than the gas flow pressure at the first nasal delivery element.

7. The nasal interface of claim 6, It is characterized in that The nasal interface is configured such that a gas flow pressure differential between the first nasal delivery element and the second nasal delivery element is higher during an inhalation phase than during an exhalation phase.

8. The nasal interface of claim 7, It is characterized in that The nasal interface is configured such that during both the inhalation phase and the exhalation phase, the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

9. The nasal interface of claim 1, It is characterized in that The nasal interface is configured to achieve a patient pressure at the first and second nasal delivery elements of between 2 cmH2O and 30 cmH2O in use.

10. The nasal interface of claim 9, It is characterized in that The nasal interface is configured to achieve a patient pressure at the first and second nasal delivery elements of between 2 cmH2O and 20 cmH2O in use.

11. The nasal interface of claim 1, It is characterized in that The pressure differential between the first nasal delivery element and the second nasal delivery element is configured to provide an asymmetric flow of at least 1 lpm through the upper airway of the patient.

12. The nasal interface of claim 11, It is characterized in that The asymmetric flow promotes removal of CO from the patient's anatomical dead space 2 .

13. A respiratory therapy system, It is characterized in that Respiratory therapy systems include: a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas; a breathing tube for receiving said pressure-controlled breathing gas; and A nasal interface according to any one of claims 1 to 12, wherein the nasal interface is connected to the breathing tube fluid to deliver the breathing gas to the patient.

14. A respiratory therapy system, It is characterized in that Respiratory therapy systems include: a gas source of breathing gas, the gas source being configured to provide pressure-controlled breathing gas; a breathing tube for receiving said pressure-controlled breathing gas; and A nasal interface having a gas inlet, the gas inlet being fluidically connected to the breathing tube to deliver the breathing gas to the patient, the nasal interface comprising a first nasal delivery element and a second nasal delivery element, wherein the first nasal delivery element and the second nasal delivery element are each configured to seal a corresponding nostril of the patient, wherein the nasal interface is configured to generate a pressure difference between the first nasal delivery element and the second nasal delivery element when gas is delivered from the gas inlet to both the first nasal delivery element and the second nasal delivery element, so that the pressure at the first nasal delivery element is higher than the pressure at the second nasal delivery element.

15. The respiratory therapy system of claim 13, It is characterized in that The respiratory therapy system includes a breathing conduit for receiving pressure-controlled breathing gas from the breathing tube, wherein the breathing conduit is in fluid communication with the breathing tube and a gas inlet of the nasal interface.

16. The respiratory therapy system of claim 13, It is characterized in that The respiratory therapy system further includes a respiratory gas filter.

17. The respiratory therapy system of claim 16, It is characterized in that The breathing gas filter is located between the breathing tube and the breathing conduit.

18. The respiratory therapy system of claim 17, It is characterized in that The breathing gas filter is located between the gas manifold and the bias flow restriction.

19. The respiratory therapy system of claim 13, It is characterized in that The respiratory therapy system further includes a humidifier configured to humidify the pressure-controlled breathing gas before it is delivered to the nasal interface.

20. The respiratory therapy system of claim 19, It is characterized in that The breathing tube is a heated breathing tube and is configured to receive pressure-controlled breathing gases from the humidifier.

21. The respiratory therapy system of claim 13, It is characterized in that The temperature of the gas flow leaving the first and second nasal delivery elements is between 31°C and 41°C.

22. The respiratory therapy system of claim 21, It is characterized in that The temperature of the gas flow leaving the first and second nasal delivery elements is between 31°C and 37°C.